10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

___________________________

 FORM 10-Q

_________________________

 (Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2019

OR

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the transition period from________ to________ .

Commission File Number: 1-644

COLGATE-PALMOLIVE COMPANY

(Exact name of registrant as specified in its charter)

Delaware	13-1815595
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

 

	300 Park Avenue
	New York,	New York	10022
(Address of principal executive offices)			(Zip Code)

(212) 310-2000

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $1.00 par value	CL	New York Stock Exchange
0.500% Notes due 2026	CL 26	New York Stock Exchange
1.375% Notes due 2034	CL 34	New York Stock Exchange

NO CHANGES

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒  No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    

Yes ☒  No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). 

Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:

Class	Shares Outstanding	Date
Common stock, $1.00 par value	858,006,448	June 30, 2019

PART I.    FINANCIAL INFORMATION

COLGATE-PALMOLIVE COMPANY

Condensed Consolidated Statements of Income

(Dollars in Millions Except Per Share Amounts)

(Unaudited)

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2019		2018		2019		2018
Net sales	$	3,866	$	3,886	$	7,750	$	7,888
Cost of sales	1,558		1,585		3,155		3,179
Gross profit	2,308		2,301		4,595		4,709
Selling, general and administrative expenses	1,369		1,300		2,734		2,692
Other (income) expense, net	51		55		94		88
Operating profit	888		946		1,767		1,929
Non-service related postretirement costs	27		23		52		47
Interest (income) expense, net	38		35		78		70
Income before income taxes	823		888		1,637		1,812
Provision for income taxes	205		213		419		459
Net income including noncontrolling interests	618		675		1,218		1,353
Less: Net income attributable to noncontrolling interests	32		38		72		82
Net income attributable to Colgate-Palmolive Company	$	586	$	637	$	1,146	$	1,271
Earnings per common share, basic	$	0.68	$	0.73	$	1.33	$	1.46
Earnings per common share, diluted	$	0.68	$	0.73	$	1.33	$	1.45

See Notes to Condensed Consolidated Financial Statements.

3

COLGATE-PALMOLIVE COMPANY

Condensed Consolidated Statements of Comprehensive Income

(Dollars in Millions)

(Unaudited)

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2019			2018			2019			2018
Net income including noncontrolling interests	$	618		$	675		$	1,218		$	1,353
Other comprehensive income (loss), net of tax:
Cumulative translation adjustments	25			(305		)	51			(198		)
Retirement plans and other retiree benefit adjustments	13			14			25			28
Gains (losses) on cash flow hedges	(2		)	11			(7		)	10
Total Other comprehensive income (loss), net of tax	36			(280		)	69			(160		)
Total Comprehensive income including noncontrolling interests	654			395			1,287			1,193
Less: Net income attributable to noncontrolling interests	32			38			72			82
Less: Cumulative translation adjustments attributable to noncontrolling interests	(5		)	(16		)	—			(14		)
Total Comprehensive income attributable to noncontrolling interests	27			22			72			68
Total Comprehensive income attributable to Colgate-Palmolive Company	$	627		$	373		$	1,215		$	1,125

See Notes to Condensed Consolidated Financial Statements.

4

COLGATE-PALMOLIVE COMPANY

Condensed Consolidated Balance Sheets

(Dollars in Millions)

(Unaudited)

	June 30, 2019			December 31, 2018
Assets
Current Assets
Cash and cash equivalents	$	863		$	726
Receivables (net of allowances of $87 and $82, respectively)	1,590			1,400
Inventories	1,322			1,250
Other current assets	480			417
Total current assets	4,255			3,793
Property, plant and equipment:
Cost	8,476			8,336
Less: Accumulated depreciation	(4,683		)	(4,455		)
	3,793			3,881
Goodwill	2,536			2,530
Other intangible assets, net	1,609			1,637
Deferred income taxes	167			152
Other assets	791			168
Total assets	$	13,151		$	12,161
Liabilities and Shareholders’ Equity
Current Liabilities
Notes and loans payable	$	4		$	12
Current portion of long-term debt	1			—
Accounts payable	1,209			1,222
Accrued income taxes	293			411
Other accruals	2,275			1,696
Total current liabilities	3,782			3,341
Long-term debt	6,640			6,354
Deferred income taxes	303			235
Other liabilities	2,436			2,034
Total liabilities	13,161			11,964
Shareholders’ Equity
Common stock	1,466			1,466
Additional paid-in capital	2,338			2,204
Retained earnings	21,653			21,615
Accumulated other comprehensive income (loss)	(4,119		)	(4,188		)
Unearned compensation	(3		)	(3		)
Treasury stock, at cost	(21,682		)	(21,196		)
Total Colgate-Palmolive Company shareholders’ equity	(347		)	(102		)
Noncontrolling interests	337			299
Total equity	(10		)	197
Total liabilities and equity	$	13,151		$	12,161

See Notes to Condensed Consolidated Financial Statements.

5

COLGATE-PALMOLIVE COMPANY

Condensed Consolidated Statements of Cash Flows

(Dollars in Millions)

(Unaudited)

	Six Months Ended
	June 30,
	2019			2018
Operating Activities
Net income including noncontrolling interests	$	1,218		$	1,353
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations:
Depreciation and amortization	256			258
Restructuring and termination benefits, net of cash	21			(14		)
Stock-based compensation expense	34			47
Deferred income taxes	53			2
Voluntary benefit plan contributions	(102		)	—
Cash effects of changes in:
Receivables	(178		)	(200		)
Inventories	(63		)	(30		)
Accounts payable and other accruals	(14		)	(96		)
Other non-current assets and liabilities	24			(23		)
Net cash provided by operations	1,249			1,297
Investing Activities
Capital expenditures	(146		)	(216		)
Purchases of marketable securities and investments	(80		)	(96		)
Proceeds from sale of marketable securities and investments	14			19
Payment for acquisitions, net of cash acquired	—			(727		)
Other	—			7
Net cash used in investing activities	(212		)	(1,013		)
Financing Activities
Principal payments on debt	(3,105		)	(3,953		)
Proceeds from issuance of debt	3,368			4,266
Dividends paid	(770		)	(756		)
Purchases of treasury shares	(664		)	(696		)
Proceeds from exercise of stock options	267			160
Net cash used in financing activities	(904		)	(979		)
Effect of exchange rate changes on Cash and cash equivalents	4			(7		)
Net increase (decrease) in Cash and cash equivalents	137			(702		)
Cash and cash equivalents at beginning of the period	726			1,535
Cash and cash equivalents at end of the period	$	863		$	833
Supplemental Cash Flow Information
Income taxes paid	$	463		$	468

See Notes to Condensed Consolidated Financial Statements.

6

COLGATE-PALMOLIVE COMPANY

Condensed Consolidated Statements of Changes in Shareholders’ Equity

(Dollars in Millions)

(Unaudited)

Three Months Ended June 30, 2019
	Colgate-Palmolive Company Shareholders’ Equity																	Noncontrolling Interests
	Common Stock		Additional Paid-in Capital			Unearned Compensation			Treasury Stock			Retained Earnings			Accumulated Other Comprehensive Income (Loss)(1)
Balance, March 31, 2019	$	1,466	$	2,241		$	(3	)	$	(21,532	)	$	21,436		$	(4,160	)	$	342
Net income												586						32
Other comprehensive income (loss), net of tax															41			(5		)
Dividends ($0.43)/per share)												(369		)				(32		)
Stock-based compensation expense			17
Shares issued for stock options			81						113
Shares issued for restricted stock units			(1		)				1
Treasury stock acquired									(265		)
Other									1
Balance, June 30, 2019	$	1,466	$	2,338		$	(3	)	$	(21,682	)	$	21,653		$	(4,119	)	$	337

Three Months Ended June 30, 2018
	Colgate-Palmolive Company Shareholders’ Equity																	Noncontrolling Interests
	Common Stock		Additional Paid-in Capital			Unearned Compensation			Treasury Stock			Retained Earnings			Accumulated Other Comprehensive Income (Loss)(1)
Balance, March 31, 2018	$	1,466	$	2,047		$	(2	)	$	(20,441	)	$	20,581		$	(3,900	)	$	350
Net income												637						38
Other comprehensive income (loss), net of tax															(264		)	(16		)
Dividends ($0.42)/per share)												(367		)				(38		)
Stock-based compensation expense			19
Shares issued for stock options			16						27
Shares issued for restricted stock units			(2		)				2
Treasury stock acquired									(345		)
Other			1			2
Balance, June 30, 2018	$	1,466	$	2,081		$	—		$	(20,757	)	$	20,851		$	(4,164	)	$	334

⁽¹⁾ Accumulated other comprehensive income (loss) includes cumulative translation losses of $3,104 at June 30, 2019 ($3,121 at June 30, 2018) and $3,134 at March 31, 2019 ($2,832 at March 31, 2018), respectively, and unrecognized retirement plan and other retiree benefits costs of $1,013 at June 30, 2019 ($1,048 at June 30, 2018) and $1,026 at March 31, 2019 ($1,062 at March 31, 2018), respectively.

See Notes to Condensed Consolidated Financial Statements.

7

COLGATE-PALMOLIVE COMPANY

Condensed Consolidated Statements of Changes in Shareholders’ Equity

(Dollars in Millions)

(Unaudited)

Six Months Ended June 30, 2019
	Colgate-Palmolive Company Shareholders’ Equity																	Noncontrolling Interests
	Common Stock		Additional Paid-in Capital			Unearned Compensation			Treasury Stock			Retained Earnings			Accumulated Other Comprehensive Income (Loss)(1)
Balance, December 31, 2018	$	1,466	$	2,204		$	(3	)	$	(21,196	)	$	21,615		$	(4,188	)	$	299
Net income												1,146						72
Other comprehensive income (loss), net of tax															69			—
Dividends ($1.28)/per share)*												(1,103		)				(34		)
Stock-based compensation expense			34
Shares issued for stock options			114						162
Shares issued for restricted stock units			(14		)				14
Treasury stock acquired									(664		)
Other									2			(5		)
Balance, June 30, 2019	$	1,466	$	2,338		$	(3	)	$	(21,682	)	$	21,653		$	(4,119	)	$	337

Six Months Ended June 30, 2018
	Colgate-Palmolive Company Shareholders’ Equity																		Noncontrolling Interests
	Common Stock		Additional Paid-in Capital			Unearned Compensation			Treasury Stock			Retained Earnings			Accumulated Other Comprehensive Income (Loss)(1)
Balance, December 31, 2017	$	1,466	$	1,984		$	(5	)	$	(20,181	)	$	20,531		$	(3,855	)		$	303
Net income												1,271							82
Other comprehensive income (loss), net of tax															(146		)		(14		)
Dividends ($1.24)/per share)*												(1,085		)					(37		)
Stock-based compensation expense			47
Shares issued for stock options			64						104
Shares issued for restricted stock units			(14		)				14
Treasury stock acquired									(696		)
Other			—			5			2			134			(163		)	(2)
Balance, June 30, 2018	$	1,466	$	2,081		$	—		$	(20,757	)	$	20,851		$	(4,164	)		$	334

⁽¹⁾ Accumulated other comprehensive income (loss) includes cumulative translation losses of $3,104 at June 30, 2019 ($3,121 at June 30, 2018) and $3,155 at December 31, 2018 ($2,927 at December 31, 2017), respectively, and unrecognized retirement plan and other retiree benefits costs of $1,013 at June 30, 2019 ($1,048 at June 30, 2018) and $1,038 at December 31, 2018 ($923 at December 31, 2017), respectively.

⁽²⁾ As a result of the early adoption of ASU 2018-02, the Company reclassified the stranded tax effects in Accumulated other comprehensive income (loss) resulting from the Tax Cuts and Jobs Act (the “TCJA” or “U.S. tax reform”) to Retained earnings. See Note 2, Summary of Accounting Policies in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018 for additional information.

* Two dividends were declared in each of the first quarters of 2019 and 2018.

See Notes to Condensed Consolidated Financial Statements.

8

COLGATE-PALMOLIVE COMPANY

 Notes to Condensed Consolidated Financial Statements

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

1. Basis of Presentation

The Condensed Consolidated Financial Statements reflect all normal recurring adjustments which, in management’s opinion, are necessary for a fair statement of the results for interim periods. Results of operations for interim periods may not be representative of results to be expected for a full year. Colgate-Palmolive Company (together with its subsidiaries, the “Company” or “Colgate”) reclassifies certain prior year amounts, as applicable, to conform to the current year presentation.

For a complete set of financial statement notes, including the Company’s significant accounting policies, refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2018, filed with the Securities and Exchange Commission (the “SEC”).

2. Use of Estimates

Provisions for certain expenses, including income taxes, advertising and consumer promotion, are based on full year assumptions and are included in the accompanying Condensed Consolidated Financial Statements in proportion with estimated annual tax rates, the passage of time or estimated annual sales, as applicable.

3. Recent Accounting Pronouncements

In April 2019, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2019-04, Codification Improvements to Financial Instruments-Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Financial Instruments (Topic 825). This extensive ASU clarifies three topics related to financial instruments accounting. This new guidance is effective for the Company beginning on January 1, 2020, with early adoption permitted. This new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements.

In October 2018, the FASB issued ASU No. 2018-16, “Derivatives and Hedging (Topic 815): Inclusion of the Secured Overnight Financing Rate (“SOFR”) Overnight Index Swap (“OIS”) Rate as Benchmark Interest Rate for Hedge Accounting Purposes.” The new guidance permits the use of the OIS rate based on the SOFR as a U.S. benchmark interest rate for hedge accounting purposes under Topic 815. The new guidance was effective for the Company on a prospective basis beginning on January 1, 2019, concurrently with the adoption of ASU 2017-12, and did not have an impact on the Company’s Consolidated Financial Statements.

In August 2018, the FASB issued ASU No. 2018-15, “Intangibles-Goodwill and Other-Internal-Use Software (Topic 350): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract.” This new guidance aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. This new guidance is effective for the Company on a prospective or retrospective basis beginning on January 1, 2020, with early adoption permitted. The Company elected to adopt this guidance early, beginning on January 1, 2019 on a prospective basis. The new guidance did not have a material impact on the Company’s Consolidated Financial Statements.

In August 2018, the FASB issued ASU No. 2018-14, “Compensation-Retirement Benefits-Defined Benefit Plans-General (Topic 715): Disclosure Framework-Changes to the Disclosure Requirements for Defined Benefit Plans.” This new guidance removes certain disclosures that are not considered cost beneficial, clarifies certain required disclosures and requires certain additional disclosures. This new guidance is effective for the Company on a retrospective basis beginning on January 1, 2020, with early adoption permitted. While the Company is currently assessing the impact of the new guidance, it is not expected to have a material impact on the Company’s Consolidated Financial Statements.

9

COLGATE-PALMOLIVE COMPANY

 Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

In August 2018, the FASB issued ASU No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement.” This new guidance removes certain disclosure requirements related to the fair value hierarchy, modifies existing disclosure requirements related to measurement uncertainty and adds new disclosure requirements. The new disclosure requirements include disclosing the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. This new guidance is effective for the Company beginning on January 1, 2020, with early adoption permitted. Certain disclosure requirements in the new guidance will need to be applied on a retrospective basis and others on a prospective basis. While the Company is currently assessing the impact of the new guidance, it is not expected to have a material impact on the Company’s Consolidated Financial Statements.

In August 2017, the FASB issued ASU No. 2017-12, “Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities,” amending the eligibility criteria for hedged items and transactions to expand an entity’s ability to hedge nonfinancial and financial risk components. The new guidance eliminates the requirement to separately measure and present hedge ineffectiveness and aligns the presentation of hedge gains and losses with the underlying hedge item. The new guidance also simplifies the hedge documentation and hedge effectiveness assessment requirements. The amended presentation and disclosure requirements must be adopted on a prospective basis, while any amendments to cash flow and net investment hedge relationships that exist on the date of adoption must be applied on a “modified retrospective” basis, meaning a cumulative effect adjustment to the opening balance of retained earnings as of the beginning of the year of adoption. The new guidance was effective for the Company on January 1, 2019 and did not have a material impact on the Company’s Consolidated Financial Statements.

In January 2017, the FASB issued ASU No. 2017-04, “Intangibles–Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,” eliminating the requirement to calculate implied fair value, essentially eliminating step two from the goodwill impairment test. The new standard requires goodwill impairment to be based upon the results of step one of the impairment test, which is defined as the excess of the carrying value of a reporting unit over its fair value. The impairment charge will be limited to the amount of goodwill allocated to that reporting unit. The standard is effective for the Company on a prospective basis beginning on January 1, 2020, with early adoption permitted. This new guidance is not expected to have an impact on the Company’s Consolidated Financial Statements.

In February 2016, the FASB issued its final standard on lease accounting, ASU No. 2016-02, “Leases (Topic 842),” which superseded Topic 840, “Leases,” which was further modified in ASU No. 2018-10, “Codification Improvements to Topic 842, Leases,” ASU No. 2018-11, “Leases (Topic 842) Targeted Improvements” and ASU No. 2019-01 “Leases (Topic 842) Codification Improvements” to clarify the implementation guidance. The new accounting standard was effective for the Company beginning on January 1, 2019 and required the recognition on the balance sheet of right-of-use assets and lease liabilities for all long-term leases, including operating leases, on the balance sheet. The Company elected the optional transition method and adopted the new guidance on January 1, 2019, on a modified retrospective basis with no restatement of prior period amounts. As allowed under the new accounting standard, the Company elected to apply practical expedients to carry forward the original lease determinations, lease classifications and accounting of initial direct costs for all asset classes at the time of adoption. The Company also elected not to separate lease components from non-lease components and to exclude short-term leases from its Consolidated Balance Sheet. The Company’s adoption of the new standard resulted in the recognition of right-of-use assets of $458 and liabilities of $574, with no material cumulative effect adjustment to equity as of the date of adoption. In connection with the adoption of this guidance, as required, the Company reclassified certain restructuring reserves incurred in connection with the Global Growth and Efficiency Program (see Note 4, Restructuring and Related Implementation Charges for additional information) and deferred rent liabilities as reductions to lease assets. Adoption of the new standard did not have a material impact on the Company’s Consolidated Statements of Income or Cash Flows. See Note 13, Leases for additional information.

10

COLGATE-PALMOLIVE COMPANY

 Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

4. Restructuring and Related Implementation Charges

In the fourth quarter of 2012, the Company commenced a restructuring program (the “Global Growth and Efficiency Program”). The program was expanded in 2014 and expanded and extended in each of 2015 and 2017. The program runs through December 31, 2019.

Initiatives under the Global Growth and Efficiency Program continue to fit within the program’s three focus areas of expanding commercial hubs, extending shared business services and streamlining global functions and optimizing the global supply chain and facilities.

Cumulative pretax charges resulting from the Global Growth and Efficiency Program, once all phases are approved and implemented, are estimated to be in the range of $1,820 to $1,870 ($1,350 to $1,380 aftertax). The Company anticipates that pretax charges for 2019 will approximate $100 to $150 ($70 to $100 aftertax). It is expected that substantially all charges resulting from the Global Growth and Efficiency Program will be incurred by December 31, 2019.

The pretax charges resulting from the Global Growth and Efficiency Program are estimated to be comprised of the following categories: Employee-Related Costs, including severance, pension and other termination benefits (40%); asset-related costs, primarily Incremental Depreciation and Asset Impairments (10%); and Other charges, which include contract termination costs, consisting primarily of related implementation charges resulting directly from exit activities (30%) and the implementation of new strategies (20%). Over the course of the Global Growth and Efficiency Program, it is estimated that approximately 75% of the charges will result in cash expenditures.

The Company expects that the cumulative pretax charges, once all projects are approved and implemented, will relate to initiatives undertaken in North America (15%), Europe (20%), Latin America (5%), Asia Pacific (5%), Africa/Eurasia (5%), Hill’s Pet Nutrition (10%) and Corporate (40%), which includes substantially all of the costs related to the implementation of new strategies, noted above, on a global basis. The Company expects that, when it has been fully implemented, the Global Growth and Efficiency Program will have contributed a net reduction of approximately 4,000 to 4,400 positions from the Company’s global employee workforce.

For the three and six months ended June 30, 2019 and 2018, restructuring and related implementation charges are reflected in the Condensed Consolidated Statements of Income as follows:

	Three Months Ended					Six Months Ended
	June 30,					June 30,
	2019			2018		2019		2018
Cost of sales	$	(3	)	$	5	$	8	$	11
Selling, general and administrative expenses	10			10		14		15
Other (income) expense, net	33			43		46		56
Non-service related postretirement costs	2			3		3		7
Total Global Growth and Efficiency Program charges, pretax	$	42		$	61	$	71	$	89
Total Global Growth and Efficiency Program charges, aftertax	$	31		$	51	$	53	$	71

Restructuring and related implementation charges in the preceding table are recorded in the Corporate segment as these initiatives are predominantly centrally directed and controlled and are not included in internal measures of segment operating performance.

11

COLGATE-PALMOLIVE COMPANY

 Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

Total charges incurred for the Global Growth and Efficiency Program relate to initiatives undertaken by the following reportable operating segments:

	Three Months Ended				Six Months Ended				Program-to-date
	June 30,				June 30,				Accumulated Charges
	2019		2018		2019		2018
North America	—	%	8	%	3	%	17	%	18	%
Latin America	8	%	11	%	21	%	11	%	5	%
Europe	(3	)%	2	%	1	%	2	%	19	%
Asia Pacific	7	%	(6	)%	7	%	1	%	4	%
Africa/Eurasia	(2	)%	7	%	(1	)%	6	%	5	%
Hill’s Pet Nutrition	1	%	22	%	6	%	21	%	8	%
Corporate	89	%	56	%	63	%	42	%	41	%
Total	100	%	100	%	100	%	100	%	100	%

Since the inception of the Global Growth and Efficiency Program in the fourth quarter of 2012, the Company has incurred cumulative pretax charges of $1,793 ($1,331 aftertax) in connection with the implementation of various projects as follows:

	Cumulative Charges
	as of June 30, 2019
Employee-Related Costs	$	695
Incremental Depreciation	102
Asset Impairments	58
Other	938
Total	$	1,793

The majority of costs incurred since inception relate to the following projects: the implementation of the Company’s overall hubbing strategy; the consolidation of facilities; the extension of shared business services and streamlining of global functions; the closing of the Morristown, New Jersey personal care facility; the simplification and streamlining of the Company’s research and development capabilities and oral care supply chain, both in Europe; redesigning the European commercial organization; restructuring how the Company will provide future retirement benefits to substantially all of the U.S.-based employees participating in the Company’s defined benefit retirement plan by shifting them to the Company’s defined contribution plan; and the implementation of a Corporate efficiencies program.

The following tables summarize the activity for the restructuring and related implementation charges discussed above and the related accruals:

	Three Months Ended June 30, 2019
	Employee-Related Costs			Incremental Depreciation			Asset Impairments		Other			Total
Balance at March 31, 2019	$	52		$	—		$	—	$	94		$	146
Charges	4			5			—		33			42
Cash payments	(12		)	—			—		(14		)	(26		)
Charges against assets	(2		)	(5		)	—		(27		)	(34		)
Foreign exchange	(1		)	—			—		—			(1		)
Other	—			—			—		—			—
Balance at June 30, 2019	$	41		$	—		$	—	$	86		$	127

12

COLGATE-PALMOLIVE COMPANY

 Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

	Six Months Ended June 30, 2019
	Employee-Related Costs			Incremental Depreciation			Asset Impairments			Other			Total
Balance at December 31, 2018	$	60		$	—		$	—		$	142		$	202
Charges	14			10			6			41			71
Cash payments	(28		)	—			—			(22		)	(50		)
Charges against assets	(3		)	(10		)	(6		)	(27		)	(46		)
Foreign exchange	(2		)	—			—			—			(2		)
Other	—			—			—			(48		)	(48		)
Balance at June 30, 2019	$	41		$	—		$	—		$	86		$	127

Employee-Related Costs primarily include severance and other termination benefits and are calculated based on long-standing benefit practices, local statutory requirements and, in certain cases, voluntary termination arrangements. Employee-Related Costs also include pension and other retiree benefit enhancements amounting to $2 and $3 for the three and six months ended June 30, 2019, respectively, which are reflected as Charges against assets within Employee-Related Costs in the preceding tables as the corresponding balance sheet amounts are reflected as a reduction of pension assets or an increase in pension and other retiree benefit liabilities. See Note 8, Retirement Plans and Other Retiree Benefits for additional information.

Incremental Depreciation is recorded to reflect changes in useful lives and estimated residual values for long-lived assets that will be taken out of service prior to the end of their normal service period. Asset Impairments are recorded to write down inventories and assets held for sale or disposal to their fair value based on amounts expected to be realized. Charges against assets within Asset Impairments are net of cash proceeds pertaining to the sale of certain assets.

Other charges consist primarily of charges resulting directly from exit activities and the implementation of new strategies as a result of the Global Growth and Efficiency Program. These charges for the three and six months ended June 30, 2019 include third-party incremental costs related to the development and implementation of new business and strategic initiatives of $5 and $10, respectively, and contract termination costs and charges resulting directly from exit activities of $0 and $3, respectively. These charges were expensed as incurred. Other charges also included a charge for exit costs related to office space consolidation of $28 for the three and six months ended June 30, 2019.

Other decreases to the restructuring accruals reflects the reclassification of restructuring accruals to lease assets as a result of the Company’s adoption of ASU No. 2018-10, “Codification Improvements to Topic 842, Leases,” on January 1, 2019. See Note 3, Recent Accounting Pronouncements and Note 13, Leases for additional information.

5.    Inventories

Inventories by major class are as follows:

	June 30, 2019		December 31, 2018
Raw materials and supplies	$	258	$	253
Work-in-process	42		37
Finished goods	1,022		960
Total Inventories	$	1,322	$	1,250

13

COLGATE-PALMOLIVE COMPANY

 Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

6.    Earnings Per Share

For the three months ended June 30, 2019 and 2018, earnings per share were as follows:

	Three Months Ended
	June 30, 2019					June 30, 2018
	Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share		Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share
Basic EPS	$	586	859.4	$	0.68	$	637	871.7	$	0.73
Stock options and restricted stock units			2.5					2.3
Diluted EPS	$	586	861.9	$	0.68	$	637	874.0	$	0.73

For the three months ended June 30, 2019 and 2018, the average number of stock options and restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 18,334,488 and 16,303,599, respectively.

For the six months ended June 30, 2019 and 2018, earnings per share were as follows:

	Six Months Ended
	June 30, 2019					June 30, 2018
	Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share		Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share
Basic EPS	$	1,146	860.7	$	1.33	$	1,271	873.5	$	1.46
Stock options and restricted stock units			2.0					3.5
Diluted EPS	$	1,146	862.7	$	1.33	$	1,271	877.0	$	1.45

For the six months ended June 30, 2019 and 2018, the average number of stock options and restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 21,751,174 and 16,284,602, respectively.

Basic and diluted earnings per share are computed independently for each quarter and any year-to-date period presented. As a result of changes in the number of shares outstanding during the year and rounding, the sum of the quarters’ earnings per share may not necessarily equal the earnings per share for any year-to-date period.

14

COLGATE-PALMOLIVE COMPANY

 Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

7. Other Comprehensive Income (Loss)

Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the three months ended June 30, 2019 and 2018 were as follows:

	2019						2018
	Pretax			Net of Tax			Pretax			Net of Tax
Cumulative translation adjustments	$	23		$	30		$	(274	)	$	(289	)
Retirement plans and other retiree benefits:
Net actuarial gain (loss) and prior service costs arising during the period	—			—			—			—
Amortization of net actuarial loss, transition and prior service costs (1)	18			13			18			14
Retirement plans and other retiree benefits adjustments	18			13			18			14
Cash flow hedges:
Unrealized gains (losses) on cash flow hedges	(1		)	(1		)	14			10
Reclassification of (gains) losses into net earnings on cash flow hedges (2)	(1		)	(1		)	2			1
Gains (losses) on cash flow hedges	(2		)	(2		)	16			11
Total Other comprehensive income (loss)	$	39		$	41		$	(240	)	$	(264	)

⁽¹⁾ These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 8, Retirement Plans and Other Retiree Benefits for additional details.

⁽²⁾ These (gains) losses are reclassified into Cost of sales. See Note 12, Fair Value Measurements and Financial Instruments for additional details.

There were no tax impacts on Other comprehensive income (loss) (“OCI”) attributable to Noncontrolling interests.

Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the six months ended June 30, 2019 and 2018 were as follows:

	2019						2018
	Pretax			Net of Tax			Pretax			Net of Tax
Cumulative translation adjustments	$	50		$	51		$	(178	)	$	(184	)
Retirement plans and other retiree benefits:
Net actuarial gain (loss) and prior service costs arising during the period	(1		)	(1		)	—			—
Amortization of net actuarial loss, transition and prior service costs (1)	35			26			36			28
Retirement plans and other retiree benefits adjustments	34			25			36			28
Cash flow hedges:
Unrealized gains (losses) on cash flow hedges	(3		)	(3		)	6			4
Reclassification of (gains) losses into net earnings on cash flow hedges (2)	(5		)	(4		)	8			6
Gains (losses) on cash flow hedges	(8		)	(7		)	14			10
Total Other comprehensive income (loss)	$	76		$	69		$	(128	)	$	(146	)

⁽¹⁾ These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 8, Retirement Plans and Other Retiree Benefits for additional details.

⁽²⁾ These (gains) losses are reclassified into Cost of sales. See Note 12, Fair Value Measurements and Financial Instruments for additional details.

There were no tax impacts on OCI attributable to Noncontrolling interests.

15

COLGATE-PALMOLIVE COMPANY

 Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

8. Retirement Plans and Other Retiree Benefits

Components of Net periodic benefit cost for the three and six months ended June 30, 2019 and 2018 were as follows:

	Pension Benefits												Other Retiree Benefits
	United States						International
	Three Months Ended June 30,
	2019			2018			2019			2018			2019		2018
Service cost	$	—		$	1		$	3		$	3		$	3	$	4
Interest cost	23			22			5			5			9		9
Expected return on plan assets	(24		)	(29		)	(4		)	(5		)	—		—
Amortization of actuarial loss (gain)	12			11			3			2			3		5
Net periodic benefit cost	$	11		$	5		$	7		$	5		$	15	$	18

	Pension Benefits												Other Retiree Benefits
	United States						International
	Six Months Ended June 30,
	2019			2018			2019			2018			2019			2018
Service cost	$	—		$	1		$	7		$	7		$	7		$	8
Interest cost	46			43			10			11			20			19
Expected return on plan assets	(49		)	(58		)	(9		)	(11		)	(1		)	—
Amortization of actuarial loss (gain)	25			23			5			4			5			9
Net periodic benefit cost	$	22		$	9		$	13		$	11		$	31		$	36

For the six months ended June 30, 2019 and 2018, the Company made voluntary contributions to its U.S. postretirement plans of $102 and $0, respectively.

16

COLGATE-PALMOLIVE COMPANY

 Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

9. Income Taxes

On December 22, 2017, the Tax Cuts and Jobs Act (the “TCJA” or “U.S. tax reform”) was enacted, which, among other things, lowered the U.S. corporate income tax rate to 21% from 35% and established a modified territorial system requiring a mandatory deemed repatriation tax on undistributed earnings of foreign subsidiaries. Beginning in 2018, the TCJA also requires a minimum tax on certain earnings generated by foreign subsidiaries while providing for tax-free repatriation of such earnings through a 100% dividends-received deduction. The Company’s effective income tax rate in 2017 included a provisional charge of $275, recorded in the fourth quarter of 2017, based on its initial analysis of the TCJA. During 2018, the Company finalized its assessment of the impact of the TCJA and recognized an additional tax expense of $80 reflecting the impact of transition tax guidance issued by the U.S. Treasury and the update of certain estimates and calculations based on information available through the end of 2018.

The impact, if any, of further transitional tax guidance that may be issued by the U.S. Treasury would be reflected in the Company’s provision for income tax in the period such guidance is effective.

10. Contingencies

As a global company serving consumers in more than 200 countries and territories, the Company is routinely subject to a wide variety of legal proceedings. These include disputes relating to intellectual property, contracts, product liability, marketing, advertising, foreign exchange controls, antitrust and trade regulation, as well as labor and employment, pension, data privacy and security, environmental and tax matters and consumer class actions. Management proactively reviews and monitors the Company’s exposure to, and the impact of, environmental matters. The Company is party to various environmental matters and, as such, may be responsible for all or a portion of the cleanup, restoration and post-closure monitoring of several sites.

The Company establishes accruals for loss contingencies when it has determined that a loss is probable and that the amount of loss, or range of loss, can be reasonably estimated. Any such accruals are adjusted thereafter as appropriate to reflect changes in circumstances.

The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible and it is able to determine such estimates. For those matters disclosed below for which the amount of any potential losses can be reasonably estimated, the Company currently estimates that the aggregate range of reasonably possible losses in excess of any accrued liabilities is $0 to approximately $225 (based on current exchange rates). The estimates included in this amount are based on the Company’s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate amount may not represent the ultimate loss to the Company. Thus, the Company’s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above.

Based on current knowledge, management does not believe that the ultimate resolution of loss contingencies arising from the matters discussed herein will have a material effect on the Company’s consolidated financial position or its ongoing results of operations or cash flows. However, in light of the inherent uncertainties noted above, an adverse outcome in one or more matters could be material to the Company’s results of operations or cash flows for any particular quarter or year.

17

COLGATE-PALMOLIVE COMPANY

 Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

Brazilian Matters

There are certain tax and civil proceedings outstanding, as described below, related to the Company’s 1995 acquisition of the Kolynos oral care business from Wyeth (the “Seller”).

The Brazilian internal revenue authority has disallowed interest deductions and foreign exchange losses taken by the Company’s Brazilian subsidiary for certain years in connection with the financing of the Kolynos acquisition. The tax assessments with interest, penalties and any court-mandated fees, at the current exchange rate, are approximately $158. This amount includes additional assessments received from the Brazilian internal revenue authority in April 2016 relating to net operating loss carryforwards used by the Company’s Brazilian subsidiary to offset taxable income that had also been deducted from the authority’s original assessments. The Company has been disputing the disallowances by appealing the assessments since October 2001. There is one case currently on appeal at the administrative level. In the event the Company is ultimately unsuccessful in this administrative appeal, further appeals are available within the Brazilian federal courts.

In September 2015, the Company lost one of its appeals at the administrative level and filed a lawsuit in Brazilian federal court. In February 2017, the Company lost an additional administrative appeal and filed a lawsuit in Brazilian federal court. In April 2019, the Company lost another administrative appeal and filed a lawsuit in Brazilian federal court. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the disallowances are without merit and that the Company should ultimately prevail. The Company is challenging these disallowances vigorously.

In July 2002, the Brazilian Federal Public Attorney filed a civil action against the federal government of Brazil, Laboratorios Wyeth-Whitehall Ltda. (the Brazilian subsidiary of the Seller) and the Company, as represented by its Brazilian subsidiary, in the 6th. Lower Federal Court in the City of São Paulo, seeking to annul an April 2000 decision by the Brazilian Board of Tax Appeals that found in favor of the Seller’s Brazilian subsidiary on the issue of whether it had incurred taxable capital gains as a result of the divestiture of Kolynos. The action seeks to make the Company’s Brazilian subsidiary jointly and severally liable for any tax due from the Seller’s Brazilian subsidiary. The case has been pending since 2002, and the Lower Federal Court has not issued a decision. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the Company should ultimately prevail in this action. The Company is challenging this action vigorously.

In December 2005, the Brazilian internal revenue authority issued to the Company’s Brazilian subsidiary a tax assessment with interest, penalties and any court-mandated fees of approximately $66, at the current exchange rate, based on a claim that certain purchases of U.S. Treasury bills by the subsidiary and their subsequent disposition during the period 2000 to 2001 were subject to a tax on foreign exchange transactions. The Company had been disputing the assessment within the internal revenue authority’s administrative appeals process. However, in November 2015, the Superior Chamber of Administrative Tax Appeals denied the Company’s final administrative appeal, and the Company has filed a lawsuit in the Brazilian federal court. In the event the Company is unsuccessful in this lawsuit, further appeals are available within the Brazilian federal courts. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the tax assessment is without merit and that the Company should ultimately prevail. The Company is challenging this assessment vigorously.

18

COLGATE-PALMOLIVE COMPANY

 Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

Competition Matters

Certain of the Company’s subsidiaries have historically been subject to investigations, and, in some cases, fines, by governmental authorities in a number of countries related to alleged competition law violations. Substantially all of these matters also involved other consumer goods companies and/or retail customers. The Company’s policy is to comply with antitrust and competition laws and, if a violation of any such laws is found, to take appropriate remedial action and to cooperate fully with any related governmental inquiry. The status as of June 30, 2019 of competition law matters pending against the Company during the six months ended June 30, 2019 is set forth below.

▪ In December 2014, the French competition law authority found that 13 consumer goods companies, including the Company’s French subsidiary, exchanged competitively sensitive information related to the French home care and personal care sectors, for which the Company’s French subsidiary was fined $57. In addition, as a result of the Company’s acquisition of the Sanex personal care business in 2011 from Unilever N.V. and Unilever PLC (together with Unilever N.V., “Unilever,”), pursuant to a Business and Share Sale and Purchase Agreement (the “Sale and Purchase Agreement”), the French competition law authority found that the Company’s French subsidiary, along with Hillshire Brands Company (formerly Sara Lee Corporation (“Sara Lee”)), were jointly and severally liable for fines of $25 assessed against Sara Lee’s French subsidiary. The Company is indemnified for these fines by Unilever pursuant to the Sale and Purchase Agreement. The fines were confirmed by the Court of Appeal in October 2016. The Company appealed the decision of the Court of Appeal on behalf of the Company and Sara Lee in the French Supreme Court. In March 2019, the French Supreme Court denied the Company’s appeal.

▪ In July 2014, the Greek competition law authority issued a statement of objections alleging a restriction of parallel imports into Greece. The Company responded to this statement of objections. In July 2017, the Company received the decision from the Greek competition law authority in which the Company was fined $11. The Company appealed the decision to the Greek courts. In April 2019, the Greek courts affirmed the judgment against the Company’s Greek subsidiary, but reduced the fine to $10.5 and dismissed the case against Colgate-Palmolive Company. The Company’s Greek subsidiary is appealing the decision to the Greek Supreme Court.

Talcum Powder Matters

The Company has been named as a defendant in civil actions alleging that certain talcum powder products that were sold prior to 1996 were contaminated with asbestos. Most of these actions involve a number of co-defendants from a variety of different industries, including suppliers of asbestos and manufacturers of products that, unlike the Company’s products, were designed to contain asbestos. As of June 30, 2019, there were 237 individual cases pending against the Company in state and federal courts throughout the United States, as compared to 229 cases as of March 31, 2019 and 239 cases as of December 31, 2018. During the quarter ended June 30, 2019, 25 new cases were filed and 17 cases were resolved by voluntary dismissal, dismissal by the court, judgment in the Company’s favor or settlement. During the quarter ended June 30, 2019, one case resulted in an adverse jury verdict after a trial, which the Company plans to appeal. During the six months ended June 30, 2019, 62 new cases were filed and 64 cases were resolved by voluntary dismissal, dismissal by the court, judgment in the Company’s favor or settlement. The value of the settlements and of the adverse jury verdict in the quarter and the year-to-date period presented was not material, either individually or in the aggregate, to each such period’s results of operations.

The Company believes that a significant portion of its costs incurred in defending and resolving these claims will be covered by insurance policies issued by several primary, excess and umbrella insurance carriers, subject to deductibles, exclusions, retentions and policy limits.

While the Company and its legal counsel believe that these cases are without merit and intend to challenge them vigorously, there can be no assurances regarding the ultimate resolution of these matters. With the exception of the case where the Company received an adverse jury verdict, the range of reasonably possible losses in excess of accrued liabilities disclosed above does not include any amount relating to these cases because the amount of any possible losses from such cases currently cannot be reasonably estimated.

19

COLGATE-PALMOLIVE COMPANY

 Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

ERISA Matter

In June 2016, a putative class action claiming that residual annuity payments made to certain participants in the Colgate-Palmolive Company Employees’ Retirement Income Plan (the “Plan”) did not comply with the Employee Retirement Income Security Act was filed against the Plan, the Company and certain individuals in the United States District Court for the Southern District of New York. This action has been certified as a class action. The relief sought includes recalculation of benefits, pre- and post-judgment interest and attorneys’ fees. The Company is contesting this action vigorously. Since the amount of any potential loss from this case currently cannot be reasonably estimated, the range of reasonably possible losses in excess of accrued liabilities disclosed above does not include any amount relating to the case.

11. Segment Information

The Company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition. 

The operations of the Oral, Personal and Home Care product segment are managed geographically in five reportable operating segments: North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of operating segment performance because it excludes the impact of Corporate-driven decisions related to interest expense and income taxes.

The accounting policies of the operating segments are generally the same as those described in Note 2, Summary of Significant Accounting Policies to the Company’s Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018. Intercompany sales have been eliminated. Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation charges and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of segment operating performance used by the Company to measure the underlying performance of the operating segments.

Net sales by segment were as follows:

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2019		2018		2019		2018
Net sales
Oral, Personal and Home Care
North America	$	846	$	824	$	1,699	$	1,651
Latin America	929		933		1,818		1,862
Europe	588		620		1,190		1,268
Asia Pacific	646		674		1,346		1,433
Africa/Eurasia	244		243		484		498
Total Oral, Personal and Home Care	3,253		3,294		6,537		6,712
Pet Nutrition	613		592		1,213		1,176
Total Net sales	$	3,866	$	3,886	$	7,750	$	7,888

Approximately 70% of the Company’s Net sales are generated from markets outside the U.S., with approximately 50% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe).

20

COLGATE-PALMOLIVE COMPANY

 Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

The Company’s Net sales of Oral, Personal and Home Care and Pet Nutrition products accounted for the following percentages of the Company’s Net sales:

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2019		2018		2019		2018
Net sales
Oral Care	45	%	47	%	47	%	48	%
Personal Care	21	%	20	%	19	%	19	%
Home Care	18	%	18	%	18	%	18	%
Pet Nutrition	16	%	15	%	16	%	15	%
Total Net sales	100	%	100	%	100	%	100	%

Operating profit by segment was as follows:

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2019			2018			2019			2018
Operating profit
Oral, Personal and Home Care
North America	$	254		$	264		$	503		$	521
Latin America	251			262			483			535
Europe	148			156			299			318
Asia Pacific	174			203			363			429
Africa/Eurasia	47			42			93			92
Total Oral, Personal and Home Care	874			927			1,741			1,895
Pet Nutrition	167			165			331			329
Corporate	(153		)	(146		)	(305		)	(295		)
Total Operating profit	$	888		$	946		$	1,767		$	1,929

For the three and six months ended June 30, 2019, Corporate Operating profit (loss) included charges of $40 and $68, respectively, resulting from the Global Growth and Efficiency Program.

For the three and six months ended June 30, 2018, Corporate Operating profit (loss) included charges of $58 and $82, respectively, resulting from the Global Growth and Efficiency Program.

For further information regarding the Global Growth and Efficiency Program, refer to Note 4, Restructuring and Related Implementation Charges.

21

COLGATE-PALMOLIVE COMPANY

 Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

12. Fair Value Measurements and Financial Instruments

The Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. The Company is exposed to the risk of credit loss in the event of nonperformance by counterparties to financial instrument contracts; however, nonperformance is considered unlikely and any nonperformance is unlikely to be material, as it is the Company’s policy to contract only with diverse, credit-worthy counterparties based upon both strong credit ratings and other credit considerations.

The Company is exposed to market risk from foreign currency exchange rates, interest rates and commodity price fluctuations. Volatility relating to these exposures is managed on a global basis by utilizing a number of techniques, including working capital management, sourcing strategies, selling price increases, selective borrowings in local currencies and entering into selective derivative instrument transactions, issued with standard features, in accordance with the Company’s treasury and risk management policies, which prohibit the use of derivatives for speculative purposes and leveraged derivatives for any purpose. It is the Company’s policy to enter into derivative instrument contracts with terms that match the underlying exposure being hedged.

The Company’s derivative instruments include interest rate swap contracts, foreign currency contracts and commodity contracts. The Company utilizes interest rate swap contracts to manage its targeted mix of fixed and floating rate debt, and these swaps are valued using observable benchmark rates (Level 2 valuation). The Company utilizes foreign currency contracts, including forward and swap contracts, option contracts, local currency deposits and local currency borrowings to hedge portions of its foreign currency purchases, assets and liabilities arising in the normal course of business and the net investment in certain foreign subsidiaries. These contracts are valued using observable market rates (Level 2 valuation). Commodity futures contracts are utilized to hedge the purchases of raw materials used in production. These contracts are measured using quoted commodity exchange prices (Level 1 valuation). The duration of foreign currency and commodity contracts generally does not exceed 12 months.

The company adopted ASU No. 2017-12, “Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities,” beginning on January 1, 2019. Refer to Note 3, Recent Accounting Pronouncements.

The following table summarizes the fair value of the Company’s derivative instruments and other financial instruments which are carried at fair value in the Company’s Consolidated Balance Sheets at June 30, 2019 and December 31, 2018:

	Assets					Liabilities
	Account	Fair Value				Account	Fair Value
Designated derivative instruments		June 30, 2019		December 31, 2018			June 30, 2019		December 31, 2018
Interest rate swap contracts	Other current assets	$	—	$	—	Other accruals	$	—	$	1
Interest rate swap contracts	Other assets	4		—		Other liabilities	—		8
Foreign currency contracts	Other current assets	9		20		Other accruals	11		8
Foreign currency contracts	Other assets	—		—		Other liabilities	19		21
Commodity contracts	Other current assets	—		—		Other accruals	—		—
Total designated		$	13	$	20		$	30	$	38
Other financial instruments
Marketable securities	Other current assets	$	66	$	10
Total other financial instruments		$	66	$	10

22

COLGATE-PALMOLIVE COMPANY

 Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

The carrying amount of cash, cash equivalents, accounts receivable and short-term debt approximated fair value as of June 30, 2019 and December 31, 2018. The estimated fair value of the Company’s long-term debt, including the current portion, as of June 30, 2019 and December 31, 2018, was $6,545 and $6,434, respectively, and the related carrying value was $6,641 and $6,354, respectively. The estimated fair value of long-term debt was derived principally from quoted prices on the Company’s outstanding fixed-term notes (Level 2 valuation).

The following amounts were recorded on the Condensed Consolidated Balance Sheet related to cumulative basis adjustment for fair value hedges as of:

	June 30, 2019		December 31, 2018
Long-term debt:
Carrying amount of hedged item	$	402	$	888
Cumulative hedging adjustment included in the carrying amount	4		(10		)

The following tables present the notional values as of:

	June 30, 2019
	Foreign Currency Contracts		Foreign Currency Debt		Interest Rate Swaps		Commodity Contracts		Total
Fair Value Hedges	$	355	$	—	$	400	$	—	$	755
Cash Flow Hedges	744		—		—		16		760
Net Investment Hedges	544		2,189		—		—		2,733

	December 31, 2018
	Foreign Currency Contracts		Foreign Currency Debt		Interest Rate Swaps		Commodity Contracts		Total
Fair Value Hedges	$	327	$	—	$	900	$	—	$	1,227
Cash Flow Hedges	782		—		—		14		796
Net Investment Hedges	482		1,396		—		—		1,878

23

COLGATE-PALMOLIVE COMPANY

 Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

The following tables present the location and amount of gains (losses) recognized on the Company’s Condensed Consolidated Statements of Income:

	Three Months Ended June 30,
	2019								2018
	Cost of sales		Selling, general and administrative expenses			Interest (income) expense, net			Cost of sales			Selling, general and administrative expenses			Interest (income) expense, net
Gain (loss) on hedges recognized in income:
Interest rate swaps designated as fair value hedges:
Derivative instrument	$	—	$	—		$	(10	)	$	—		$	—		$	(1	)
Hedged items	—		—			10			—			—			1
Foreign currency contracts designated as fair value hedges:
Derivative instrument	—		11			—			—			6			—
Hedged items	—		(11		)	—			—			(6		)	—
Foreign currency contracts designated as cash flow hedges:
Amount reclassified from OCI	1		—			—			(2		)	—			—
Commodity contracts designated as cash flow hedges:
Amount reclassified from OCI	—		—			—			—			—			—
Total gain (loss) on hedges recognized in income	$	1	$	—		$	—		$	(2	)	$	—		$	—

	Six Months Ended June 30,
	2019								2018
	Cost of sales		Selling, general and administrative expenses			Interest (income) expense, net			Cost of sales			Selling, general and administrative expenses			Interest (income) expense, net
Gain (loss) on hedges recognized in income:
Interest rate swaps designated as fair value hedges:
Derivative instrument	$	—	$	—		$	(13	)	$	—		$	—		$	(11	)
Hedged items	—		—			13			—			—			11
Foreign currency contracts designated as fair value hedges:
Derivative instrument	—		10			—			—			(7		)	—
Hedged items	—		(10		)	—			—			7			—
Foreign currency contracts designated as cash flow hedges:
Amount reclassified from OCI	4		—			—			(8		)	—			—
Commodity contracts designated as cash flow hedges:
Amount reclassified from OCI	1		—			—			—			—			—
Total gain (loss) on hedges recognized in income	$	5	$	—		$	—		$	(8	)	$	—		$	—

24

COLGATE-PALMOLIVE COMPANY

 Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

The following tables present the location and amount of unrealized gains (losses) included in OCI:

	Three Months Ended
	June 30,
	2019			2018
Foreign currency contracts designated as cash flow hedges:
Gain (loss) recognized in OCI	$	(2	)	$	14
Commodity contracts designated as cash flow hedges:
Gain (loss) recognized in OCI	1			—
Foreign currency contracts designated as net investment hedges:
Gain (loss) on instruments	(7		)	43
Gain (loss) on hedged items	7			(41		)
Foreign currency debt designated as net investment hedges:
Gain (loss) on instruments	(24		)	78
Gain (loss) on hedged items	24			(78		)
Total unrealized gain (loss) on hedges recognized in OCI	$	(1	)	$	16

	Six Months Ended
	June 30,
	2019			2018
Foreign currency contracts designated as cash flow hedges:
Gain (loss) recognized in OCI	$	(5	)	$	6
Commodity contracts designated as cash flow hedges:
Gain (loss) recognized in OCI	2			—
Foreign currency contracts designated as net investment hedges:
Gain (loss) on instruments	(1		)	25
Gain (loss) on hedged items	1			(23		)
Foreign currency debt designated as net investment hedges:
Gain (loss) on instruments	5			59
Gain (loss) on hedged items	(5		)	(59		)
Total unrealized gain (loss) on hedges recognized in OCI	$	(3	)	$	8

25

COLGATE-PALMOLIVE COMPANY

 Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

13. Leases

The Company adopted ASU No. 2016-02 “Leases (Topic 842)” on January 1, 2019, resulting in the recognition of right-of-use assets of $458 and liabilities of $574. The Company enters into leases for land, office space, warehouses and equipment. A number of the leases include one or more options to renew the lease terms, purchase the leased property or terminate the lease. The exercise of these options is at the Company’s discretion and is therefore recognized on the balance sheet when it is reasonably certain the Company will exercise such options. As the Company’s leases typically do not contain a readily determinable implicit rate, the Company determines the present value of the lease liability using its incremental borrowing rate at the lease commencement date.

Substantially all of the Company’s leases are considered operating leases. Finance leases were not material as of June 30, 2019 or for the three and six months ended June 30, 2019.

As of June 30, 2019, the Company’s right-of use assets and liabilities for operating leases were as follows:

Other assets	$	548
Other accruals	$	153
Other liabilities	530
Total operating lease liabilities	$	683

Lease commitments under noncancellable operating leases were as follows:

Years Ending December 31,	As of June 30, 2019				As of December 31, 2018
2019	$	95		(1)	$	193
2020	155				165
2021	119				123
2022	96				102
2023	60				51
Thereafter	275				32
Total lease commitments	$	800			$	666
Less: Interest	(117		)
Present value of lease liabilities	$	683

⁽¹⁾ As of June 30, 2019, $95 represents the lease commitments for the six months remaining until December 31, 2019.

The components of the Company’s operating lease cost for the three and six months ended June 30, 2019 were as follows:

	Three Months Ended June 30, 2019		Six Months Ended June 30, 2019
Operating lease cost	$	38	$	83
Short-term lease cost	—		2
Variable lease cost	6		16
Sublease income	—		—
Total lease cost	$	44	$	101

Short-term lease cost represents the Company’s cost with respect to leases with a duration of 12 months or less and is not reflected on the Company’s Consolidated Balance Sheets. Variable lease costs are comprised of costs, such as the Company’s proportionate share of actual costs for utilities, common area maintenance, property taxes and insurance that are not included in the lease liability and are recognized in the period in which they are incurred.

26

COLGATE-PALMOLIVE COMPANY

 Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

Supplemental cash flow information related to operating leases for the six months ended June 30, 2019 was as follows:

▪ Payments against amounts included in the measurement of lease liabilities: $102

▪ Lease assets obtained in exchange for lease liabilities: $209

As of June 30, 2019, the weighted-average remaining lease term for operating leases was 8 years and the weighted-average discount rate for operating leases was 4.0%.

There were no material operating leases that the Company had entered into and that were yet to commence as of June 30, 2019.

14. Subsequent Event

On July 11, 2019, the Company announced that it entered into a Share Purchase Agreement to acquire the Laboratoires Filorga Cosmétiques (“Filorga”) skin care business from Filorga Initiatives (the “Seller”) for an equity purchase price of €1,495.5 (approximately $1,690) in cash. The consummation of the transaction is subject only to the approval of the Austrian Federal Competition Authority, the French Competition Authority and the Federal Antimonopoly Service of the Russian Federation, as well as the absence of any governmental proceeding, order or law that would prohibit the consummation of the transaction. The transaction will be financed with a combination of debt and cash and is currently expected to close in the third quarter of 2019. At the closing of the acquisition, Colgate will acquire Filorga, including cash, debt and working capital it has accrued since January 1, 2019, and the Company will pay the Seller an amount of interest on the purchase price calculated at an annual rate of 2% in respect of the period commencing January 1, 2019 and ending on the closing date of the acquisition.

27

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Executive Overview

Colgate-Palmolive Company (together with its subsidiaries, the “Company” or “Colgate”) seeks to deliver strong, consistent business results and superior shareholder returns by providing consumers globally with products that make their lives healthier and more enjoyable.

To this end, the Company is tightly focused on two product segments: Oral, Personal and Home Care; and Pet Nutrition. Within these segments, the Company follows a closely defined business strategy to grow our key product categories and increase our overall market share. Within the categories in which the Company competes, the Company prioritizes its efforts based on their capacity to maximize the use of the organization’s core competencies and strong global equities and to deliver sustainable long-term growth.

Operationally, the Company is organized along geographic lines with management teams having responsibility for the business and financial results in each region. The Company competes in more than 200 countries and territories worldwide with established businesses in all regions contributing to the Company’s sales and profitability. Approximately 70% of the Company’s Net sales are generated from markets outside the U.S., with approximately 50% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe). This geographic diversity and balance help to reduce the Company’s exposure to business and other risks in any one country or part of the world.

The Oral, Personal and Home Care product segment is managed geographically in five reportable operating segments: North America, Latin America, Europe, Asia Pacific and Africa/Eurasia, all of which sell to a variety of traditional and eCommerce retailers, wholesalers and distributors. The Company, through Hill’s Pet Nutrition, also competes on a worldwide basis in the pet nutrition market, selling its products principally through authorized pet supply retailers, veterinarians and eCommerce retailers.

On an ongoing basis, management focuses on a variety of key indicators to monitor business health and performance. These indicators include market share, net sales (including volume, pricing and foreign exchange components), organic sales growth (net sales growth excluding, as applicable, the impact of foreign exchange, acquisitions and divestments), a non-GAAP financial measure, and gross profit margin, operating profit, net income and earnings per share, in each case, on a GAAP and non-GAAP basis, as well as measures used to optimize the management of working capital, capital expenditures, cash flow and return on capital. The monitoring of these indicators and the Company’s Code of Conduct and corporate governance practices help to maintain business health and strong internal controls. For additional information regarding non-GAAP financial measures, see “Non-GAAP Financial Measures” below.

To achieve its business and financial objectives, the Company focuses the organization on initiatives to drive and fund growth. The Company seeks to capture significant opportunities for growth by identifying and meeting consumer needs within its core categories, through its focus on innovation and the deployment of valuable consumer and shopper insights in the development of successful new products. To enhance these efforts, the Company has developed key initiatives to build strong relationships with consumers, dental, veterinary and skin care professionals and traditional and eCommerce retailers. In addition, the Company has enhanced its digital marketing capabilities and intends to broaden its eCommerce offerings, including direct-to-consumer and subscription services. Growth opportunities are greater in those areas of the world in which economic development and rising consumer incomes expand the size and number of markets for the Company’s products.

The investments needed to support growth are developed through continuous, Company-wide initiatives to lower costs and increase effective asset utilization. Through these initiatives, which are referred to as the Company’s funding-the-growth initiatives, the Company seeks to become even more effective and efficient throughout its businesses. These initiatives are designed to reduce costs associated with direct materials, indirect expenses, distribution and logistics, and advertising and promotional materials, among other things, and encompass a wide range of projects, examples of which include raw material substitution, reduction of packaging materials, consolidating suppliers to leverage volumes and increasing manufacturing efficiency through SKU reductions and formulation simplification. The Company also continues to prioritize its investments toward its higher margin businesses, specifically Oral Care, Personal Care and Pet Nutrition.

28

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

On July 11, 2019, the Company announced that it entered into a Share Purchase Agreement to acquire the Laboratoires Filorga Cosmétiques (“Filorga”) skin care business from Filorga Initiatives (the “Seller”) for an equity purchase price of €1,495.5 (approximately $1,690) in cash. The consummation of the transaction is subject only to the approval of the Austrian Federal Competition Authority, the French Competition Authority and the Federal Antimonopoly Service of the Russian Federation, as well as the absence of any governmental proceeding, order or law that would prohibit the consummation of the transaction. The transaction will be financed with a combination of debt and cash and is currently expected to close in the third quarter of 2019. At the closing of the acquisition, Colgate will acquire Filorga, including cash, debt and working capital it has accrued since January 1, 2019, and the Company will pay the Seller an amount of interest on the purchase price calculated at an annual rate of 2% in respect of the period commencing January 1, 2019 and ending on the closing date of the acquisition.

Significant Items Impacting Comparability

On December 22, 2017, the Tax Cuts and Jobs Act (the “TCJA” or “U.S. tax reform”) was enacted, which, among other things, lowered the U.S. corporate income tax rate to 21% from 35% and established a modified territorial system requiring a mandatory deemed repatriation tax on undistributed earnings of foreign subsidiaries. Beginning in 2018, the TCJA also requires a minimum tax on certain future earnings generated by foreign subsidiaries while providing for future tax-free repatriation of such earnings through a 100% dividends-received deduction.

During 2018, the Company finalized its assessment of the impact of the TCJA and recognized tax expense of $80 reflecting the impact of transition tax guidance issued by the U.S. Treasury and the update of certain estimates and calculations based on information available through the end of 2018. Any further guidance issued after December 31, 2018 may have an impact to the Company’s Provision for income tax in the period such guidance is effective. Refer to “Results of Operations-Income Taxes” below for additional details.

The Company’s restructuring program, known as the “Global Growth and Efficiency Program,” runs through December 31, 2019. The program’s initiatives are expected to help the Company ensure sustained solid worldwide growth in unit volume, organic sales, operating profit and earnings per share and to enhance its global leadership positions in its core businesses. Implementation of the Global Growth and Efficiency Program remains on track and is in its final year.

The initiatives under the Global Growth and Efficiency Program are focused on the following areas:

▪ Expanding Commercial Hubs

▪ Extending Shared Business Services and Streamlining Global Functions

▪ Optimizing Global Supply Chain and Facilities

Savings, substantially all of which are expected to increase future cash flows, are projected to be in the range of $590 to $635 pretax ($550 to $575 aftertax) annually, once all projects are approved and implemented. Cumulative pretax charges resulting from the Global Growth and Efficiency Program, once all phases are approved and implemented, are estimated to be in the range of $1,820 to $1,870 ($1,350 to $1,380 aftertax).

In the three and six months ended June 30, 2019, the Company incurred aftertax costs of $31 and $53, respectively, resulting from the Global Growth and Efficiency Program.

For more information regarding the Global Growth and Efficiency Program, see “Restructuring and Related Implementation Charges” below and Note 4, Restructuring and Related Implementation Charges to the Condensed Consolidated Financial Statements.

29

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Outlook

Looking forward, the Company expects global macroeconomic and market conditions to remain challenging. Although the Company has seen improvement in category growth rates, the Company expects category growth rates to remain below historical levels. While the global marketplace in which the Company operates has always been highly competitive, the Company continues to experience heightened competitive activity in certain markets from strong local competitors and from other large multinational companies, some of which have greater resources than the Company does. Such activities have included more aggressive product claims and marketing challenges, as well as increased promotional spending and geographic expansion. The Company has also been negatively affected by changes in the policies or practices of its retail trade customers in key markets, such as inventory de-stocking, limitations on access to shelf space or delisting of the Company’s products. In addition, the retail landscape in many of the Company’s markets continues to be impacted by the rapid growth of eCommerce retailers, changing consumer preferences (as consumers increasingly shop online) and the emergence of alternative retail channels, such as subscription services and direct-to-consumer businesses. This rapid growth in eCommerce and emergence of alternative retail channels may create pricing pressures and/or adversely affect the Company’s relationships with its key retailers. In addition, given that approximately 70% of the Company’s Net sales originate in markets outside the U.S., the Company has experienced and may continue to experience volatile foreign currency fluctuations and high raw and packaging material costs. While the Company has taken, and will continue to take, measures to mitigate the effect of these conditions, should they persist, they could adversely affect the Company’s future results.

In summary, the Company believes it is well prepared to meet the challenges ahead due to its strong financial condition, experience operating in challenging environments and continued focus on the Company’s key priorities: growing sales through engaging with consumers, developing world-class innovation and working with retail partners; driving efficiency on every line of the income statement to increase margins; generating strong cash flow performance and utilizing that cash effectively to enhance total shareholder return; and leading to win by staying true to the Company’s culture and focusing on its stakeholders. The Company’s commitment to these priorities, together with the strength of the Company’s global brands, its broad international presence in both developed and emerging markets and cost-saving initiatives, such as the Company’s funding-the-growth initiatives and the Global Growth and Efficiency Program, should position the Company well to increase shareholder value over the long term.

30

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Results of Operations

Three Months

Worldwide Net sales were $3,866 in the second quarter of 2019, down 0.5% from the second quarter of 2018, as volume growth of 1.0% and net selling price increases of 3.0% were more than offset by negative foreign exchange of 4.5%. Organic sales (Net sales excluding the impact of foreign exchange, acquisitions and divestments), a non-GAAP financial measure, increased 4.0% in the second quarter of 2019. A reconciliation of net sales growth to organic sales growth is provided under “Non-GAAP Financial Measures” below.

Net sales in the Oral, Personal and Home Care product segment were $3,253 in the second quarter of 2019, down 1.5% from the second quarter of 2018, as volume growth of 1.0% and net selling price increases of 2.5% were more than offset by negative foreign exchange of 5.0%. Organic sales in the Oral, Personal and Home Care product segment increased 3.5% in the second quarter of 2019.

The Company’s share of the global toothpaste market was 41.4% on a year-to-date basis, down 0.9 share points from the year ago period, and its share of the global manual toothbrush market was 31.7% on a year-to-date basis, down 0.7 share points from the year ago period. Year-to-date market shares in toothpaste were flat in Africa/Eurasia and down in North America, Latin America, Europe and Asia Pacific versus the comparable 2018 period. In the manual toothbrush category, year-to-date market shares were down in North America, Latin America, Europe, Asia Pacific and Africa/Eurasia versus the comparable 2018 period. For additional information regarding market shares, see “Market Share Information” below.

Net sales in the Hill’s Pet Nutrition segment were $613 in the second quarter of 2019, up 3.5% from the second quarter of 2018, as volume growth of 2.0% and net selling price increases of 4.0% were partially offset by negative foreign exchange of 2.5%. Organic sales in the Hill’s Pet Nutrition segment increased 6.0% in the second quarter of 2019.

Gross Profit/Margin

Worldwide Gross profit increased to $2,308 in the second quarter of 2019 from $2,301 in the second quarter of 2018. Gross profit in both periods included charges resulting from the Global Growth and Efficiency Program. Excluding these charges in both periods, Gross profit decreased to $2,305 in the second quarter of 2019 from $2,306 in the second quarter of 2018. This decrease in Gross profit reflects a decrease of $13 resulting from lower Net sales, partially offset by an increase of $12 resulting from higher Gross profit margin.

Worldwide Gross profit margin increased to 59.7% in the second quarter of 2019 from 59.2% in the second quarter of 2018. Excluding charges resulting from the Global Growth and Efficiency Program in both periods, Gross profit margin increased by 30 basis points (bps) to 59.6% in the second quarter of 2019 from 59.3% in the second quarter of 2018. This increase in Gross profit margin was primarily due to cost savings from the Company’s funding-the-growth initiatives (220 bps) and higher pricing (100 bps), partially offset by higher raw and packaging material costs (300 bps), which included foreign exchange transaction costs.

	Three Months Ended June 30,
	2019			2018
Gross profit, GAAP	$	2,308		$	2,301
Global Growth and Efficiency Program	(3		)	5
Gross profit, non-GAAP	$	2,305		$	2,306

	Three Months Ended June 30,
	2019		2018		Basis Point Change
Gross profit margin, GAAP	59.7	%	59.2	%	50
Global Growth and Efficiency Program	(0.1	)	0.1
Gross profit margin, non-GAAP	59.6	%	59.3	%	30

31

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Selling, General and Administrative Expenses

Selling, general and administrative expenses increased 5% to $1,369 in the second quarter of 2019 from $1,300 in the second quarter of 2018. Selling, general and administrative expenses in both periods included charges resulting from the Global Growth and Efficiency Program. Excluding these charges in both periods, Selling, general and administrative expenses increased to $1,359 in the second quarter of 2019 from $1,290 in the second quarter of 2018, reflecting higher overhead expenses of $56 and increased advertising investment of $13.

Selling, general and administrative expenses as a percentage of Net sales increased to 35.4% in the second quarter of 2019 from 33.5% in the second quarter of 2018. Excluding charges resulting from the Global Growth and Efficiency Program in both periods, Selling, general and administrative expenses as a percentage of Net sales increased by 200 bps to 35.2% in the second quarter of 2019 as compared to 33.2% in the second quarter of 2018. This increase was due to higher overhead expenses (160 bps) and higher advertising investment (40 bps), both as a percentage of Net sales. The increase in overhead expenses as a percentage of Net sales reflects higher compensation and logistics costs in the second quarter of 2019 and foreign exchange transaction gains and other one-time credits in the second quarter of 2018. In the second quarter of 2019, advertising investment increased as a percentage of Net sales to 10.8% from 10.4% in the second quarter of 2018 or 3% in absolute terms to $416, as compared with $403 in the second quarter of 2018.

	Three Months Ended June 30,
	2019			2018
Selling, general and administrative expenses, GAAP	$	1,369		$	1,300
Global Growth and Efficiency Program	(10		)	(10		)
Selling, general and administrative expenses, non-GAAP	$	1,359		$	1,290

	Three Months Ended June 30,
	2019		2018		Basis Point Change
Selling, general and administrative expenses as a percentage of Net sales, GAAP	35.4	%	33.5	%	190
Global Growth and Efficiency Program	(0.2	)	(0.3	)
Selling, general and administrative expenses as a percentage of Net sales, non-GAAP	35.2	%	33.2	%	200

32

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Operating Profit

Operating profit decreased 6% to $888 in the second quarter of 2019 from $946 in the second quarter of 2018. Operating profit in both periods included charges resulting from the Global Growth and Efficiency Program. Excluding these charges in both periods, Operating profit decreased 8% to $928 in the second quarter of 2019 from $1,004 in the second quarter of 2018, primarily due to an increase in Selling, general and administrative expenses.

Operating profit margin was 23.0% in the second quarter of 2019, a decrease of 130 bps compared to 24.3% in the second quarter of 2018. Excluding charges resulting from the Global Growth and Efficiency Program in both periods, Operating profit margin was 24.0% in the second quarter of 2019, a decrease of 180 bps compared to 25.8% in the second quarter of 2018. This decrease in Operating profit margin was primarily due to an increase in Selling, general and administrative expenses (200 bps) as a percentage of Net sales, partially offset by an increase in Gross profit (30 bps), both as a percentage of Net sales.

	Three Months Ended June 30,
	2019		2018		% Change
Operating profit, GAAP	$	888	$	946	(6	)%
Global Growth and Efficiency Program	40		58
Operating profit, non-GAAP	$	928	$	1,004	(8	)%

	Three Months Ended June 30,
	2019		2018		Basis Point Change
Operating profit margin, GAAP	23.0	%	24.3	%	(130	)
Global Growth and Efficiency Program	1.0		1.5
Operating profit margin, non-GAAP	24.0	%	25.8	%	(180	)

Non-Service Related Postretirement Costs

Non-service related postretirement costs were $27 in the second quarter of 2019, as compared to $23 in the second quarter of 2018. Non-service related postretirement costs in both periods included charges resulting from the Global Growth and Efficiency Program. Excluding these charges in both periods, Non-service related postretirement costs were $25 in the second quarter of 2019, as compared to $20 in the second quarter of 2018.

	Three Months Ended June 30,
	2019			2018
Non-service related postretirement costs, GAAP	$	27		$	23
Global Growth and Efficiency Program	(2		)	(3		)
Non-service related postretirement costs, non-GAAP	$	25		$	20

Interest (Income) Expense, Net

Interest (income) expense, net was $38 in the second quarter of 2019 as compared to $35 in the second quarter of 2018, primarily due to higher average interest rates on debt.

33

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Net Income Attributable to Colgate-Palmolive Company and Earnings Per Share

Net income attributable to Colgate-Palmolive Company for the second quarter of 2019 decreased to $586 from $637 in the second quarter of 2018, and Earnings per common share on a diluted basis decreased to $0.68 per share in the second quarter of 2019 from $0.73 in the second quarter of 2018. Net income attributable to Colgate-Palmolive Company in both periods included charges resulting from the Global Growth and Efficiency Program and, in the second quarter of 2018, included a benefit from a foreign tax matter.

Excluding the items described above in both periods as applicable, Net income attributable to Colgate-Palmolive Company in the second quarter of 2019 decreased 8% to $617 from $673 in the second quarter of 2018, and Earnings per common share on a diluted basis decreased 6% to $0.72 in the second quarter of 2019 from $0.77 in the second quarter of 2018.

	Three Months Ended June 30, 2019
	Income Before Income Taxes		Provision For Income Taxes(1)		Net Income Including Noncontrolling Interests		Net Income Attributable To Colgate-Palmolive Company		Diluted Earnings Per Share(2)
As Reported GAAP	$	823	$	205	$	618	$	586	$	0.68
Global Growth and Efficiency Program	42		11		31		31		0.04
Non-GAAP	$	865	$	216	$	649	$	617	$	0.72

	Three Months Ended June 30, 2018
	Income Before Income Taxes		Provision For Income Taxes(1)		Net Income Including Noncontrolling Interests			Less: Income Attributable to Noncontrolling Interests			Net Income Attributable To Colgate-Palmolive Company			Diluted Earnings Per Share(2)
As Reported GAAP	$	888	$	213	$	675		$	38		$	637		$	0.73
Global Growth and Efficiency Program	61		13		48			(3		)	51			0.06
Benefit from a foreign tax matter	—		15		(15		)	—			(15		)	(0.02		)
Non-GAAP	$	949	$	241	$	708		$	35		$	673		$	0.77

⁽¹⁾ The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.

⁽²⁾ The impact of non-GAAP adjustments on diluted earnings per share may not necessarily equal the difference between “GAAP” and “non-GAAP” as a result of rounding.

34

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Net Sales and Operating Profit by Segment

Oral, Personal and Home Care

North America

	Three Months Ended June 30,
	2019			2018			Change
Net sales	$	846		$	824		2.5		%
Operating profit	$	254		$	264		(4	)	%
% of Net sales	30.0		%	32.0		%	(200	)	bps

Net sales in North America increased 2.5% in the second quarter of 2019 to $846, as volume growth of 2.0% and net selling price increases of 1.0% were partially offset by negative foreign exchange of 0.5%. Organic sales in North America increased 3.0% in the second quarter of 2019.

The increase in organic sales in North America in the second quarter of 2019 versus the second quarter of 2018 was due to increases in Oral Care, Personal Care and Home Care organic sales. The increase in Oral Care was primarily due to organic sales growth in the toothpaste category, which was partially offset by a decline in organic sales in the mouthwash and manual toothbrush categories. The increase in Personal Care was primarily due to organic sales growth in the professional skin care, bar soap and body wash categories. The increase in Home Care was primarily due to organic sales growth in the liquid cleaner category.

Operating profit in North America decreased 4% in the second quarter of 2019 to $254, or 200 bps to 30.0% of Net sales. This decrease in Operating profit as a percentage of Net sales was primarily due to a decrease in Gross profit (70 bps) and an increase in Selling, general and administrative expenses (100 bps), both as a percentage of Net sales. This decrease in Gross profit was primarily due to higher raw and packaging material costs (290 bps), partially offset by cost savings from the Company’s funding-the-growth initiatives (190 bps). This increase in Selling, general and administrative expenses was due to higher overhead expenses, primarily related to higher logistics costs (80 bps), and increased advertising investment (20 bps).

Latin America

	Three Months Ended June 30,
	2019			2018			Change
Net sales	$	929		$	933		(0.5	)	%
Operating profit	$	251		$	262		(4	)	%
% of Net sales	27.0		%	28.1		%	(110	)	bps

Net sales in Latin America decreased 0.5% in the second quarter of 2019 to $929, as volume growth of 1.5% and net selling price increases of 5.5% were more than offset by negative foreign exchange of 7.5%. Volume gains in Mexico and Colombia were partially offset by volume declines in Brazil. Organic sales in Latin America increased 7.0% in the second quarter of 2019.

The increase in organic sales in Latin America in the second quarter of 2019 versus the second quarter of 2018 was due to increases in Oral Care, Personal Care and Home Care organic sales. The increase in Oral Care was primarily due to organic sales growth in the toothpaste category. The increase in Personal Care was primarily due to organic sales growth in the bar soap and shampoo categories. The increase in Home Care was primarily due to organic sales growth in the liquid cleaner, fabric softener and hand dish categories.

35

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Operating profit in Latin America decreased 4% in the second quarter of 2019 to $251, or 110 bps to 27.0% of Net sales. This decrease in Operating profit as a percentage of Net sales was primarily due to an increase in Selling, general and administrative expenses (190 bps), partially offset by an increase in Gross profit (90 bps), both as a percentage of Net sales. This increase in Gross profit was primarily due to cost savings from the Company’s funding-the-growth initiatives (260 bps) and higher pricing, partially offset by higher raw and packaging material costs (400 bps), which included foreign exchange transaction costs. This increase in Selling, general and administrative expenses was due to higher overhead expenses (180 bps) and increased advertising investment (10 bps).

Europe

	Three Months Ended June 30,
	2019			2018			Change
Net sales	$	588		$	620		(5	)	%
Operating profit	$	148		$	156		(5	)	%
% of Net sales	25.2		%	25.2		%	—		bps

Net sales in Europe decreased 5.0% in the second quarter of 2019 to $588, as net selling price increases of 1.0% were more than offset by negative foreign exchange of 6.0%, while volume was flat. Volume gains in Spain and Greece were offset by volume declines in Germany and France. Organic sales in Europe increased 1.0% in the second quarter of 2019.

The increase in organic sales in Europe in the second quarter of 2019 versus the second quarter of 2018 was primarily due to an increase in Oral Care organic sales partially offset by a decrease in Home Care organic sales. The increase in Oral Care was primarily due to organic sales growth in the toothpaste category. The decrease in Home Care was primarily due to a decline in organic sales in the fabric softener category.

Operating profit in Europe decreased 5% in the second quarter of 2019 to $148, while as a percentage of Net sales it was 25.2%, even with the year ago period, as an increase in Gross profit (70 bps) largely offset an increase in Selling, general and administrative expenses, all as a percentage of Net sales. This increase in Gross profit was primarily due to cost savings from the Company’s funding-the-growth initiatives (180 bps), partially offset by higher raw and packaging material costs (160 bps). This increase in Selling, general and administrative expenses was due to higher overhead expenses (50 bps) and increased advertising investment (40 bps).

Asia Pacific

	Three Months Ended June 30,
	2019			2018			Change
Net sales	$	646		$	674		(4.0	)	%
Operating profit	$	174		$	203		(14	)	%
% of Net sales	26.9		%	30.1		%	(320	)	bps

Net sales in Asia Pacific decreased 4.0% in the second quarter of 2019 to $646, as net selling price increases of 0.5% were more than offset by volume declines of 1.5% and negative foreign exchange of 3.0%. Volume declines in the Greater China region were partially offset by volume gains in Thailand. Organic sales in Asia Pacific decreased 1.0% in the second quarter of 2019.

The decrease in organic sales in Asia Pacific in the second quarter of 2019 was due to a decrease in Oral Care organic sales, which was primarily due to declines in organic sales in the toothpaste and manual toothbrush categories.

Operating profit in Asia Pacific decreased 14% in the second quarter of 2019 to $174, or 320 bps to 26.9% of Net sales. This decrease in Operating profit as a percentage of Net sales was primarily due to an increase in Selling, general and administrative expenses (300 bps) as a percentage of Net sales. This increase in Selling, general and administrative expenses was due to higher overhead expenses (90 bps), reflecting foreign exchange transaction gains in the second quarter of 2018, and increased advertising investment (210 bps).

36

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Africa/Eurasia

	Three Months Ended June 30,
	2019			2018			Change
Net sales	$	244		$	243		0.5	%
Operating profit	$	47		$	42		12	%
% of Net sales	19.3		%	17.3		%	200	bps

Net sales in Africa/Eurasia increased 0.5% in the second quarter of 2019 to $244, as volume growth of 3.5% and net selling price increases of 6.0% were partially offset by negative foreign exchange of 9.0%. Volume gains in Russia and the Gulf States were partially offset by volume declines in South Africa and Saudi Arabia. Organic sales in Africa/Eurasia increased 9.5% in the second quarter of 2019.

The increase in organic sales in Africa/Eurasia in the second quarter of 2019 versus the second quarter of 2018 was due to increases in Oral Care, Personal Care and Home Care organic sales. The increase in Oral Care was primarily due to organic sales growth in the toothpaste and manual toothbrush categories. The increase in Personal Care was primarily due to organic sales growth in the body wash and shampoo categories. The increase in Home Care was primarily due to organic sales growth in the fabric softener category.

Operating profit in Africa/Eurasia increased 12% in the second quarter of 2019 to $47, or 200 bps to 19.3% of Net sales. This increase in Operating profit as a percentage of Net sales was primarily due to a increase in Gross profit (240 bps) as a percentage of Net sales. This increase in Gross profit was primarily due to cost savings from the Company’s funding-the-growth initiatives (300 bps) and higher pricing, partially offset by higher raw and packaging material costs (500 bps), which included foreign exchange transaction costs.

37

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Hill’s Pet Nutrition

	Three Months Ended June 30,
	2019			2018			Change
Net sales	$	613		$	592		3.5		%
Operating profit	$	167		$	165		1		%
% of Net sales	27.3		%	27.9		%	(60	)	bps

Net sales for Hill’s Pet Nutrition increased 3.5% in the second quarter of 2019 to $613, as volume growth of 2.0% and net selling price increases of 4.0% were partially offset by negative foreign exchange of 2.5%. Volume gains in the United States, South Africa and Western Europe were partially offset by volume declines in Japan. Organic sales in Hill’s Pet Nutrition increased 6.0% in the second quarter of 2019. 

The increase in organic sales in the second quarter of 2019 versus the second quarter of 2018 was due to increases in organic sales in the Prescription Diet and Advanced Nutrition categories, partially offset by a decline in organic sales in the Naturals category.

Operating profit in Hill’s Pet Nutrition increased 1.0% in the second quarter of 2019 to $167, or decreased 60 bps to 27.3% of Net Sales. This decrease in Operating profit as a percentage of Net sales was primarily due to a decrease in Gross profit (50 bps) as a percentage of Net sales. This decrease in Gross profit was primarily due to higher raw and packaging material costs (260 bps), partially offset by cost savings from the Company’s funding-the-growth initiatives (150 bps) and higher pricing.

During the quarter ended March 31, 2019, Hill’s announced a voluntary recall, which was subsequently expanded, of select canned dog food products due to potentially elevated levels of Vitamin D resulting from a supplier error. In the United States, the voluntary recall was conducted in cooperation with the U.S. Food and Drug Administration. Following the announcement of the voluntary recall, and as of June 30, 2019, Hill’s and/or the Company have been named as defendants in 35 putative class action lawsuits and one individual action filed in various jurisdictions in the United States related to the voluntary recall, three of which were voluntarily dismissed. Hill’s is entitled to indemnification from the supplier related to the voluntary recall. Sales of products voluntarily recalled represent less than 2% of Hill’s annual Net sales. The sales loss and other costs associated with the voluntary recall and subsequent expansion did not have a material impact on the Company’s Net sales or Operating profit for the three and six months ended June 30, 2019 and are not expected to have a material impact in future periods.

Corporate

	Three Months Ended June 30,
	2019			2018			Change
Operating profit (loss)	$	(153	)	$	(146	)	5	%

Operating profit (loss) related to Corporate was ($153) in the second quarter of 2019 as compared to ($146) in the second quarter of 2018. In the second quarter of 2019, Corporate Operating profit (loss) included charges of $40 resulting from the Global Growth and Efficiency Program. In the second quarter of 2018, Corporate Operating profit (loss) included charges of $58 resulting from the Global Growth and Efficiency Program.

38

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Six Months

Worldwide Net sales were $7,750 in the first six months of 2019, down 2.0% as compared to the first six months of 2018, driven by negative foreign exchange of 5.5%, partially offset by volume growth of 1.0% and net selling price increases of 2.5%. Organic sales increased 3.5% in the first six months of 2019.

Net sales in the Oral, Personal and Home Care product segment were $6,537 in the first six months of 2019, a decrease of 2.5% as compared to the first six months of 2018, as negative foreign exchange of 5.5% was partially offset by volume growth of 1.0% and net selling price increases of 2.0%. Organic sales in the Oral, Personal and Home Care product segment increased 3.0% in the first six months of 2019.

The increase in organic sales in the first six months of 2019 versus the first six months of 2018 was due to increases in Oral Care, Personal Care and Home Care organic sales. The increase in Oral Care was primarily due to organic sales growth in the toothpaste category. The increase in Personal Care was primarily due to organic sales growth in the professional skin care, bar soap, body wash and shampoo categories. The increase in Home Care was due to organic sales growth in the liquid cleaner and fabric softener categories.

Net sales in the Hill’s Pet Nutrition segment were $1,213 in the first six months of 2019, an increase of 3.0% as compared to the first six months of 2018, driven by volume growth of 2.0% and net selling price increases of 4.0%, partially offset by negative foreign exchange of 3.0%. Organic sales for the Hill’s Pet Nutrition segment increased 6.0% in the first six months of 2019 as organic sales growth in the Prescription Diet and Advanced Nutrition categories were partially offset by a decline in organic sales in the Naturals category.

39

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Net Sales and Operating Profit by Segment

Net sales and Operating profit by segment were as follows:

	Six Months Ended June 30,
	2019			2018
Net sales
Oral, Personal and Home Care
North America	$	1,699		$	1,651
Latin America	1,818			1,862
Europe	1,190			1,268
Asia Pacific	1,346			1,433
Africa/Eurasia	484			498
Total Oral, Personal and Home Care	6,537			6,712
Pet Nutrition	1,213			1,176
Total Net sales	$	7,750		$	7,888
Operating profit
Oral, Personal and Home Care
North America	$	503		$	521
Latin America	483			535
Europe	299			318
Asia Pacific	363			429
Africa/Eurasia	93			92
Total Oral, Personal and Home Care	1,741			1,895
Pet Nutrition	331			329
Corporate	(305		)	(295		)
Total Operating profit	$	1,767		$	1,929

Within the Oral, Personal and Home Care product segment, North America Net sales increased 3.0%, driven by volume growth of 2.0% and net selling price increases of 1.5%, partially offset by negative foreign exchange of 0.5%. Organic sales in North America increased 3.5%. Latin America Net sales decreased 2.5%, driven by negative foreign exchange of 9.0%, partially offset by volume growth of 2.0% and net selling price increases of 4.5%. Organic sales in Latin America increased 6.5%. Europe Net sales decreased 6.0%, driven by negative foreign exchange of 6.5%, partially offset by volume growth of 0.5%, while net selling prices were flat. Organic sales in Europe increased 0.5%. Asia Pacific Net sales decreased 6.0%, driven by volume declines of 2.0% and negative foreign exchange of 4.0%, while net selling prices were flat. Organic sales in Asia Pacific decreased 2.0%. Africa/Eurasia Net sales decreased 3.0%, as negative foreign exchange of 11.0% was partially offset by volume growth of 1.5% and net selling price increases of 6.5%. Organic sales in Africa/Eurasia increased 8.0%.

In the first six months of 2019, Operating profit (loss) related to Corporate was ($305) as compared to ($295) in the first six months of 2018. In the first six months of 2019 and 2018, Corporate Operating profit (loss) included charges of $68 and $82 respectively, resulting from the Global Growth and Efficiency Program.

40

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Gross Profit/Margin

Worldwide Gross profit decreased to $4,595 in the first six months of 2019 from $4,709 in the first six months of 2018. Gross profit in both periods included charges resulting from the Global Growth and Efficiency Program. Excluding these charges in both periods, Gross profit decreased to $4,603 in the first six months of 2019 from $4,720 in the first six months of 2018. This decrease in Gross profit reflects a decrease of $32 resulting from lower Net sales and a decrease of $85 resulting from lower Gross profit margin in the first six months of 2019.

Worldwide Gross profit margin was 59.3% in the first six months of 2019 as compared to 59.7% in the first six months of 2018. Excluding the charges resulting from the Global Growth and Efficiency Program in both periods, Gross profit margin decreased by 40 bps to 59.4% in the first six months of 2019, from 59.8% in the first six months of 2018, due to higher raw and packaging material costs (330 bps), which included foreign exchange transaction costs, partially offset by cost savings from the Company’s funding-the-growth initiatives (170 bps) and higher pricing (90 bps).

	Six Months Ended June 30,
	2019		2018
Gross profit, GAAP	$	4,595	$	4,709
Global Growth and Efficiency Program	8		11
Gross profit, non-GAAP	$	4,603	$	4,720

	Six Months Ended June 30,
	2019		2018		Basis Point Change
Gross profit margin, GAAP	59.3	%	59.7	%	(40	)
Global Growth and Efficiency Program	0.1		0.1
Gross profit margin, non-GAAP	59.4	%	59.8	%	(40	)

41

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Selling, General and Administrative Expenses

Selling, general and administrative expenses increased 2% to $2,734 in the first six months of 2019 from $2,692 in the first six months of 2018. Selling, general and administrative expenses in both periods included charges resulting from the Global Growth and Efficiency Program. Excluding these charges in both periods, Selling, general and administrative expenses increased to $2,720 in the first six months of 2019 from $2,677 in the first six months of 2018, reflecting increased advertising investment of $26 and higher overhead expenses of $17.

Selling, general and administrative expenses as a percentage of Net sales increased to 35.3% in the first six months of 2019 from 34.1% in the first six months of 2018. Excluding charges resulting from the Global Growth and Efficiency Program in both periods, Selling, general and administrative expenses as a percentage of Net sales were 35.1% in the first six months of 2019, an increase of 120 bps as compared to the first six months of 2018. This increase was a result of higher overhead expenses (70 bps) and increased advertising investment (50 bps), both as a percentage of Net sales. In the first six months of 2019, advertising investment increased 3% to $845, as compared with $819 in the first six months of 2018, while as a percentage of Net sales, it increased to 10.9% in the first six months of 2019 from 10.4% in the first six months of 2018.

	Six Months Ended June 30,
	2019			2018
Selling, general and administrative expenses, GAAP	$	2,734		$	2,692
Global Growth and Efficiency Program	(14		)	(15		)
Selling, general and administrative expenses, non-GAAP	$	2,720		$	2,677

	Six Months Ended June 30,
	2019		2018		Basis Point Change
Selling, general and administrative expenses as a percentage of Net sales, GAAP	35.3	%	34.1	%	120
Global Growth and Efficiency Program	(0.2	)	(0.2	)
Selling, general and administrative expenses as a percentage of Net sales, non- GAAP	35.1	%	33.9	%	120

42

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Operating Profit

Operating profit decreased 8% to $1,767 in the first six months of 2019 from $1,929 in the first six months of 2018. Operating profit in both periods included charges resulting from the Global Growth and Efficiency Program. Excluding these charges in both periods, Operating profit for the first six months of 2019 decreased 9% to $1,835 from $2,011 in the first six months of 2018, primarily due to a decrease in Gross profit and an increase in Selling, general and administrative expenses.

Operating profit margin was 22.8% in the first six months of 2019, a decrease of 170 bps compared to 24.5% in the first six months of 2018. Excluding charges resulting from the Global Growth and Efficiency Program in both periods, Operating profit margin was 23.7%, a decrease of 180 bps from 25.5% in the first six months of 2018. This decrease was primarily due to lower Gross profit margin (40 bps) and an increase in Selling, general and administrative expenses (120 bps), both as a percentage of Net sales.

	Six Months Ended June 30,
	2019		2018		% Change
Operating profit, GAAP	$	1,767	$	1,929	(8	)%
Global Growth and Efficiency Program	68		82
Operating profit, non-GAAP	$	1,835	$	2,011	(9	)%

	Six Months Ended June 30,
	2019		2018		Basis Point Change
Operating profit margin, GAAP	22.8	%	24.5	%	(170	)
Global Growth and Efficiency Program	0.9		1.0
Operating profit margin, non-GAAP	23.7	%	25.5	%	(180	)

Non-Service Related Postretirement Costs

Non-service related postretirement costs were $52 in the first six months of 2019, as compared to $47 in the first six months of 2018. Non-service related postretirement costs in both periods included charges resulting from the Global Growth and Efficiency Program. Excluding these charges in both periods, Non-service related postretirement costs were $49 in the first six months of 2019, as compared to $40 in the first six months of 2018.

	Six Months Ended June 30,
	2019			2018
Non-service related postretirement costs, GAAP	$	52		$	47
Global Growth and Efficiency Program	(3		)	(7		)
Non-service related postretirement costs, non-GAAP	$	49		$	40

Interest (Income) Expense, Net

Interest (income) expense, net was $78 in the first six months of 2019 as compared to $70 in the first six months of 2018, primarily due to higher average interest rates on debt.

43

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Income Taxes

The effective income tax rate was 24.9% for the second quarter of 2019 as compared to 24.0% for the second quarter of 2018. As reflected in the tables below, the non-GAAP effective income tax rate was 25.0% for the second quarter of 2019, as compared to 25.4% in the comparable period of 2018.

The effective income tax rate was 25.6% for the first six months of 2019 as compared to 25.3% for the first six months of 2018. As reflected in the table below, the non-GAAP effective income tax rate was 25.6% for the six months ended June 30, 2019 as compared to 26.0% in the comparable period of 2018.

The quarterly provision for income taxes is determined based on the Company’s estimated full year effective income tax rate adjusted by the amount of tax attributable to infrequent or unusual items that are separately recognized on a discrete basis in the income tax provision in the quarter in which they occur. The Company’s current estimate of its full year effective income tax rate before discrete period items is 25.7%, compared to 26.4% in the second quarter of 2018.

	Three Months Ended June 30,
	2019						2018
	Income Before Income Taxes		Provision For Income Taxes(1)		Effective Income Tax Rate(2)		Income Before Income Taxes		Provision For Income Taxes(1)		Effective Income Tax Rate(2)
As Reported GAAP	$	823	$	205	24.9	%	$	888	$	213	24.0	%
Global Growth and Efficiency Program	42		11		0.1		61		13		(0.2	)
Benefit from a foreign tax matter	—		—		—		—		15		1.6
Non-GAAP	$	865	$	216	25.0	%	$	949	$	241	25.4	%

	Six Months Ended June 30,
	2019						2018
	Income Before Income Taxes		Provision For Income Taxes(1)		Effective Income Tax Rate(2)		Income Before Income Taxes		Provision For Income Taxes(1)		Effective Income Tax Rate(2)
As Reported GAAP	$	1,637	$	419	25.6	%	$	1,812	$	459	25.3	%
Global Growth and Efficiency Program	71		18		—		89		21		(0.1	)
Benefit from a foreign tax matter	—		—		—		—		15		0.8
Non-GAAP	$	1,708	$	437	25.6	%	$	1,901	$	495	26.0	%

⁽¹⁾ The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.

⁽²⁾ The impact of non-GAAP items on the Company’s effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustment on Income before income taxes and Provision for income taxes.

On December 22, 2017, the TCJA was enacted, which, among other things, lowered the U.S. corporate income tax rate to 21% from 35% and established a modified territorial system requiring a mandatory deemed repatriation tax on undistributed earnings of foreign subsidiaries. Beginning in 2018, the TCJA also requires a minimum tax on certain earnings generated by foreign subsidiaries while providing for tax-free repatriation of such earnings through a 100% dividends-received deduction. The Company’s effective income tax rate in 2017 included a provisional charge of $275, recorded in the fourth quarter of 2017, based on its initial analysis of the TCJA. During 2018, the Company finalized its assessment of the impact of the TCJA and recognized an additional tax expense of $80 reflecting the impact of transition tax guidance issued by the U.S. Treasury and the update of certain estimates and calculations based on information available through the end of 2018.

The impact, if any, of further transitional tax guidance that may be issued by the U.S. Treasury would be reflected in the Company’s provision for income tax in the period such guidance is effective.

44

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Net Income Attributable to Colgate-Palmolive Company and Earnings Per Share

Net income attributable to Colgate-Palmolive Company in the first six months of 2019 decreased to $1,146 from $1,271 in the comparable 2018 period. Earnings per common share on a diluted basis decreased to $1.33 per share from $1.45 per share in the comparable 2018 period. Net income attributable to Colgate-Palmolive Company in both periods included charges resulting from the Global Growth and Efficiency Program and, in the first six months of 2018, included a benefit from a foreign tax matter. See “Income Taxes” above for additional information.

Excluding the items described above in both periods, as applicable, Net income attributable to Colgate-Palmolive Company decreased 10% to $1,199 in the first six months of 2019 from $1,327 in the first six months of 2018 and Earnings per common share on a diluted basis decreased 8% to $1.39 in the first six months of 2019 from $1.51 in the first six months of 2018.

	Six Months Ended June 30, 2019
		Income Before Income Taxes		Provision For Income Taxes(1)		Net Income Including Noncontrolling Interests		Net Income Attributable To Colgate- Palmolive Company		Diluted Earnings Per Share(2)
As Reported GAAP		$	1,637	$	419	$	1,218	$	1,146	$	1.33
Global Growth and Efficiency Program		71		18		53		53		0.06
Non-GAAP		$	1,708	$	437	$	1,271	$	1,199	$	1.39

	Six Months Ended June 30, 2018
		Income Before Income Taxes		Provision For Income Taxes(1)		Net Income Including Noncontrolling Interests			Less: Income Attributable To Noncontrolling Interests			Net Income Attributable To Colgate- Palmolive Company			Diluted Earnings Per Share(2)
As Reported GAAP		$	1,812	$	459	$	1,353		$	82		$	1,271		$	1.45
Global Growth and Efficiency Program		89		21		68			(3		)	71			0.08
Benefit from a foreign tax matter		—		15		(15		)	—			(15		)	(0.02		)
Non-GAAP		$	1,901	$	495	$	1,406		$	79		$	1,327		$	1.51

⁽¹⁾ The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.

⁽²⁾ The impact of non-GAAP adjustments on diluted earnings per share may not necessarily equal the difference between “GAAP” and “non-GAAP” as a result of rounding.

45

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Restructuring and Related Implementation Charges

Global Growth and Efficiency Program

In the fourth quarter of 2012, the Company commenced the Global Growth and Efficiency Program. The program was expanded in 2014 and expanded and extended in each of 2015 and 2017. The program runs through December 31, 2019.

Initiatives under the Global Growth and Efficiency Program are expected to help the Company ensure sustained solid worldwide growth in unit volume, organic sales, operating profit and earnings per share and to enhance its global leadership positions in its core businesses, producing significant benefits in the Company’s long-term business performance. The major objectives of the program include:

▪ Becoming even stronger on the ground through the continued evolution and expansion of proven global and regional commercial capabilities.

▪ Simplifying and standardizing how work gets done by increasing technology-enabled collaboration and taking advantage of global data and analytic capabilities, leading to smarter and faster decisions.

▪ Reducing structural costs to continue to increase the Company’s gross and operating profit.

▪ Building on Colgate’s current position of strength to enhance its leading market share positions worldwide and ensure sustained sales and earnings growth.

The initiatives under the Global Growth and Efficiency Program continue to be focused on the following areas:

▪ Expanding Commercial Hubs – Building on the success of the hub structure implemented around the world, streamlining operations in order to drive smarter and faster decision-making, strengthen capabilities available on the ground and improve cost structure.

▪ Extending Shared Business Services and Streamlining Global Functions – Optimizing the Company’s shared service organizational model in all regions of the world and continuing to streamline global functions to improve cost structure.

▪ Optimizing Global Supply Chain and Facilities – Continuing to optimize manufacturing efficiencies, global warehouse networks and office locations for greater efficiency, lower cost and speed to bring innovation to market.

Implementation of the Global Growth and Efficiency Program remains on track and is in its final year. Savings, substantially all of which are expected to increase future cash flows, are projected to be in the range of $590 to $635 pretax ($550 to $575 aftertax) annually, once all projects are approved and implemented. The Company expects savings in 2019 to be approximately $25 to $55 pretax ($40 to $60 aftertax).

Cumulative pretax charges resulting from the Global Growth and Efficiency Program, once all phases are approved and implemented, are estimated to be in the range of $1,820 to $1,870 ($1,350 to $1,380 aftertax). The Company anticipates that pretax charges for 2019 will approximate $100 to $150 ($70 to $100 aftertax). It is expected that substantially all charges resulting from the Global Growth and Efficiency Program will be incurred by December 31, 2019.

The pretax charges resulting from the Global Growth and Efficiency Program are estimated to be comprised of the following categories: Employee-Related Costs, including severance, pension and other termination benefits (40%); asset-related costs, primarily Incremental Depreciation and Asset Impairments (10%); and Other charges, which include contract termination costs, consisting primarily of related implementation charges resulting directly from exit activities (30%) and the implementation of new strategies (20%). Over the course of the Global Growth and Efficiency Program, it is estimated that approximately 75% of the charges will result in cash expenditures.

46

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

The Company expects that the cumulative pretax charges, once all projects are approved and implemented, will relate to initiatives undertaken in North America (15%), Europe (20%), Latin America (5%), Asia Pacific (5%), Africa/Eurasia (5%), Hill’s Pet Nutrition (10%) and Corporate (40%), which includes substantially all of the costs related to the implementation of new strategies, noted above, on a global basis. The Company expects that, when it has been fully implemented, the Global Growth and Efficiency Program will have contributed a net reduction of approximately 4,000 to 4,400 positions from the Company’s global employee workforce.

For the three and six months ended June 30, 2019 and 2018, restructuring and related implementation charges are reflected in the Condensed Consolidated Statements of Income as follows:

	Three Months Ended					Six Months Ended
	June 30,					June 30,
	2019			2018		2019		2018
Cost of sales	$	(3	)	$	5	$	8	$	11
Selling, general and administrative expenses	10			10		14		15
Other (income) expense, net	33			43		46		56
Non-service related postretirement costs	2			3		3		7
Total Global Growth and Efficiency Program charges, pretax	$	42		$	61	$	71	$	89
Total Global Growth and Efficiency Program charges, aftertax	$	31		$	51	$	53	$	71

Restructuring and related implementation charges in the preceding table are recorded in the Corporate segment as these initiatives are predominantly centrally directed and controlled and are not included in internal measures of segment operating performance.

Total charges incurred for the Global Growth and Efficiency Program relate to initiatives undertaken by the following reportable operating segments:

	Three Months Ended				Six Months Ended				Program-to-date
	June 30,				June 30,				Accumulated Charges
	2019		2018		2019		2018
North America	—	%	8	%	3	%	17	%	18	%
Latin America	8	%	11	%	21	%	11	%	5	%
Europe	(3	)%	2	%	1	%	2	%	19	%
Asia Pacific	7	%	(6	)%	7	%	1	%	4	%
Africa/Eurasia	(2	)%	7	%	(1	)%	6	%	5	%
Hill’s Pet Nutrition	1	%	22	%	6	%	21	%	8	%
Corporate	89	%	56	%	63	%	42	%	41	%
Total	100	%	100	%	100	%	100	%	100	%

47

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Since the inception of the Global Growth and Efficiency Program in the fourth quarter of 2012, the Company has incurred cumulative pretax charges of $1,793 ($1,331 aftertax) in connection with the implementation of various projects as follows:

	Cumulative Charges
	as of June 30, 2019
Employee-Related Costs	$	695
Incremental Depreciation	102
Asset Impairments	58
Other	938
Total	$	1,793

The majority of costs incurred since inception relate to the following projects: the implementation of the Company’s overall hubbing strategy; the consolidation of facilities; the extension of shared business services and streamlining of global functions; the closing of the Morristown, New Jersey personal care facility; the simplification and streamlining of the Company’s research and development capabilities and oral care supply chain, both in Europe; redesigning the European commercial organization; restructuring how the Company will provide future retirement benefits to substantially all of the U.S.-based employees participating in the Company’s defined benefit retirement plan by shifting them to the Company’s defined contribution plan; and the implementation of a Corporate efficiencies program.

The following tables summarize the activity for the restructuring and related implementation charges discussed above and the related accruals:

	Three Months Ended June 30, 2019
	Employee-Related Costs			Incremental Depreciation			Asset Impairments		Other			Total
Balance at March 31, 2019	$	52		$	—		$	—	$	94		$	146
Charges	4			5			—		33			42
Cash payments	(12		)	—			—		(14		)	(26		)
Charges against assets	(2		)	(5		)	—		(27		)	(34		)
Foreign exchange	(1		)	—			—		—			(1		)
Other	—			—			—		—			—
Balance at June 30, 2019	$	41		$	—		$	—	$	86		$	127

	Six Months Ended June 30, 2019
	Employee-Related Costs			Incremental Depreciation			Asset Impairments			Other			Total
Balance at December 31, 2018	$	60		$	—		$	—		$	142		$	202
Charges	14			10			6			41			71
Cash payments	(28		)	—			—			(22		)	(50		)
Charges against assets	(3		)	(10		)	(6		)	(27		)	(46		)
Foreign exchange	(2		)	—			—			—			(2		)
Other	—			—			—			(48		)	(48		)
Balance at June 30, 2019	$	41		$	—		$	—		$	86		$	127

48

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Employee-Related Costs primarily include severance and other termination benefits and are calculated based on long-standing benefit practices, local statutory requirements and, in certain cases, voluntary termination arrangements. Employee-Related Costs also include pension and other retiree benefit enhancements amounting to $2 and $3 for the three and six months ended June 30, 2019, respectively, which are reflected as Charges against assets within Employee-Related Costs in the preceding tables as the corresponding balance sheet amounts are reflected as a reduction of pension assets or an increase in pension and other retiree benefit liabilities. See Note 8, Retirement Plans and Other Retiree Benefits to the Condensed Consolidated Financial Statements for additional information.

Incremental Depreciation is recorded to reflect changes in useful lives and estimated residual values for long-lived assets that will be taken out of service prior to the end of their normal service period. Asset Impairments are recorded to write down inventories and assets held for sale or disposal to their fair value based on amounts expected to be realized. Charges against assets within Asset Impairments are net of cash proceeds pertaining to the sale of certain assets.

Other charges consist primarily of charges resulting directly from exit activities and the implementation of new strategies as a result of the Global Growth and Efficiency Program. These charges for the three and six months ended June 30, 2019 include third-party incremental costs related to the development and implementation of new business and strategic initiatives of $5 and $10, respectively, and contract termination costs and charges resulting directly from exit activities of $0 and $3, respectively. These charges were expensed as incurred. Other charges also included a charge for exit costs related to office space consolidation of $28 for the three and six months ended June 30, 2019.

Other decreases to the restructuring accruals reflects the reclassification of restructuring accruals to lease assets as a result of the Company’s adoption of ASU No. 2018-10, “Codification Improvements to Topic 842, Leases,” on January 1, 2019. See Note 3, Recent Accounting Pronouncements and Note 13, Leases for additional information.

49

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Non-GAAP Financial Measures

This Quarterly Report on Form 10-Q discusses certain financial measures on both a GAAP and a non-GAAP basis. The Company uses the non-GAAP financial measures described below internally in its budgeting process, to evaluate segment and overall operating performance and as a factor in determining compensation. The Company believes that these non-GAAP financial measures are useful in evaluating the Company’s underlying business performance and trends; however, this information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP. In addition, these non-GAAP financial measures may not be the same as similar measures presented by other companies.

Net sales growth (GAAP) and organic sales growth (Net sales growth excluding the impact of foreign exchange, acquisitions and divestments) (non-GAAP) are discussed in this Quarterly Report on Form 10-Q. Management believes the organic sales growth measure provides investors and analysts with useful supplemental information regarding the Company’s underlying sales trends by presenting sales growth excluding the external factor of foreign exchange, as well as the impact of acquisitions and divestments, as applicable. A reconciliation of organic sales growth to Net sales growth for the three and six months ended June 30, 2019 is provided below.

Worldwide Gross profit, Gross profit margin, Selling, general and administrative expenses, Selling, general and administrative expenses as a percentage of Net sales, Other (income) expense, net, Operating profit, Operating profit margin, Non-service related postretirement costs, effective income tax rate, Net income attributable to Colgate-Palmolive Company and Earnings per share on a diluted basis are discussed in this Quarterly Report on Form 10-Q both on a GAAP basis and excluding the charges resulting from the Global Growth and Efficiency Program and, as applicable, the benefit from a foreign tax matter. These non-GAAP financial measures exclude items that, either by their nature or amount, management would not expect to occur as part of the Company’s normal business on a regular basis, such as restructuring charges, charges for certain litigation and tax matters, gains and losses from certain divestitures and certain unusual, non-recurring items. Investors and analysts use these financial measures in assessing the Company’s business performance and management believes that presenting these financial measures on a non-GAAP basis provides them with useful supplemental information to enhance their understanding of the Company’s underlying business performance and trends. These non-GAAP financial measures also enhance the ability to compare period-to-period financial results. A reconciliation of each of these non-GAAP financial measures to the most directly comparable GAAP financial measures for the three and six months ended June 30, 2019 and 2018 is presented within the applicable section of Results of Operations.

The following tables provide a quantitative reconciliation of Net sales growth to organic sales growth for the three and six months ended June 30, 2019:

Three Months Ended June 30, 2019	Net Sales Growth (GAAP)	Foreign Exchange Impact	Acquisitions and Divestments Impact	Organic Sales Growth (Non-GAAP)
Oral, Personal and Home Care
North America	2.5%	(0.5)%	—%	3.0%
Latin America	(0.5)%	(7.5)%	—%	7.0%
Europe	(5.0)%	(6.0)%	—%	1.0%
Asia Pacific	(4.0)%	(3.0)%	—%	(1.0)%
Africa/Eurasia	0.5%	(9.0)%	—%	9.5%
Total Oral, Personal and Home Care	(1.5)%	(5.0)%	—%	3.5%
Pet Nutrition	3.5%	(2.5)%	—%	6.0%
Total Company	(0.5)%	(4.5)%	—%	4.0%

50

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Six Months Ended June 30, 2019	Net Sales Growth (GAAP)	Foreign Exchange Impact	Acquisitions and Divestments Impact	Organic Sales Growth (Non-GAAP)
Oral, Personal and Home Care
North America	3.0%	(0.5)%	—%	3.5%
Latin America	(2.5)%	(9.0)%	—%	6.5%
Europe	(6.0)%	(6.5)%	—%	0.5%
Asia Pacific	(6.0)%	(4.0)%	—%	(2.0)%
Africa/Eurasia	(3.0)%	(11.0)%	—%	8.0%
Total Oral, Personal and Home Care	(2.5)%	(5.5)%	—%	3.0%
Pet Nutrition	3.0%	(3.0)%	—%	6.0%
Total Company	(2.0)%	(5.5)%	—%	3.5%

51

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Liquidity and Capital Resources

The Company expects cash flow from operations and debt issuances will be sufficient to meet foreseeable business operating and recurring cash needs (including for debt service, dividends, capital expenditures, charges resulting from the Global Growth and Efficiency Program, stock repurchases and the acquisition of Filorga). The Company believes its strong cash generation and financial position should continue to allow it broad access to global credit and capital markets.

Net cash provided by operations decreased 4% to $1,249 in the first six months of 2019, compared with $1,297 in the comparable period of 2018, primarily due to lower net income and higher voluntary contributions to the Company’s pension plans, partially offset by the change in working capital. The Company’s working capital was (2.9%) as a percentage of Net sales in the first six months of 2019 as compared to (2.1%) in the first six months of 2018. This change in working capital as a percent of Net sales is primarily due to the Company’s adoption of the new lease accounting standard effective January 1, 2019. See Note 13, Leases for additional information. The Company defines working capital as the difference between current assets (excluding Cash and cash equivalents and marketable securities, the latter of which is reported in Other current assets) and current liabilities (excluding short-term debt).

In the fourth quarter of 2012, the Company commenced the Global Growth and Efficiency Program. The program was expanded in 2014 and expanded and extended in each of 2015 and 2017. The program runs through December 31, 2019.

Implementation of the Global Growth and Efficiency Program remains on track and is in its final year. Including the most recent expansion, total program charges resulting from the Global Growth and Efficiency Program are estimated to be in the range of $1,820 to $1,870 ($1,350 to $1,380 aftertax). Approximately 75% of total program charges resulting from the Global Growth and Efficiency Program are expected to result in cash expenditures. Savings from the Global Growth and Efficiency Program, substantially all of which are expected to increase future cash flows, are projected to be in the range of $590 to $635 pretax ($550 to $575 aftertax) annually, once all projects are approved and implemented.

The Company anticipates that pretax charges for 2019 will approximate $100 to $150 ($70 to $100 aftertax). The Company expects savings in 2019 to amount to approximately $25 to $55 pretax ($40 to $60 aftertax). It is anticipated that cash requirements for the Global Growth and Efficiency Program will be funded from operating cash flows. Approximately 75% of the restructuring accrual at June 30, 2019 is expected to be paid in the next twelve months.

Investing activities used $212 of cash in the first six months of 2019, compared with $1,013 in the comparable period of 2018. Investing activities in 2018 includes the Company’s acquisition of the outstanding equity interests of Physicians Care Alliance, LLC and Elta MD Holdings, Inc., professional skin care businesses, for aggregate cash consideration of approximately $730.

On July 11, 2019, the Company announced that it entered into a Share Purchase Agreement to acquire the Filorga skin care business from the Seller for an equity purchase price of €1,495.5 (approximately $1,690). The transaction will be financed with a combination of debt and cash and is currently expected to close in the third quarter of 2019. At the closing of the acquisition, the Company will acquire Filorga, including cash, debt and working capital it has accrued since January 1, 2019, and the Company will pay the Seller an amount of interest on the purchase price calculated at an annual rate of 2% in respect of the period commencing January 1, 2019 and ending on the closing date of the acquisition.

Capital spending was $146 in the first six months of 2019 compared to $216 in the comparable period of 2018. Capital expenditures for 2019 are expected to be approximately 2.3% to 2.6% of Net sales. The Company continues to focus its capital spending on projects that are expected to yield high aftertax returns. 

Financing activities used $904 of cash during the first six months of 2019, compared with $979 in the comparable period of 2018, primarily reflecting higher proceeds from the exercise of stock options in the first six months of 2019 compared with the comparable period of 2018.

52

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Long-term debt, including the current portion, increased to $6,641 as of June 30, 2019 as compared to $6,354 as of December 31, 2018 and total debt increased to $6,645 as of June 30, 2019 as compared to $6,366 as of December 31, 2018 primarily due to higher outstanding commercial paper and higher debt. During the first quarter of 2019, the Company issued €500 of seven-year notes at a fixed coupon rate of 0.50% and €500 of fifteen-year notes at a fixed coupon rate of 1.375%. The debt issuances were under the Company’s shelf registration statement. The debt issuances support the Company’s capital structure objectives of funding its business and growth initiatives while minimizing its risk-adjusted cost of capital. Proceeds from the debt issuances were used for general corporate purposes, which includes the retirement of commercial paper and the repayment of the Company’s $500 1.75% fixed rate notes which became due March 2019 and €500 floating rate notes which became due May 2019.

Domestic and foreign commercial paper outstanding was $737 and $741 as of June 30, 2019 and 2018, respectively. The average daily balances outstanding for commercial paper in the first six months of 2019 and 2018 were $1,584 and $1,910, respectively. The Company classifies commercial paper and certain current maturities of notes payable as long-term debt when it has the intent and ability to refinance such obligations on a long-term basis, including, if necessary, by utilizing its line of credit that expires in November 2023.

Certain of the agreements with respect to the Company’s bank borrowings contain financial and other covenants as well as cross-default provisions. Noncompliance with these requirements could ultimately result in the acceleration of amounts owed. The Company is in full compliance with all such requirements and believes the likelihood of noncompliance is remote. Refer to Note 6, Long term Debt and Credit Facilities, on the Company’s Annual report on Form 10-K for the year ended December 31, 2018 for further information about the Company’s long-term debt and credit facilities.

In the first quarter of 2019, the Company increased the annualized common stock dividend to $1.72 per share from $1.68 per share previously, effective in the second quarter of 2019.

Cash and cash equivalents increased $137 during the first six months of 2019 to $863 at June 30, 2019, compared to $726 at December 31, 2018, most of which ($806 and $651, respectively) were held by the Company’s foreign subsidiaries.

For additional information regarding liquidity and capital resources, please refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2018.

53

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Market Share Information

Management uses market share information as a key indicator to monitor business health and performance. References to market share in this Quarterly Report on Form 10-Q are based on a combination of consumption and market share data provided by third-party vendors, primarily Nielsen, and internal estimates. All market share references represent the percentage of the dollar value of sales of our products, relative to all product sales in the category in the countries in which the Company competes and purchases data (excluding Venezuela from all periods).

Market share data is subject to limitations on the availability of up-to-date information. In particular, market share data is currently not generally available for certain retail channels, such as eCommerce or certain discounters. The Company measures year-to-date market shares from January 1 of the relevant year through the most recent period for which market share data is available, which typically reflects a lag time of one or two months. The Company believes that the third-party vendors it uses to provide data are reliable, but it has not verified the accuracy or completeness of the data or any assumptions underlying the data. In addition, market share information reported by the Company may be different from market share information reported by other companies due to differences in category definitions, the use of data from different countries, internal estimates and other factors.

Cautionary Statement on Forward-Looking Statements

This Quarterly Report on Form 10-Q may contain forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995 or by the SEC in its rules, regulations and releases that set forth anticipated results based on management’s current plans and assumptions. Such statements may relate, for example, to sales or volume growth, net selling price increases, organic sales growth, profit or profit margin growth, earnings per share growth, financial goals, the impact of foreign exchange volatility, cost-reduction plans including the Global Growth and Efficiency Program, tax rates, U.S. tax reform, new product introductions, commercial investment levels, acquisitions, including the recently announced agreement to acquire the Filorga skin care business, and divestitures, or legal or tax proceedings, among other matters. These statements are made on the basis of the Company’s views and assumptions as of this time and the Company undertakes no obligation to update these statements whether as a result of new information, future events or otherwise, except as required by law or by the rules and regulations of the SEC. Moreover, the Company does not, nor does any other person, assume responsibility for the accuracy and completeness of those statements. The Company cautions investors that any such forward-looking statements are not guarantees of future performance and that actual events or results may differ materially from those statements. Actual events or results may differ materially because of factors that affect international businesses and global economic conditions, as well as matters specific to the Company and the markets it serves, including the uncertain economic environment in different countries and its effect on consumer spending habits, increased competition and evolving competitive practices, foreign currency rate fluctuations, exchange controls, price or profit controls, labor relations, changes in foreign or domestic laws, or regulations or their interpretation, political and fiscal developments, including changes in trade, tax and immigration policies, disruptions in global supply chain, the availability and cost of raw and packaging materials, the ability to maintain or increase selling prices as needed, the ability to implement the Global Growth and Efficiency Program as planned or differences between the actual and the estimated costs or savings under such program, changes in the policies of retail trade customers, the emergence of new sales channels, the growth of eCommerce and the changing retail landscape, the ability to lower costs, the ability to complete acquisitions and divestitures as planned, the ability to successfully integrate acquired businesses, and the uncertainty of the outcome of legal proceedings, whether or not the Company believes they have merit. For information about these and other factors that could impact the Company’s business and cause actual results to differ materially from forward-looking statements, refer to the Company’s filings with the SEC (including, but not limited to, the information set forth under the captions “Risk Factors” and “Cautionary Statement on Forward-Looking Statements” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018 and subsequent Quarterly Reports on Form 10-Q).

Quantitative and Qualitative Disclosures about Market Risk

There is no material change in the information reported under Part II, Item 7, “Managing Foreign Currency, Interest Rate, Commodity Price and Credit Risk Exposure” contained in our Annual Report on Form 10-K for the year ended December 31, 2018.

54

COLGATE-PALMOLIVE COMPANY

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

The Company’s management, under the supervision and with the participation of the Company’s President and Chief Executive Officer and the Chief Financial Officer, carried out an evaluation of the effectiveness of the design and operation of the Company’s disclosure controls and procedures as of June 30, 2019 (the “Evaluation”). Based upon the Evaluation, the Company’s President and Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934) are effective.

Changes in Internal Control Over Financial Reporting

There were no changes in the Company’s internal control over financial reporting that occurred during the Company’s most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

55

COLGATE-PALMOLIVE COMPANY

PART II.    OTHER INFORMATION

Item 1.    Legal Proceedings

For information regarding legal matters, please refer to Note 10, Contingencies to the Condensed Consolidated Financial Statements contained in Part I of this Quarterly Report on Form 10-Q, which is incorporated herein by reference.

Item 1A.    Risk Factors

There have been no material changes from the risk factors disclosed in Part 1, Item 1A. Risk Factors of the Company’s Annual Report on Form 10-K for the year ended December 31, 2018.

56

COLGATE-PALMOLIVE COMPANY

Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds    

On June 18, 2018, the Board authorized the repurchase of shares of the Company’s common stock having an aggregate purchase price of up to $5 billion under a new share repurchase program (the “2018 Program”), which replaced a previously authorized share repurchase program. The Board also has authorized share repurchases on an ongoing basis to fulfill certain requirements of the Company’s compensation and benefit programs. The shares are repurchased from time to time in open market or privately negotiated transactions at the Company’s discretion, subject to market conditions, customary blackout periods and other factors.

The following table shows the stock repurchase activity for the three months in the quarter ended June 30, 2019:

Month	Total Number of Shares Purchased(1)	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(2)	Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs(3) (in millions)
April 1 through 30, 2019	1,156,227	$	68.78	1,108,282	$	3,971
May 1 through 31, 2019	1,421,488	$	71.23	1,391,000	$	3,872
June 1 through 30, 2019	1,072,296	$	72.63	1,042,235	$	3,796
Total	3,650,011	$	70.87	3,541,517

⁽¹⁾ Includes share repurchases under the 2018 Program and those associated with certain employee elections under the Company’s compensation and benefit programs.

⁽²⁾ The difference between the total number of shares purchased and the total number of shares purchased as part of publicly announced plans or programs is 108,494 shares, which represents shares deemed surrendered to the Company to satisfy certain employee elections under the Company’s compensation and benefit programs.

⁽³⁾ Includes approximate dollar value of shares that were available to be purchased under the publicly announced plans or programs that were in effect as of June 30, 2019.

Item 3.    Defaults Upon Senior Securities

None.

Item 4.    Mine Safety Disclosures

Not Applicable.

Item 5.    Other Information

None.

57

COLGATE-PALMOLIVE COMPANY

Item 6.    Exhibits

Exhibit No.	Description
31-A	Certificate of the President and Chief Executive Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.
31-B	Certificate of the Chief Financial Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.
32	Certificate of the President and Chief Executive Officer and the Chief Financial Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. § 1350.
101	The following materials from Colgate-Palmolive Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2019, formatted in eXtensible Business Reporting Language (XBRL): (i) the Condensed Consolidated Statements of Income; (ii) the Condensed Consolidated Statements of Comprehensive Income; (iii) the Condensed Consolidated Balance Sheets; (iv) the Condensed Consolidated Statements of Cash Flows; (v) Condensed Consolidated Statements of Changes in Shareholders’ Equity and (vi) Notes to Condensed Consolidated Financial Statements.

58

COLGATE-PALMOLIVE COMPANY

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	COLGATE-PALMOLIVE COMPANY
	(Registrant)
	Principal Executive Officer:
July 26, 2019	/s/ Noel R. Wallace
	Noel R. Wallace
	President and Chief Executive Officer
	Principal Financial Officer:
July 26, 2019	/s/ Henning I. Jakobsen
	Henning I. Jakobsen
	Chief Financial Officer
	Principal Accounting Officer:
July 26, 2019	/s/ Philip G. Shotts
	Philip G. Shotts
	Vice President and Controller

59

EX-31.A

EXHIBIT 31-A

I, Noel R. Wallace, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Colgate-Palmolive Company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: July 26, 2019

/s/ Noel R. Wallace

Noel R. Wallace

President and

Chief Executive Officer

EX-31.B

EXHIBIT 31-B

I, Henning I. Jakobsen, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Colgate-Palmolive Company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: July 26, 2019

/s/ Henning I. Jakobsen

Henning I. Jakobsen

Chief Financial Officer

EX-32

EXHIBIT 32

The undersigned President and Chief Executive Officer and Chief Financial Officer of Colgate-Palmolive Company each certify, pursuant to Rule 13a-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. § 1350, that:

(1) the Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2019 (the “Periodic Report”) which this statement accompanies fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

(2) information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of Colgate-Palmolive Company.

Date: July 26, 2019

/s/ Noel R. Wallace

Noel R. Wallace

President and

Chief Executive Officer

/s/ Henning I. Jakobsen

Henning I. Jakobsen

Chief Financial Officer

XML

Cover Page	6 Months Ended
	Jun. 30, 2019 shares
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2019
Document Transition Report	false
Entity File Number	1-644
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	13-1815595
Entity Address, Address Line One	300 Park Avenue
Entity Address, City or Town	New York,
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10022
City Area Code	212
Local Phone Number	310-2000
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding	858,006,448
Entity Registrant Name	COLGATE PALMOLIVE CO
Entity Central Index Key	0000021665
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q2
Amendment Flag	false
Common Stock
Entity Information [Line Items]
Title of 12(b) Security	Common Stock, $1.00 par value
Trading Symbol	CL
Security Exchange Name	NYSE
0.500% Notes Due 2026
Entity Information [Line Items]
Title of 12(b) Security	0.500% Notes due 2026
Trading Symbol	CL 26
Security Exchange Name	NYSE
1.375% Notes Due 2034
Entity Information [Line Items]
Title of 12(b) Security	1.375% Notes due 2034
Trading Symbol	CL 34
Security Exchange Name	NYSE

XML

CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Income Statement [Abstract]
Net sales	$ 3,866	$ 3,886	$ 7,750	$ 7,888
Cost of sales	1,558	1,585	3,155	3,179
Gross profit	2,308	2,301	4,595	4,709
Selling, general and administrative expenses	1,369	1,300	2,734	2,692
Other (income) expense, net	51	55	94	88
Operating profit	888	946	1,767	1,929
Non-service related postretirement costs	27	23	52	47
Interest (income) expense, net	38	35	78	70
Income before income taxes	823	888	1,637	1,812
Provision for income taxes	205	213	419	459
Net income including noncontrolling interests	618	675	1,218	1,353
Less: Net income attributable to noncontrolling interests	32	38	72	82
Net income attributable to Colgate-Palmolive Company	$ 586	$ 637	$ 1,146	$ 1,271
Earnings per common share, basic (in dollars per share)	$ 0.68	$ 0.73	$ 1.33	$ 1.46
Earnings per common share, diluted (in dollars per share)	$ 0.68	$ 0.73	$ 1.33	$ 1.45

XML

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Statement of Comprehensive Income [Abstract]
Net income including noncontrolling interests	$ 618	$ 675	$ 1,218	$ 1,353
Other comprehensive income (loss), net of tax:
Cumulative translation adjustments	25	(305)	51	(198)
Retirement plans and other retiree benefit adjustments	13	14	25	28
Gains (losses) on cash flow hedges	(2)		(7)
Gains (losses) on cash flow hedges		11		10
Total Other comprehensive income (loss), net of tax	36	(280)	69	(160)
Total Comprehensive income including noncontrolling interests	654	395	1,287	1,193
Less: Net income attributable to noncontrolling interests	32	38	72	82
Less: Cumulative translation adjustments attributable to noncontrolling interests	(5)	(16)	0	(14)
Total Comprehensive income attributable to noncontrolling interests	27	22	72	68
Total Comprehensive income attributable to Colgate-Palmolive Company	$ 627	$ 373	$ 1,215	$ 1,125

XML

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Jun. 30, 2019	Dec. 31, 2018
Current Assets
Cash and cash equivalents	$ 863	$ 726
Receivables (net of allowances of $87 and $82, respectively)	1,590	1,400
Inventories	1,322	1,250
Other current assets	480	417
Total current assets	4,255	3,793
Property, plant and equipment:
Cost	8,476	8,336
Less: Accumulated depreciation	(4,683)	(4,455)
Property, plant and equipment, net	3,793	3,881
Goodwill	2,536	2,530
Other intangible assets, net	1,609	1,637
Deferred income taxes	167	152
Other assets	791	168
Total assets	13,151	12,161
Current Liabilities
Notes and loans payable	4	12
Current portion of long-term debt	1	0
Accounts payable	1,209	1,222
Accrued income taxes	293	411
Other accruals	2,275	1,696
Total current liabilities	3,782	3,341
Long-term debt	6,640	6,354
Deferred income taxes	303	235
Other liabilities	2,436	2,034
Total liabilities	13,161	11,964
Shareholders’ Equity
Common stock	1,466	1,466
Additional paid-in capital	2,338	2,204
Retained earnings	21,653	21,615
Accumulated other comprehensive income (loss)	(4,119)	(4,188)
Unearned compensation	(3)	(3)
Treasury stock, at cost	(21,682)	(21,196)
Total Colgate-Palmolive Company shareholders’ equity	(347)	(102)
Noncontrolling interests	337	299
Total equity	(10)	197
Total liabilities and equity	$ 13,151	$ 12,161

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Millions	Jun. 30, 2019	Dec. 31, 2018
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 87	$ 82

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Operating Activities
Net income including noncontrolling interests	$ 1,218	$ 1,353
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations:
Depreciation and amortization	256	258
Restructuring and termination benefits, net of cash	21	(14)
Stock-based compensation expense	34	47
Deferred income taxes	53	2
Voluntary benefit plan contributions	(102)	0
Cash effects of changes in:
Receivables	(178)	(200)
Inventories	(63)	(30)
Accounts payable and other accruals	(14)	(96)
Other non-current assets and liabilities	24	(23)
Net cash provided by operations	1,249	1,297
Investing Activities
Capital expenditures	(146)	(216)
Purchases of marketable securities and investments	(80)	(96)
Proceeds from sale of marketable securities and investments	14	19
Payment for acquisitions, net of cash acquired	0	(727)
Other	0	7
Net cash used in investing activities	(212)	(1,013)
Financing Activities
Principal payments on debt	(3,105)	(3,953)
Proceeds from issuance of debt	3,368	4,266
Dividends paid	(770)	(756)
Purchases of treasury shares	(664)	(696)
Proceeds from exercise of stock options	267	160
Net cash used in financing activities	(904)	(979)
Effect of exchange rate changes on Cash and cash equivalents	4	(7)
Net increase (decrease) in Cash and cash equivalents	137	(702)
Cash and cash equivalents at beginning of the period	726	1,535
Cash and cash equivalents at end of the period	863	833
Supplemental Cash Flow Information
Income taxes paid	$ 463	$ 468

XML

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY $ in Millions		USD ($) Dividend	Common Stock USD ($)	Additional Paid-in Capital USD ($)	Unearned Compensation USD ($)	Treasury Stock USD ($)	Retained Earnings USD ($)	Accumulated Other Comprehensive Income (Loss) USD ($)		Noncontrolling Interests USD ($)
Accumulated other comprehensive income (loss), cumulative translation losses		$ 2,927
Accumulated other comprehensive income (loss), unrecognized retirement plan and other retiree benefit costs		$ 923
Number of dividends declared per quarter | Dividend		2
Beginning balance at Dec. 31, 2017			$ 1,466	$ 1,984	$ (5)	$ (20,181)	$ 20,531	$ (3,855)	[1]	$ 303
Ending balance at Mar. 31, 2018			1,466	2,047	(2)	(20,441)	20,581	(3,900)	[2]	350
Beginning balance at Dec. 31, 2017			1,466	1,984	(5)	(20,181)	20,531	(3,855)	[1]	303
Changes in Shareholders' Equity [Roll Forward]
Net income		$ 1,353					1,271			82
Other comprehensive income (loss), net of tax		(160)						(146)	[1]	(14)
Dividends	[3]						(1,085)			(37)
Stock-based compensation expense				47
Shares issued for stock options				64		104
Shares issued for restricted stock units				(14)		14
Treasury stock acquired						(696)
Other				0	5	2	134	(163)	[1],[4]
Ending balance at Jun. 30, 2018			1,466	2,081	0	(20,757)	20,851	(4,164)	[1],[2]	334
Accumulated other comprehensive income (loss), cumulative translation losses		2,832
Accumulated other comprehensive income (loss), unrecognized retirement plan and other retiree benefit costs		1,062
Beginning balance at Mar. 31, 2018			1,466	2,047	(2)	(20,441)	20,581	(3,900)	[2]	350
Changes in Shareholders' Equity [Roll Forward]
Net income		675					637			38
Other comprehensive income (loss), net of tax		(280)						(264)	[2]	(16)
Dividends							(367)			(38)
Stock-based compensation expense				19
Shares issued for stock options				16		27
Shares issued for restricted stock units				(2)		2
Treasury stock acquired						(345)
Other				1	2
Ending balance at Jun. 30, 2018			1,466	2,081	0	(20,757)	20,851	(4,164)	[1],[2]	334
Accumulated other comprehensive income (loss), cumulative translation losses		3,121
Accumulated other comprehensive income (loss), unrecognized retirement plan and other retiree benefit costs		1,048
Accumulated other comprehensive income (loss), cumulative translation losses		3,155
Accumulated other comprehensive income (loss), unrecognized retirement plan and other retiree benefit costs		$ 1,038
Number of dividends declared per quarter | Dividend		2
Beginning balance at Dec. 31, 2018		$ 197	1,466	2,204	(3)	(21,196)	21,615	(4,188)	[1]	299
Ending balance at Mar. 31, 2019			1,466	2,241	(3)	(21,532)	21,436	(4,160)	[2]	342
Beginning balance at Dec. 31, 2018		197	1,466	2,204	(3)	(21,196)	21,615	(4,188)	[1]	299
Changes in Shareholders' Equity [Roll Forward]
Net income		1,218					1,146			72
Other comprehensive income (loss), net of tax		69						69	[1]	0
Dividends	[3]						(1,103)			(34)
Stock-based compensation expense				34
Shares issued for stock options				114		162
Shares issued for restricted stock units				(14)		14
Treasury stock acquired						(664)
Other						2	(5)
Ending balance at Jun. 30, 2019		(10)	1,466	2,338	(3)	(21,682)	21,653	(4,119)	[1],[2]	337
Accumulated other comprehensive income (loss), cumulative translation losses		3,134
Accumulated other comprehensive income (loss), unrecognized retirement plan and other retiree benefit costs		1,026
Beginning balance at Mar. 31, 2019			1,466	2,241	(3)	(21,532)	21,436	(4,160)	[2]	342
Changes in Shareholders' Equity [Roll Forward]
Net income		618					586			32
Other comprehensive income (loss), net of tax		36						41	[2]	(5)
Dividends							(369)			(32)
Stock-based compensation expense				17
Shares issued for stock options				81		113
Shares issued for restricted stock units				(1)		1
Treasury stock acquired						(265)
Other						1
Ending balance at Jun. 30, 2019		(10)	$ 1,466	$ 2,338	$ (3)	$ (21,682)	$ 21,653	$ (4,119)	[1],[2]	$ 337
Accumulated other comprehensive income (loss), cumulative translation losses		3,104
Accumulated other comprehensive income (loss), unrecognized retirement plan and other retiree benefit costs		$ 1,013

[1] Accumulated other comprehensive income (loss) includes cumulative translation losses of $3,104 at June 30, 2019 ($3,121 at June 30, 2018) and $3,155 at December 31, 2018 ($2,927 at December 31, 2017), respectively, and unrecognized retirement plan and other retiree benefits costs of $1,013 at June 30, 2019 ($1,048 at June 30, 2018) and $1,038 at December 31, 2018 ($923 at December 31, 2017), respectively.

[2] Accumulated other comprehensive income (loss) includes cumulative translation losses of $3,104 at June 30, 2019 ($3,121 at June 30, 2018) and $3,134 at March 31, 2019 ($2,832 at March 31, 2018), respectively, and unrecognized retirement plan and other retiree benefits costs of $1,013 at June 30, 2019 ($1,048 at June 30, 2018) and $1,026 at March 31, 2019 ($1,062 at March 31, 2018), respectively.

[3] Two dividends were declared in each of the first quarters of 2019 and 2018.

[4] As a result of the early adoption of ASU 2018-02, the Company reclassified the stranded tax effects in Accumulated other comprehensive income (loss) resulting from the Tax Cuts and Jobs Act (the “TCJA” or “U.S. tax reform”) to Retained earnings. See Note 2, Summary of Accounting Policies in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018 for additional information.

XML

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical) - $ / shares	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Statement of Stockholders' Equity [Abstract]
Dividends declared per common share (in dollars per share)	$ 0.43	$ 0.42	$ 1.28	$ 1.24

XML

Basis of Presentation

6 Months Ended

Jun. 30, 2019

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation

Basis of Presentation

The Condensed Consolidated Financial Statements reflect all normal recurring adjustments which, in management’s opinion, are necessary for a fair statement of the results for interim periods. Results of operations for interim periods may not be representative of results to be expected for a full year. Colgate-Palmolive Company (together with its subsidiaries, the “Company” or “Colgate”) reclassifies certain prior year amounts, as applicable, to conform to the current year presentation.

For a complete set of financial statement notes, including the Company’s significant accounting policies, refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2018, filed with the Securities and Exchange Commission (the “SEC”).

XML

Use of Estimates

6 Months Ended

Jun. 30, 2019

Accounting Policies [Abstract]

Use of Estimates

Use of Estimates

Provisions for certain expenses, including income taxes, advertising and consumer promotion, are based on full year assumptions and are included in the accompanying Condensed Consolidated Financial Statements in proportion with estimated annual tax rates, the passage of time or estimated annual sales, as applicable.

XML

Recent Accounting Pronouncements

6 Months Ended

Jun. 30, 2019

New Accounting Pronouncements and Changes in Accounting Principles [Abstract]

Recent Accounting Pronouncements

Recent Accounting Pronouncements

In April 2019, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2019-04, Codification Improvements to Financial Instruments-Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Financial Instruments (Topic 825). This extensive ASU clarifies three topics related to financial instruments accounting. This new guidance is effective for the Company beginning on January 1, 2020, with early adoption permitted. This new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements.

In October 2018, the FASB issued ASU No. 2018-16, “Derivatives and Hedging (Topic 815): Inclusion of the Secured Overnight Financing Rate (“SOFR”) Overnight Index Swap (“OIS”) Rate as Benchmark Interest Rate for Hedge Accounting Purposes.” The new guidance permits the use of the OIS rate based on the SOFR as a U.S. benchmark interest rate for hedge accounting purposes under Topic 815. The new guidance was effective for the Company on a prospective basis beginning on January 1, 2019, concurrently with the adoption of ASU 2017-12, and did not have an impact on the Company’s Consolidated Financial Statements.

In August 2018, the FASB issued ASU No. 2018-15, “Intangibles-Goodwill and Other-Internal-Use Software (Topic 350): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract.” This new guidance aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. This new guidance is effective for the Company on a prospective or retrospective basis beginning on January 1, 2020, with early adoption permitted. The Company elected to adopt this guidance early, beginning on January 1, 2019 on a prospective basis. The new guidance did not have a material impact on the Company’s Consolidated Financial Statements.

In August 2018, the FASB issued ASU No. 2018-14, “Compensation-Retirement Benefits-Defined Benefit Plans-General (Topic 715): Disclosure Framework-Changes to the Disclosure Requirements for Defined Benefit Plans.” This new guidance removes certain disclosures that are not considered cost beneficial, clarifies certain required disclosures and requires certain additional disclosures. This new guidance is effective for the Company on a retrospective basis beginning on January 1, 2020, with early adoption permitted. While the Company is currently assessing the impact of the new guidance, it is not expected to have a material impact on the Company’s Consolidated Financial Statements.

In August 2018, the FASB issued ASU No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement.” This new guidance removes certain disclosure requirements related to the fair value hierarchy, modifies existing disclosure requirements related to measurement uncertainty and adds new disclosure requirements. The new disclosure requirements include disclosing the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. This new guidance is effective for the Company beginning on January 1, 2020, with early adoption permitted. Certain disclosure requirements in the new guidance will need to be applied on a retrospective basis and others on a prospective basis. While the Company is currently assessing the impact of the new guidance, it is not expected to have a material impact on the Company’s Consolidated Financial Statements.

In August 2017, the FASB issued ASU No. 2017-12, “Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities,” amending the eligibility criteria for hedged items and transactions to expand an entity’s ability to hedge nonfinancial and financial risk components. The new guidance eliminates the requirement to separately measure and present hedge ineffectiveness and aligns the presentation of hedge gains and losses with the underlying hedge item. The new guidance also simplifies the hedge documentation and hedge effectiveness assessment requirements. The amended presentation and disclosure requirements must be adopted on a prospective basis, while any amendments to cash flow and net investment hedge relationships that exist on the date of adoption must be applied on a “modified retrospective” basis, meaning a cumulative effect adjustment to the opening balance of retained earnings as of the beginning of the year of adoption. The new guidance was effective for the Company on January 1, 2019 and did not have a material impact on the Company’s Consolidated Financial Statements.

In January 2017, the FASB issued ASU No. 2017-04, “Intangibles–Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,” eliminating the requirement to calculate implied fair value, essentially eliminating step two from the goodwill impairment test. The new standard requires goodwill impairment to be based upon the results of step one of the impairment test, which is defined as the excess of the carrying value of a reporting unit over its fair value. The impairment charge will be limited to the amount of goodwill allocated to that reporting unit. The standard is effective for the Company on a prospective basis beginning on January 1, 2020, with early adoption permitted. This new guidance is not expected to have an impact on the Company’s Consolidated Financial Statements.

In February 2016, the FASB issued its final standard on lease accounting, ASU No. 2016-02, “Leases (Topic 842),” which superseded Topic 840, “Leases,” which was further modified in ASU No. 2018-10, “Codification Improvements to Topic 842, Leases,” ASU No. 2018-11, “Leases (Topic 842) Targeted Improvements” and ASU No. 2019-01 “Leases (Topic 842) Codification Improvements” to clarify the implementation guidance. The new accounting standard was effective for the Company beginning on January 1, 2019 and required the recognition on the balance sheet of right-of-use assets and lease liabilities for all long-term leases, including operating leases, on the balance sheet. The Company elected the optional transition method and adopted the new guidance on January 1, 2019, on a modified retrospective basis with no restatement of prior period amounts. As allowed under the new accounting standard, the Company elected to apply practical expedients to carry forward the original lease determinations, lease classifications and accounting of initial direct costs for all asset classes at the time of adoption. The Company also elected not to separate lease components from non-lease components and to exclude short-term leases from its Consolidated Balance Sheet. The Company’s adoption of the new standard resulted in the recognition of right-of-use assets of $458 and liabilities of $574, with no material cumulative effect adjustment to equity as of the date of adoption. In connection with the adoption of this guidance, as required, the Company reclassified certain restructuring reserves incurred in connection with the Global Growth and Efficiency Program (see Note 4, Restructuring and Related Implementation Charges for additional information) and deferred rent liabilities as reductions to lease assets. Adoption of the new standard did not have a material impact on the Company’s Consolidated Statements of Income or Cash Flows. See Note 13, Leases for additional information.

XML

Restructuring and Related Implementation Charges

6 Months Ended

Jun. 30, 2019

Restructuring and Related Activities [Abstract]

Restructuring and Related Implementation Charges

Restructuring and Related Implementation Charges

In the fourth quarter of 2012, the Company commenced a restructuring program (the “Global Growth and Efficiency Program”). The program was expanded in 2014 and expanded and extended in each of 2015 and 2017. The program runs through December 31, 2019.

Initiatives under the Global Growth and Efficiency Program continue to fit within the program’s three focus areas of expanding commercial hubs, extending shared business services and streamlining global functions and optimizing the global supply chain and facilities.

Cumulative pretax charges resulting from the Global Growth and Efficiency Program, once all phases are approved and implemented, are estimated to be in the range of $1,820 to $1,870 ($1,350 to $1,380 aftertax). The Company anticipates that pretax charges for 2019 will approximate $100 to $150 ($70 to $100 aftertax). It is expected that substantially all charges resulting from the Global Growth and Efficiency Program will be incurred by December 31, 2019.

The pretax charges resulting from the Global Growth and Efficiency Program are estimated to be comprised of the following categories: Employee-Related Costs, including severance, pension and other termination benefits (40%); asset-related costs, primarily Incremental Depreciation and Asset Impairments (10%); and Other charges, which include contract termination costs, consisting primarily of related implementation charges resulting directly from exit activities (30%) and the implementation of new strategies (20%). Over the course of the Global Growth and Efficiency Program, it is estimated that approximately 75% of the charges will result in cash expenditures.

The Company expects that the cumulative pretax charges, once all projects are approved and implemented, will relate to initiatives undertaken in North America (15%), Europe (20%), Latin America (5%), Asia Pacific (5%), Africa/Eurasia (5%), Hill’s Pet Nutrition (10%) and Corporate (40%), which includes substantially all of the costs related to the implementation of new strategies, noted above, on a global basis. The Company expects that, when it has been fully implemented, the Global Growth and Efficiency Program will have contributed a net reduction of approximately 4,000 to 4,400 positions from the Company’s global employee workforce.

For the three and six months ended June 30, 2019 and 2018, restructuring and related implementation charges are reflected in the Condensed Consolidated Statements of Income as follows:

	Three Months Ended					Six Months Ended
	June 30,					June 30,
	2019			2018		2019		2018
Cost of sales	$	(3	)	$	5	$	8	$	11
Selling, general and administrative expenses	10			10		14		15
Other (income) expense, net	33			43		46		56
Non-service related postretirement costs	2			3		3		7
Total Global Growth and Efficiency Program charges, pretax	$	42		$	61	$	71	$	89
Total Global Growth and Efficiency Program charges, aftertax	$	31		$	51	$	53	$	71

Restructuring and related implementation charges in the preceding table are recorded in the Corporate segment as these initiatives are predominantly centrally directed and controlled and are not included in internal measures of segment operating performance.

Total charges incurred for the Global Growth and Efficiency Program relate to initiatives undertaken by the following reportable operating segments:

	Three Months Ended				Six Months Ended				Program-to-date
	June 30,				June 30,				Accumulated Charges
	2019		2018		2019		2018
North America	—	%	8	%	3	%	17	%	18	%
Latin America	8	%	11	%	21	%	11	%	5	%
Europe	(3	)%	2	%	1	%	2	%	19	%
Asia Pacific	7	%	(6	)%	7	%	1	%	4	%
Africa/Eurasia	(2	)%	7	%	(1	)%	6	%	5	%
Hill’s Pet Nutrition	1	%	22	%	6	%	21	%	8	%
Corporate	89	%	56	%	63	%	42	%	41	%
Total	100	%	100	%	100	%	100	%	100	%

Since the inception of the Global Growth and Efficiency Program in the fourth quarter of 2012, the Company has incurred cumulative pretax charges of $1,793 ($1,331 aftertax) in connection with the implementation of various projects as follows:

	Cumulative Charges
	as of June 30, 2019
Employee-Related Costs	$	695
Incremental Depreciation	102
Asset Impairments	58
Other	938
Total	$	1,793

The majority of costs incurred since inception relate to the following projects: the implementation of the Company’s overall hubbing strategy; the consolidation of facilities; the extension of shared business services and streamlining of global functions; the closing of the Morristown, New Jersey personal care facility; the simplification and streamlining of the Company’s research and development capabilities and oral care supply chain, both in Europe; redesigning the European commercial organization; restructuring how the Company will provide future retirement benefits to substantially all of the U.S.-based employees participating in the Company’s defined benefit retirement plan by shifting them to the Company’s defined contribution plan; and the implementation of a Corporate efficiencies program.

The following tables summarize the activity for the restructuring and related implementation charges discussed above and the related accruals:

	Three Months Ended June 30, 2019
	Employee-Related Costs			Incremental Depreciation			Asset Impairments		Other			Total
Balance at March 31, 2019	$	52		$	—		$	—	$	94		$	146
Charges	4			5			—		33			42
Cash payments	(12		)	—			—		(14		)	(26		)
Charges against assets	(2		)	(5		)	—		(27		)	(34		)
Foreign exchange	(1		)	—			—		—			(1		)
Other	—			—			—		—			—
Balance at June 30, 2019	$	41		$	—		$	—	$	86		$	127

	Six Months Ended June 30, 2019
	Employee-Related Costs			Incremental Depreciation			Asset Impairments			Other			Total
Balance at December 31, 2018	$	60		$	—		$	—		$	142		$	202
Charges	14			10			6			41			71
Cash payments	(28		)	—			—			(22		)	(50		)
Charges against assets	(3		)	(10		)	(6		)	(27		)	(46		)
Foreign exchange	(2		)	—			—			—			(2		)
Other	—			—			—			(48		)	(48		)
Balance at June 30, 2019	$	41		$	—		$	—		$	86		$	127

Employee-Related Costs primarily include severance and other termination benefits and are calculated based on long-standing benefit practices, local statutory requirements and, in certain cases, voluntary termination arrangements. Employee-Related Costs also include pension and other retiree benefit enhancements amounting to $2 and $3 for the three and six months ended June 30, 2019, respectively, which are reflected as Charges against assets within Employee-Related Costs in the preceding tables as the corresponding balance sheet amounts are reflected as a reduction of pension assets or an increase in pension and other retiree benefit liabilities. See Note 8, Retirement Plans and Other Retiree Benefits for additional information.

Incremental Depreciation is recorded to reflect changes in useful lives and estimated residual values for long-lived assets that will be taken out of service prior to the end of their normal service period. Asset Impairments are recorded to write down inventories and assets held for sale or disposal to their fair value based on amounts expected to be realized. Charges against assets within Asset Impairments are net of cash proceeds pertaining to the sale of certain assets.

Other charges consist primarily of charges resulting directly from exit activities and the implementation of new strategies as a result of the Global Growth and Efficiency Program. These charges for the three and six months ended June 30, 2019 include third-party incremental costs related to the development and implementation of new business and strategic initiatives of $5 and $10, respectively, and contract termination costs and charges resulting directly from exit activities of $0 and $3, respectively. These charges were expensed as incurred. Other charges also included a charge for exit costs related to office space consolidation of $28 for the three and six months ended June 30, 2019.

Other decreases to the restructuring accruals reflects the reclassification of restructuring accruals to lease assets as a result of the Company’s adoption of ASU No. 2018-10, “Codification Improvements to Topic 842, Leases,” on January 1, 2019. See Note 3, Recent Accounting Pronouncements and Note 13, Leases for additional information.

XML

Inventories

6 Months Ended

Jun. 30, 2019

Inventory, Net, Items Net of Reserve Alternative [Abstract]

Inventories

Inventories

Inventories by major class are as follows:

	June 30, 2019		December 31, 2018
Raw materials and supplies	$	258	$	253
Work-in-process	42		37
Finished goods	1,022		960
Total Inventories	$	1,322	$	1,250

XML

Earnings Per Share

6 Months Ended

Jun. 30, 2019

Earnings Per Share [Abstract]

Earnings Per Share

Earnings Per Share

For the three months ended June 30, 2019 and 2018, earnings per share were as follows:

	Three Months Ended
	June 30, 2019					June 30, 2018
	Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share		Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share
Basic EPS	$	586	859.4	$	0.68	$	637	871.7	$	0.73
Stock options and restricted stock units			2.5					2.3
Diluted EPS	$	586	861.9	$	0.68	$	637	874.0	$	0.73

For the three months ended June 30, 2019 and 2018, the average number of stock options and restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 18,334,488 and 16,303,599, respectively.

For the six months ended June 30, 2019 and 2018, earnings per share were as follows:

	Six Months Ended
	June 30, 2019					June 30, 2018
	Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share		Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share
Basic EPS	$	1,146	860.7	$	1.33	$	1,271	873.5	$	1.46
Stock options and restricted stock units			2.0					3.5
Diluted EPS	$	1,146	862.7	$	1.33	$	1,271	877.0	$	1.45

For the six months ended June 30, 2019 and 2018, the average number of stock options and restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 21,751,174 and 16,284,602, respectively.

Basic and diluted earnings per share are computed independently for each quarter and any year-to-date period presented. As a result of changes in the number of shares outstanding during the year and rounding, the sum of the quarters’ earnings per share may not necessarily equal the earnings per share for any year-to-date period.

XML

Other Comprehensive Income (Loss)

6 Months Ended

Jun. 30, 2019

Equity [Abstract]

Other Comprehensive Income (Loss)

Other Comprehensive Income (Loss)

Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the three months ended June 30, 2019 and 2018 were as follows:

	2019						2018
	Pretax			Net of Tax			Pretax			Net of Tax
Cumulative translation adjustments	$	23		$	30		$	(274	)	$	(289	)
Retirement plans and other retiree benefits:
Net actuarial gain (loss) and prior service costs arising during the period	—			—			—			—
Amortization of net actuarial loss, transition and prior service costs (1)	18			13			18			14
Retirement plans and other retiree benefits adjustments	18			13			18			14
Cash flow hedges:
Unrealized gains (losses) on cash flow hedges	(1		)	(1		)	14			10
Reclassification of (gains) losses into net earnings on cash flow hedges (2)	(1		)	(1		)	2			1
Gains (losses) on cash flow hedges	(2		)	(2		)	16			11
Total Other comprehensive income (loss)	$	39		$	41		$	(240	)	$	(264	)

⁽¹⁾ These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 8, Retirement Plans and Other Retiree Benefits for additional details.

⁽²⁾ These (gains) losses are reclassified into Cost of sales. See Note 12, Fair Value Measurements and Financial Instruments for additional details.

There were no tax impacts on Other comprehensive income (loss) (“OCI”) attributable to Noncontrolling interests.

Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the six months ended June 30, 2019 and 2018 were as follows:

	2019						2018
	Pretax			Net of Tax			Pretax			Net of Tax
Cumulative translation adjustments	$	50		$	51		$	(178	)	$	(184	)
Retirement plans and other retiree benefits:
Net actuarial gain (loss) and prior service costs arising during the period	(1		)	(1		)	—			—
Amortization of net actuarial loss, transition and prior service costs (1)	35			26			36			28
Retirement plans and other retiree benefits adjustments	34			25			36			28
Cash flow hedges:
Unrealized gains (losses) on cash flow hedges	(3		)	(3		)	6			4
Reclassification of (gains) losses into net earnings on cash flow hedges (2)	(5		)	(4		)	8			6
Gains (losses) on cash flow hedges	(8		)	(7		)	14			10
Total Other comprehensive income (loss)	$	76		$	69		$	(128	)	$	(146	)

⁽¹⁾ These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 8, Retirement Plans and Other Retiree Benefits for additional details.

⁽²⁾ These (gains) losses are reclassified into Cost of sales. See Note 12, Fair Value Measurements and Financial Instruments for additional details.

There were no tax impacts on OCI attributable to Noncontrolling interests.

XML

Retirement Plans and Other Retiree Benefits

6 Months Ended

Jun. 30, 2019

Retirement Benefits [Abstract]

Retirement Plans and Other Retiree Benefits

Retirement Plans and Other Retiree Benefits

Components of Net periodic benefit cost for the three and six months ended June 30, 2019 and 2018 were as follows:

	Pension Benefits												Other Retiree Benefits
	United States						International
	Three Months Ended June 30,
	2019			2018			2019			2018			2019		2018
Service cost	$	—		$	1		$	3		$	3		$	3	$	4
Interest cost	23			22			5			5			9		9
Expected return on plan assets	(24		)	(29		)	(4		)	(5		)	—		—
Amortization of actuarial loss (gain)	12			11			3			2			3		5
Net periodic benefit cost	$	11		$	5		$	7		$	5		$	15	$	18

	Pension Benefits												Other Retiree Benefits
	United States						International
	Six Months Ended June 30,
	2019			2018			2019			2018			2019			2018
Service cost	$	—		$	1		$	7		$	7		$	7		$	8
Interest cost	46			43			10			11			20			19
Expected return on plan assets	(49		)	(58		)	(9		)	(11		)	(1		)	—
Amortization of actuarial loss (gain)	25			23			5			4			5			9
Net periodic benefit cost	$	22		$	9		$	13		$	11		$	31		$	36

For the six months ended June 30, 2019 and 2018, the Company made voluntary contributions to its U.S. postretirement plans of $102 and $0, respectively.

XML

Income Taxes

6 Months Ended

Jun. 30, 2019

Income Tax Disclosure [Abstract]

Income Taxes

Income Taxes

On December 22, 2017, the Tax Cuts and Jobs Act (the “TCJA” or “U.S. tax reform”) was enacted, which, among other things, lowered the U.S. corporate income tax rate to 21% from 35% and established a modified territorial system requiring a mandatory deemed repatriation tax on undistributed earnings of foreign subsidiaries. Beginning in 2018, the TCJA also requires a minimum tax on certain earnings generated by foreign subsidiaries while providing for tax-free repatriation of such earnings through a 100% dividends-received deduction. The Company’s effective income tax rate in 2017 included a provisional charge of $275, recorded in the fourth quarter of 2017, based on its initial analysis of the TCJA. During 2018, the Company finalized its assessment of the impact of the TCJA and recognized an additional tax expense of $80 reflecting the impact of transition tax guidance issued by the U.S. Treasury and the update of certain estimates and calculations based on information available through the end of 2018.

The impact, if any, of further transitional tax guidance that may be issued by the U.S. Treasury would be reflected in the Company’s provision for income tax in the period such guidance is effective.

XML

Contingencies

6 Months Ended

Jun. 30, 2019

Loss Contingency [Abstract]

Contingencies

Contingencies

As a global company serving consumers in more than 200 countries and territories, the Company is routinely subject to a wide variety of legal proceedings. These include disputes relating to intellectual property, contracts, product liability, marketing, advertising, foreign exchange controls, antitrust and trade regulation, as well as labor and employment, pension, data privacy and security, environmental and tax matters and consumer class actions. Management proactively reviews and monitors the Company’s exposure to, and the impact of, environmental matters. The Company is party to various environmental matters and, as such, may be responsible for all or a portion of the cleanup, restoration and post-closure monitoring of several sites.

The Company establishes accruals for loss contingencies when it has determined that a loss is probable and that the amount of loss, or range of loss, can be reasonably estimated. Any such accruals are adjusted thereafter as appropriate to reflect changes in circumstances.

The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible and it is able to determine such estimates. For those matters disclosed below for which the amount of any potential losses can be reasonably estimated, the Company currently estimates that the aggregate range of reasonably possible losses in excess of any accrued liabilities is $0 to approximately $225 (based on current exchange rates). The estimates included in this amount are based on the Company’s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate amount may not represent the ultimate loss to the Company. Thus, the Company’s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above.

Based on current knowledge, management does not believe that the ultimate resolution of loss contingencies arising from the matters discussed herein will have a material effect on the Company’s consolidated financial position or its ongoing results of operations or cash flows. However, in light of the inherent uncertainties noted above, an adverse outcome in one or more matters could be material to the Company’s results of operations or cash flows for any particular quarter or year.

Brazilian Matters

There are certain tax and civil proceedings outstanding, as described below, related to the Company’s 1995 acquisition of the Kolynos oral care business from Wyeth (the “Seller”).

The Brazilian internal revenue authority has disallowed interest deductions and foreign exchange losses taken by the Company’s Brazilian subsidiary for certain years in connection with the financing of the Kolynos acquisition. The tax assessments with interest, penalties and any court-mandated fees, at the current exchange rate, are approximately $158. This amount includes additional assessments received from the Brazilian internal revenue authority in April 2016 relating to net operating loss carryforwards used by the Company’s Brazilian subsidiary to offset taxable income that had also been deducted from the authority’s original assessments. The Company has been disputing the disallowances by appealing the assessments since October 2001. There is one case currently on appeal at the administrative level. In the event the Company is ultimately unsuccessful in this administrative appeal, further appeals are available within the Brazilian federal courts.

In September 2015, the Company lost one of its appeals at the administrative level and filed a lawsuit in Brazilian federal court. In February 2017, the Company lost an additional administrative appeal and filed a lawsuit in Brazilian federal court. In April 2019, the Company lost another administrative appeal and filed a lawsuit in Brazilian federal court. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the disallowances are without merit and that the Company should ultimately prevail. The Company is challenging these disallowances vigorously.

In July 2002, the Brazilian Federal Public Attorney filed a civil action against the federal government of Brazil, Laboratorios Wyeth-Whitehall Ltda. (the Brazilian subsidiary of the Seller) and the Company, as represented by its Brazilian subsidiary, in the 6th. Lower Federal Court in the City of São Paulo, seeking to annul an April 2000 decision by the Brazilian Board of Tax Appeals that found in favor of the Seller’s Brazilian subsidiary on the issue of whether it had incurred taxable capital gains as a result of the divestiture of Kolynos. The action seeks to make the Company’s Brazilian subsidiary jointly and severally liable for any tax due from the Seller’s Brazilian subsidiary. The case has been pending since 2002, and the Lower Federal Court has not issued a decision. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the Company should ultimately prevail in this action. The Company is challenging this action vigorously.

In December 2005, the Brazilian internal revenue authority issued to the Company’s Brazilian subsidiary a tax assessment with interest, penalties and any court-mandated fees of approximately $66, at the current exchange rate, based on a claim that certain purchases of U.S. Treasury bills by the subsidiary and their subsequent disposition during the period 2000 to 2001 were subject to a tax on foreign exchange transactions. The Company had been disputing the assessment within the internal revenue authority’s administrative appeals process. However, in November 2015, the Superior Chamber of Administrative Tax Appeals denied the Company’s final administrative appeal, and the Company has filed a lawsuit in the Brazilian federal court. In the event the Company is unsuccessful in this lawsuit, further appeals are available within the Brazilian federal courts. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the tax assessment is without merit and that the Company should ultimately prevail. The Company is challenging this assessment vigorously.

Competition Matters

Certain of the Company’s subsidiaries have historically been subject to investigations, and, in some cases, fines, by governmental authorities in a number of countries related to alleged competition law violations. Substantially all of these matters also involved other consumer goods companies and/or retail customers. The Company’s policy is to comply with antitrust and competition laws and, if a violation of any such laws is found, to take appropriate remedial action and to cooperate fully with any related governmental inquiry. The status as of June 30, 2019 of competition law matters pending against the Company during the six months ended June 30, 2019 is set forth below.

▪ In December 2014, the French competition law authority found that 13 consumer goods companies, including the Company’s French subsidiary, exchanged competitively sensitive information related to the French home care and personal care sectors, for which the Company’s French subsidiary was fined $57. In addition, as a result of the Company’s acquisition of the Sanex personal care business in 2011 from Unilever N.V. and Unilever PLC (together with Unilever N.V., “Unilever,”), pursuant to a Business and Share Sale and Purchase Agreement (the “Sale and Purchase Agreement”), the French competition law authority found that the Company’s French subsidiary, along with Hillshire Brands Company (formerly Sara Lee Corporation (“Sara Lee”)), were jointly and severally liable for fines of $25 assessed against Sara Lee’s French subsidiary. The Company is indemnified for these fines by Unilever pursuant to the Sale and Purchase Agreement. The fines were confirmed by the Court of Appeal in October 2016. The Company appealed the decision of the Court of Appeal on behalf of the Company and Sara Lee in the French Supreme Court. In March 2019, the French Supreme Court denied the Company’s appeal.

▪ In July 2014, the Greek competition law authority issued a statement of objections alleging a restriction of parallel imports into Greece. The Company responded to this statement of objections. In July 2017, the Company received the decision from the Greek competition law authority in which the Company was fined $11. The Company appealed the decision to the Greek courts. In April 2019, the Greek courts affirmed the judgment against the Company’s Greek subsidiary, but reduced the fine to $10.5 and dismissed the case against Colgate-Palmolive Company. The Company’s Greek subsidiary is appealing the decision to the Greek Supreme Court.

Talcum Powder Matters

The Company has been named as a defendant in civil actions alleging that certain talcum powder products that were sold prior to 1996 were contaminated with asbestos. Most of these actions involve a number of co-defendants from a variety of different industries, including suppliers of asbestos and manufacturers of products that, unlike the Company’s products, were designed to contain asbestos. As of June 30, 2019, there were 237 individual cases pending against the Company in state and federal courts throughout the United States, as compared to 229 cases as of March 31, 2019 and 239 cases as of December 31, 2018. During the quarter ended June 30, 2019, 25 new cases were filed and 17 cases were resolved by voluntary dismissal, dismissal by the court, judgment in the Company’s favor or settlement. During the quarter ended June 30, 2019, one case resulted in an adverse jury verdict after a trial, which the Company plans to appeal. During the six months ended June 30, 2019, 62 new cases were filed and 64 cases were resolved by voluntary dismissal, dismissal by the court, judgment in the Company’s favor or settlement. The value of the settlements and of the adverse jury verdict in the quarter and the year-to-date period presented was not material, either individually or in the aggregate, to each such period’s results of operations.

The Company believes that a significant portion of its costs incurred in defending and resolving these claims will be covered by insurance policies issued by several primary, excess and umbrella insurance carriers, subject to deductibles, exclusions, retentions and policy limits.

While the Company and its legal counsel believe that these cases are without merit and intend to challenge them vigorously, there can be no assurances regarding the ultimate resolution of these matters. With the exception of the case where the Company received an adverse jury verdict, the range of reasonably possible losses in excess of accrued liabilities disclosed above does not include any amount relating to these cases because the amount of any possible losses from such cases currently cannot be reasonably estimated.

ERISA Matter

In June 2016, a putative class action claiming that residual annuity payments made to certain participants in the Colgate-Palmolive Company Employees’ Retirement Income Plan (the “Plan”) did not comply with the Employee Retirement Income Security Act was filed against the Plan, the Company and certain individuals in the United States District Court for the Southern District of New York. This action has been certified as a class action. The relief sought includes recalculation of benefits, pre- and post-judgment interest and attorneys’ fees. The Company is contesting this action vigorously. Since the amount of any potential loss from this case currently cannot be reasonably estimated, the range of reasonably possible losses in excess of accrued liabilities disclosed above does not include any amount relating to the case.

XML

Segment Information

6 Months Ended

Jun. 30, 2019

Segment Reporting [Abstract]

Segment Information

Segment Information

The Company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition. 

The operations of the Oral, Personal and Home Care product segment are managed geographically in five reportable operating segments: North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of operating segment performance because it excludes the impact of Corporate-driven decisions related to interest expense and income taxes.

The accounting policies of the operating segments are generally the same as those described in Note 2, Summary of Significant Accounting Policies to the Company’s Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018. Intercompany sales have been eliminated. Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation charges and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of segment operating performance used by the Company to measure the underlying performance of the operating segments.

Net sales by segment were as follows:

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2019		2018		2019		2018
Net sales
Oral, Personal and Home Care
North America	$	846	$	824	$	1,699	$	1,651
Latin America	929		933		1,818		1,862
Europe	588		620		1,190		1,268
Asia Pacific	646		674		1,346		1,433
Africa/Eurasia	244		243		484		498
Total Oral, Personal and Home Care	3,253		3,294		6,537		6,712
Pet Nutrition	613		592		1,213		1,176
Total Net sales	$	3,866	$	3,886	$	7,750	$	7,888

Approximately 70% of the Company’s Net sales are generated from markets outside the U.S., with approximately 50% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe).

The Company’s Net sales of Oral, Personal and Home Care and Pet Nutrition products accounted for the following percentages of the Company’s Net sales:

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2019		2018		2019		2018
Net sales
Oral Care	45	%	47	%	47	%	48	%
Personal Care	21	%	20	%	19	%	19	%
Home Care	18	%	18	%	18	%	18	%
Pet Nutrition	16	%	15	%	16	%	15	%
Total Net sales	100	%	100	%	100	%	100	%

Operating profit by segment was as follows:

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2019			2018			2019			2018
Operating profit
Oral, Personal and Home Care
North America	$	254		$	264		$	503		$	521
Latin America	251			262			483			535
Europe	148			156			299			318
Asia Pacific	174			203			363			429
Africa/Eurasia	47			42			93			92
Total Oral, Personal and Home Care	874			927			1,741			1,895
Pet Nutrition	167			165			331			329
Corporate	(153		)	(146		)	(305		)	(295		)
Total Operating profit	$	888		$	946		$	1,767		$	1,929

For the three and six months ended June 30, 2019, Corporate Operating profit (loss) included charges of $40 and $68, respectively, resulting from the Global Growth and Efficiency Program.

For the three and six months ended June 30, 2018, Corporate Operating profit (loss) included charges of $58 and $82, respectively, resulting from the Global Growth and Efficiency Program.

For further information regarding the Global Growth and Efficiency Program, refer to Note 4, Restructuring and Related Implementation Charges.

XML

Fair Value Measurements and Financial Instruments

6 Months Ended

Jun. 30, 2019

Fair Value Disclosures [Abstract]

Fair Value Measurements and Financial Instruments

Fair Value Measurements and Financial Instruments

The Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. The Company is exposed to the risk of credit loss in the event of nonperformance by counterparties to financial instrument contracts; however, nonperformance is considered unlikely and any nonperformance is unlikely to be material, as it is the Company’s policy to contract only with diverse, credit-worthy counterparties based upon both strong credit ratings and other credit considerations.

The Company is exposed to market risk from foreign currency exchange rates, interest rates and commodity price fluctuations. Volatility relating to these exposures is managed on a global basis by utilizing a number of techniques, including working capital management, sourcing strategies, selling price increases, selective borrowings in local currencies and entering into selective derivative instrument transactions, issued with standard features, in accordance with the Company’s treasury and risk management policies, which prohibit the use of derivatives for speculative purposes and leveraged derivatives for any purpose. It is the Company’s policy to enter into derivative instrument contracts with terms that match the underlying exposure being hedged.

The Company’s derivative instruments include interest rate swap contracts, foreign currency contracts and commodity contracts. The Company utilizes interest rate swap contracts to manage its targeted mix of fixed and floating rate debt, and these swaps are valued using observable benchmark rates (Level 2 valuation). The Company utilizes foreign currency contracts, including forward and swap contracts, option contracts, local currency deposits and local currency borrowings to hedge portions of its foreign currency purchases, assets and liabilities arising in the normal course of business and the net investment in certain foreign subsidiaries. These contracts are valued using observable market rates (Level 2 valuation). Commodity futures contracts are utilized to hedge the purchases of raw materials used in production. These contracts are measured using quoted commodity exchange prices (Level 1 valuation). The duration of foreign currency and commodity contracts generally does not exceed 12 months.

The company adopted ASU No. 2017-12, “Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities,” beginning on January 1, 2019. Refer to Note 3, Recent Accounting Pronouncements.

The following table summarizes the fair value of the Company’s derivative instruments and other financial instruments which are carried at fair value in the Company’s Consolidated Balance Sheets at June 30, 2019 and December 31, 2018:

	Assets					Liabilities
	Account	Fair Value				Account	Fair Value
Designated derivative instruments		June 30, 2019		December 31, 2018			June 30, 2019		December 31, 2018
Interest rate swap contracts	Other current assets	$	—	$	—	Other accruals	$	—	$	1
Interest rate swap contracts	Other assets	4		—		Other liabilities	—		8
Foreign currency contracts	Other current assets	9		20		Other accruals	11		8
Foreign currency contracts	Other assets	—		—		Other liabilities	19		21
Commodity contracts	Other current assets	—		—		Other accruals	—		—
Total designated		$	13	$	20		$	30	$	38
Other financial instruments
Marketable securities	Other current assets	$	66	$	10
Total other financial instruments		$	66	$	10

The carrying amount of cash, cash equivalents, accounts receivable and short-term debt approximated fair value as of June 30, 2019 and December 31, 2018. The estimated fair value of the Company’s long-term debt, including the current portion, as of June 30, 2019 and December 31, 2018, was $6,545 and $6,434, respectively, and the related carrying value was $6,641 and $6,354, respectively. The estimated fair value of long-term debt was derived principally from quoted prices on the Company’s outstanding fixed-term notes (Level 2 valuation).

The following amounts were recorded on the Condensed Consolidated Balance Sheet related to cumulative basis adjustment for fair value hedges as of:

	June 30, 2019		December 31, 2018
Long-term debt:
Carrying amount of hedged item	$	402	$	888
Cumulative hedging adjustment included in the carrying amount	4		(10		)

The following tables present the notional values as of:

	June 30, 2019
	Foreign Currency Contracts		Foreign Currency Debt		Interest Rate Swaps		Commodity Contracts		Total
Fair Value Hedges	$	355	$	—	$	400	$	—	$	755
Cash Flow Hedges	744		—		—		16		760
Net Investment Hedges	544		2,189		—		—		2,733

	December 31, 2018
	Foreign Currency Contracts		Foreign Currency Debt		Interest Rate Swaps		Commodity Contracts		Total
Fair Value Hedges	$	327	$	—	$	900	$	—	$	1,227
Cash Flow Hedges	782		—		—		14		796
Net Investment Hedges	482		1,396		—		—		1,878

The following tables present the location and amount of gains (losses) recognized on the Company’s Condensed Consolidated Statements of Income:

	Three Months Ended June 30,
	2019								2018
	Cost of sales		Selling, general and administrative expenses			Interest (income) expense, net			Cost of sales			Selling, general and administrative expenses			Interest (income) expense, net
Gain (loss) on hedges recognized in income:
Interest rate swaps designated as fair value hedges:
Derivative instrument	$	—	$	—		$	(10	)	$	—		$	—		$	(1	)
Hedged items	—		—			10			—			—			1
Foreign currency contracts designated as fair value hedges:
Derivative instrument	—		11			—			—			6			—
Hedged items	—		(11		)	—			—			(6		)	—
Foreign currency contracts designated as cash flow hedges:
Amount reclassified from OCI	1		—			—			(2		)	—			—
Commodity contracts designated as cash flow hedges:
Amount reclassified from OCI	—		—			—			—			—			—
Total gain (loss) on hedges recognized in income	$	1	$	—		$	—		$	(2	)	$	—		$	—

	Six Months Ended June 30,
	2019								2018
	Cost of sales		Selling, general and administrative expenses			Interest (income) expense, net			Cost of sales			Selling, general and administrative expenses			Interest (income) expense, net
Gain (loss) on hedges recognized in income:
Interest rate swaps designated as fair value hedges:
Derivative instrument	$	—	$	—		$	(13	)	$	—		$	—		$	(11	)
Hedged items	—		—			13			—			—			11
Foreign currency contracts designated as fair value hedges:
Derivative instrument	—		10			—			—			(7		)	—
Hedged items	—		(10		)	—			—			7			—
Foreign currency contracts designated as cash flow hedges:
Amount reclassified from OCI	4		—			—			(8		)	—			—
Commodity contracts designated as cash flow hedges:
Amount reclassified from OCI	1		—			—			—			—			—
Total gain (loss) on hedges recognized in income	$	5	$	—		$	—		$	(8	)	$	—		$	—

The following tables present the location and amount of unrealized gains (losses) included in OCI:

	Three Months Ended
	June 30,
	2019			2018
Foreign currency contracts designated as cash flow hedges:
Gain (loss) recognized in OCI	$	(2	)	$	14
Commodity contracts designated as cash flow hedges:
Gain (loss) recognized in OCI	1			—
Foreign currency contracts designated as net investment hedges:
Gain (loss) on instruments	(7		)	43
Gain (loss) on hedged items	7			(41		)
Foreign currency debt designated as net investment hedges:
Gain (loss) on instruments	(24		)	78
Gain (loss) on hedged items	24			(78		)
Total unrealized gain (loss) on hedges recognized in OCI	$	(1	)	$	16

	Six Months Ended
	June 30,
	2019			2018
Foreign currency contracts designated as cash flow hedges:
Gain (loss) recognized in OCI	$	(5	)	$	6
Commodity contracts designated as cash flow hedges:
Gain (loss) recognized in OCI	2			—
Foreign currency contracts designated as net investment hedges:
Gain (loss) on instruments	(1		)	25
Gain (loss) on hedged items	1			(23		)
Foreign currency debt designated as net investment hedges:
Gain (loss) on instruments	5			59
Gain (loss) on hedged items	(5		)	(59		)
Total unrealized gain (loss) on hedges recognized in OCI	$	(3	)	$	8

XML

Leases

6 Months Ended

Jun. 30, 2019

Leases [Abstract]

Leases

Leases

The Company adopted ASU No. 2016-02 “Leases (Topic 842)” on January 1, 2019, resulting in the recognition of right-of-use assets of $458 and liabilities of $574. The Company enters into leases for land, office space, warehouses and equipment. A number of the leases include one or more options to renew the lease terms, purchase the leased property or terminate the lease. The exercise of these options is at the Company’s discretion and is therefore recognized on the balance sheet when it is reasonably certain the Company will exercise such options. As the Company’s leases typically do not contain a readily determinable implicit rate, the Company determines the present value of the lease liability using its incremental borrowing rate at the lease commencement date.

Substantially all of the Company’s leases are considered operating leases. Finance leases were not material as of June 30, 2019 or for the three and six months ended June 30, 2019.

As of June 30, 2019, the Company’s right-of use assets and liabilities for operating leases were as follows:

Other assets	$	548
Other accruals	$	153
Other liabilities	530
Total operating lease liabilities	$	683

Lease commitments under noncancellable operating leases were as follows:

Years Ending December 31,	As of June 30, 2019				As of December 31, 2018
2019	$	95		(1)	$	193
2020	155				165
2021	119				123
2022	96				102
2023	60				51
Thereafter	275				32
Total lease commitments	$	800			$	666
Less: Interest	(117		)
Present value of lease liabilities	$	683

⁽¹⁾ As of June 30, 2019, $95 represents the lease commitments for the six months remaining until December 31, 2019.

The components of the Company’s operating lease cost for the three and six months ended June 30, 2019 were as follows:

	Three Months Ended June 30, 2019		Six Months Ended June 30, 2019
Operating lease cost	$	38	$	83
Short-term lease cost	—		2
Variable lease cost	6		16
Sublease income	—		—
Total lease cost	$	44	$	101

Short-term lease cost represents the Company’s cost with respect to leases with a duration of 12 months or less and is not reflected on the Company’s Consolidated Balance Sheets. Variable lease costs are comprised of costs, such as the Company’s proportionate share of actual costs for utilities, common area maintenance, property taxes and insurance that are not included in the lease liability and are recognized in the period in which they are incurred.

Supplemental cash flow information related to operating leases for the six months ended June 30, 2019 was as follows:

▪ Payments against amounts included in the measurement of lease liabilities: $102

▪ Lease assets obtained in exchange for lease liabilities: $209

As of June 30, 2019, the weighted-average remaining lease term for operating leases was 8 years and the weighted-average discount rate for operating leases was 4.0%.

There were no material operating leases that the Company had entered into and that were yet to commence as of June 30, 2019.

XML

Subsequent Events

6 Months Ended

Jun. 30, 2019

Subsequent Events [Abstract]

Subsequent Events

Subsequent Event

On July 11, 2019, the Company announced that it entered into a Share Purchase Agreement to acquire the Laboratoires Filorga Cosmétiques (“Filorga”) skin care business from Filorga Initiatives (the “Seller”) for an equity purchase price of €1,495.5 (approximately $1,690) in cash. The consummation of the transaction is subject only to the approval of the Austrian Federal Competition Authority, the French Competition Authority and the Federal Antimonopoly Service of the Russian Federation, as well as the absence of any governmental proceeding, order or law that would prohibit the consummation of the transaction. The transaction will be financed with a combination of debt and cash and is currently expected to close in the third quarter of 2019. At the closing of the acquisition, Colgate will acquire Filorga, including cash, debt and working capital it has accrued since January 1, 2019, and the Company will pay the Seller an amount of interest on the purchase price calculated at an annual rate of 2% in respect of the period commencing January 1, 2019 and ending on the closing date of the acquisition.

XML

Use of Estimates (Policies)

6 Months Ended

Jun. 30, 2019

Accounting Policies [Abstract]

Use of Estimates

Provisions for certain expenses, including income taxes, advertising and consumer promotion, are based on full year assumptions and are included in the accompanying Condensed Consolidated Financial Statements in proportion with estimated annual tax rates, the passage of time or estimated annual sales, as applicable.

Recent Accounting Pronouncements

In April 2019, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2019-04, Codification Improvements to Financial Instruments-Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Financial Instruments (Topic 825). This extensive ASU clarifies three topics related to financial instruments accounting. This new guidance is effective for the Company beginning on January 1, 2020, with early adoption permitted. This new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements.

In October 2018, the FASB issued ASU No. 2018-16, “Derivatives and Hedging (Topic 815): Inclusion of the Secured Overnight Financing Rate (“SOFR”) Overnight Index Swap (“OIS”) Rate as Benchmark Interest Rate for Hedge Accounting Purposes.” The new guidance permits the use of the OIS rate based on the SOFR as a U.S. benchmark interest rate for hedge accounting purposes under Topic 815. The new guidance was effective for the Company on a prospective basis beginning on January 1, 2019, concurrently with the adoption of ASU 2017-12, and did not have an impact on the Company’s Consolidated Financial Statements.

In August 2018, the FASB issued ASU No. 2018-15, “Intangibles-Goodwill and Other-Internal-Use Software (Topic 350): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract.” This new guidance aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. This new guidance is effective for the Company on a prospective or retrospective basis beginning on January 1, 2020, with early adoption permitted. The Company elected to adopt this guidance early, beginning on January 1, 2019 on a prospective basis. The new guidance did not have a material impact on the Company’s Consolidated Financial Statements.

In August 2018, the FASB issued ASU No. 2018-14, “Compensation-Retirement Benefits-Defined Benefit Plans-General (Topic 715): Disclosure Framework-Changes to the Disclosure Requirements for Defined Benefit Plans.” This new guidance removes certain disclosures that are not considered cost beneficial, clarifies certain required disclosures and requires certain additional disclosures. This new guidance is effective for the Company on a retrospective basis beginning on January 1, 2020, with early adoption permitted. While the Company is currently assessing the impact of the new guidance, it is not expected to have a material impact on the Company’s Consolidated Financial Statements.

In August 2018, the FASB issued ASU No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement.” This new guidance removes certain disclosure requirements related to the fair value hierarchy, modifies existing disclosure requirements related to measurement uncertainty and adds new disclosure requirements. The new disclosure requirements include disclosing the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. This new guidance is effective for the Company beginning on January 1, 2020, with early adoption permitted. Certain disclosure requirements in the new guidance will need to be applied on a retrospective basis and others on a prospective basis. While the Company is currently assessing the impact of the new guidance, it is not expected to have a material impact on the Company’s Consolidated Financial Statements.

In August 2017, the FASB issued ASU No. 2017-12, “Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities,” amending the eligibility criteria for hedged items and transactions to expand an entity’s ability to hedge nonfinancial and financial risk components. The new guidance eliminates the requirement to separately measure and present hedge ineffectiveness and aligns the presentation of hedge gains and losses with the underlying hedge item. The new guidance also simplifies the hedge documentation and hedge effectiveness assessment requirements. The amended presentation and disclosure requirements must be adopted on a prospective basis, while any amendments to cash flow and net investment hedge relationships that exist on the date of adoption must be applied on a “modified retrospective” basis, meaning a cumulative effect adjustment to the opening balance of retained earnings as of the beginning of the year of adoption. The new guidance was effective for the Company on January 1, 2019 and did not have a material impact on the Company’s Consolidated Financial Statements.

In January 2017, the FASB issued ASU No. 2017-04, “Intangibles–Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,” eliminating the requirement to calculate implied fair value, essentially eliminating step two from the goodwill impairment test. The new standard requires goodwill impairment to be based upon the results of step one of the impairment test, which is defined as the excess of the carrying value of a reporting unit over its fair value. The impairment charge will be limited to the amount of goodwill allocated to that reporting unit. The standard is effective for the Company on a prospective basis beginning on January 1, 2020, with early adoption permitted. This new guidance is not expected to have an impact on the Company’s Consolidated Financial Statements.

In February 2016, the FASB issued its final standard on lease accounting, ASU No. 2016-02, “Leases (Topic 842),” which superseded Topic 840, “Leases,” which was further modified in ASU No. 2018-10, “Codification Improvements to Topic 842, Leases,” ASU No. 2018-11, “Leases (Topic 842) Targeted Improvements” and ASU No. 2019-01 “Leases (Topic 842) Codification Improvements” to clarify the implementation guidance. The new accounting standard was effective for the Company beginning on January 1, 2019 and required the recognition on the balance sheet of right-of-use assets and lease liabilities for all long-term leases, including operating leases, on the balance sheet. The Company elected the optional transition method and adopted the new guidance on January 1, 2019, on a modified retrospective basis with no restatement of prior period amounts. As allowed under the new accounting standard, the Company elected to apply practical expedients to carry forward the original lease determinations, lease classifications and accounting of initial direct costs for all asset classes at the time of adoption. The Company also elected not to separate lease components from non-lease components and to exclude short-term leases from its Consolidated Balance Sheet. The Company’s adoption of the new standard resulted in the recognition of right-of-use assets of $458 and liabilities of $574, with no material cumulative effect adjustment to equity as of the date of adoption. In connection with the adoption of this guidance, as required, the Company reclassified certain restructuring reserves incurred in connection with the Global Growth and Efficiency Program (see Note 4, Restructuring and Related Implementation Charges for additional information) and deferred rent liabilities as reductions to lease assets. Adoption of the new standard did not have a material impact on the Company’s Consolidated Statements of Income or Cash Flows. See Note 13, Leases for additional information.

XML

Restructuring and Related Implementation Charges (Tables)

6 Months Ended

Jun. 30, 2019

Restructuring and Related Activities [Abstract]

Schedule of Restructuring and Related Costs

For the three and six months ended June 30, 2019 and 2018, restructuring and related implementation charges are reflected in the Condensed Consolidated Statements of Income as follows:

	Three Months Ended					Six Months Ended
	June 30,					June 30,
	2019			2018		2019		2018
Cost of sales	$	(3	)	$	5	$	8	$	11
Selling, general and administrative expenses	10			10		14		15
Other (income) expense, net	33			43		46		56
Non-service related postretirement costs	2			3		3		7
Total Global Growth and Efficiency Program charges, pretax	$	42		$	61	$	71	$	89
Total Global Growth and Efficiency Program charges, aftertax	$	31		$	51	$	53	$	71

Schedule of Percent of Total Restructuring Charges Related To Segment for the period

Total charges incurred for the Global Growth and Efficiency Program relate to initiatives undertaken by the following reportable operating segments:

	Three Months Ended				Six Months Ended				Program-to-date
	June 30,				June 30,				Accumulated Charges
	2019		2018		2019		2018
North America	—	%	8	%	3	%	17	%	18	%
Latin America	8	%	11	%	21	%	11	%	5	%
Europe	(3	)%	2	%	1	%	2	%	19	%
Asia Pacific	7	%	(6	)%	7	%	1	%	4	%
Africa/Eurasia	(2	)%	7	%	(1	)%	6	%	5	%
Hill’s Pet Nutrition	1	%	22	%	6	%	21	%	8	%
Corporate	89	%	56	%	63	%	42	%	41	%
Total	100	%	100	%	100	%	100	%	100	%

Schedule of Restructuring and Related Costs Incurred to Date

Since the inception of the Global Growth and Efficiency Program in the fourth quarter of 2012, the Company has incurred cumulative pretax charges of $1,793 ($1,331 aftertax) in connection with the implementation of various projects as follows:

	Cumulative Charges
	as of June 30, 2019
Employee-Related Costs	$	695
Incremental Depreciation	102
Asset Impairments	58
Other	938
Total	$	1,793

Schedule of Restructuring Reserve by Type of Cost

The following tables summarize the activity for the restructuring and related implementation charges discussed above and the related accruals:

	Three Months Ended June 30, 2019
	Employee-Related Costs			Incremental Depreciation			Asset Impairments		Other			Total
Balance at March 31, 2019	$	52		$	—		$	—	$	94		$	146
Charges	4			5			—		33			42
Cash payments	(12		)	—			—		(14		)	(26		)
Charges against assets	(2		)	(5		)	—		(27		)	(34		)
Foreign exchange	(1		)	—			—		—			(1		)
Other	—			—			—		—			—
Balance at June 30, 2019	$	41		$	—		$	—	$	86		$	127

	Six Months Ended June 30, 2019
	Employee-Related Costs			Incremental Depreciation			Asset Impairments			Other			Total
Balance at December 31, 2018	$	60		$	—		$	—		$	142		$	202
Charges	14			10			6			41			71
Cash payments	(28		)	—			—			(22		)	(50		)
Charges against assets	(3		)	(10		)	(6		)	(27		)	(46		)
Foreign exchange	(2		)	—			—			—			(2		)
Other	—			—			—			(48		)	(48		)
Balance at June 30, 2019	$	41		$	—		$	—		$	86		$	127

XML

Inventories (Tables)

6 Months Ended

Jun. 30, 2019

Inventory, Net, Items Net of Reserve Alternative [Abstract]

Inventories By Major Class

Inventories by major class are as follows:

	June 30, 2019		December 31, 2018
Raw materials and supplies	$	258	$	253
Work-in-process	42		37
Finished goods	1,022		960
Total Inventories	$	1,322	$	1,250

XML

Earnings Per Share (Tables)

6 Months Ended

Jun. 30, 2019

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

For the three months ended June 30, 2019 and 2018, earnings per share were as follows:

	Three Months Ended
	June 30, 2019					June 30, 2018
	Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share		Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share
Basic EPS	$	586	859.4	$	0.68	$	637	871.7	$	0.73
Stock options and restricted stock units			2.5					2.3
Diluted EPS	$	586	861.9	$	0.68	$	637	874.0	$	0.73

For the six months ended June 30, 2019 and 2018, earnings per share were as follows:

	Six Months Ended
	June 30, 2019					June 30, 2018
	Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share		Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share
Basic EPS	$	1,146	860.7	$	1.33	$	1,271	873.5	$	1.46
Stock options and restricted stock units			2.0					3.5
Diluted EPS	$	1,146	862.7	$	1.33	$	1,271	877.0	$	1.45

XML

Other Comprehensive Income (Loss) (Tables)

6 Months Ended

Jun. 30, 2019

Equity [Abstract]

Schedule of Comprehensive Income (Loss)

Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the three months ended June 30, 2019 and 2018 were as follows:

	2019						2018
	Pretax			Net of Tax			Pretax			Net of Tax
Cumulative translation adjustments	$	23		$	30		$	(274	)	$	(289	)
Retirement plans and other retiree benefits:
Net actuarial gain (loss) and prior service costs arising during the period	—			—			—			—
Amortization of net actuarial loss, transition and prior service costs (1)	18			13			18			14
Retirement plans and other retiree benefits adjustments	18			13			18			14
Cash flow hedges:
Unrealized gains (losses) on cash flow hedges	(1		)	(1		)	14			10
Reclassification of (gains) losses into net earnings on cash flow hedges (2)	(1		)	(1		)	2			1
Gains (losses) on cash flow hedges	(2		)	(2		)	16			11
Total Other comprehensive income (loss)	$	39		$	41		$	(240	)	$	(264	)

⁽¹⁾ These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 8, Retirement Plans and Other Retiree Benefits for additional details.

⁽²⁾ These (gains) losses are reclassified into Cost of sales. See Note 12, Fair Value Measurements and Financial Instruments for additional details.

Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the six months ended June 30, 2019 and 2018 were as follows:

	2019						2018
	Pretax			Net of Tax			Pretax			Net of Tax
Cumulative translation adjustments	$	50		$	51		$	(178	)	$	(184	)
Retirement plans and other retiree benefits:
Net actuarial gain (loss) and prior service costs arising during the period	(1		)	(1		)	—			—
Amortization of net actuarial loss, transition and prior service costs (1)	35			26			36			28
Retirement plans and other retiree benefits adjustments	34			25			36			28
Cash flow hedges:
Unrealized gains (losses) on cash flow hedges	(3		)	(3		)	6			4
Reclassification of (gains) losses into net earnings on cash flow hedges (2)	(5		)	(4		)	8			6
Gains (losses) on cash flow hedges	(8		)	(7		)	14			10
Total Other comprehensive income (loss)	$	76		$	69		$	(128	)	$	(146	)

⁽¹⁾ These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 8, Retirement Plans and Other Retiree Benefits for additional details.

⁽²⁾ These (gains) losses are reclassified into Cost of sales. See Note 12, Fair Value Measurements and Financial Instruments for additional details.

XML

Retirement Plans and Other Retiree Benefits (Tables)

6 Months Ended

Jun. 30, 2019

Retirement Benefits [Abstract]

Components Of Net Periodic Benefit Cost

Components of Net periodic benefit cost for the three and six months ended June 30, 2019 and 2018 were as follows:

	Pension Benefits												Other Retiree Benefits
	United States						International
	Three Months Ended June 30,
	2019			2018			2019			2018			2019		2018
Service cost	$	—		$	1		$	3		$	3		$	3	$	4
Interest cost	23			22			5			5			9		9
Expected return on plan assets	(24		)	(29		)	(4		)	(5		)	—		—
Amortization of actuarial loss (gain)	12			11			3			2			3		5
Net periodic benefit cost	$	11		$	5		$	7		$	5		$	15	$	18

	Pension Benefits												Other Retiree Benefits
	United States						International
	Six Months Ended June 30,
	2019			2018			2019			2018			2019			2018
Service cost	$	—		$	1		$	7		$	7		$	7		$	8
Interest cost	46			43			10			11			20			19
Expected return on plan assets	(49		)	(58		)	(9		)	(11		)	(1		)	—
Amortization of actuarial loss (gain)	25			23			5			4			5			9
Net periodic benefit cost	$	22		$	9		$	13		$	11		$	31		$	36

XML

Segment Information (Tables)

6 Months Ended

Jun. 30, 2019

Segment Reporting [Abstract]

Net Sales and Operating Profit by Segment

The Company’s Net sales of Oral, Personal and Home Care and Pet Nutrition products accounted for the following percentages of the Company’s Net sales:

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2019		2018		2019		2018
Net sales
Oral Care	45	%	47	%	47	%	48	%
Personal Care	21	%	20	%	19	%	19	%
Home Care	18	%	18	%	18	%	18	%
Pet Nutrition	16	%	15	%	16	%	15	%
Total Net sales	100	%	100	%	100	%	100	%

Operating profit by segment was as follows:

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2019			2018			2019			2018
Operating profit
Oral, Personal and Home Care
North America	$	254		$	264		$	503		$	521
Latin America	251			262			483			535
Europe	148			156			299			318
Asia Pacific	174			203			363			429
Africa/Eurasia	47			42			93			92
Total Oral, Personal and Home Care	874			927			1,741			1,895
Pet Nutrition	167			165			331			329
Corporate	(153		)	(146		)	(305		)	(295		)
Total Operating profit	$	888		$	946		$	1,767		$	1,929

Net sales by segment were as follows:

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2019		2018		2019		2018
Net sales
Oral, Personal and Home Care
North America	$	846	$	824	$	1,699	$	1,651
Latin America	929		933		1,818		1,862
Europe	588		620		1,190		1,268
Asia Pacific	646		674		1,346		1,433
Africa/Eurasia	244		243		484		498
Total Oral, Personal and Home Care	3,253		3,294		6,537		6,712
Pet Nutrition	613		592		1,213		1,176
Total Net sales	$	3,866	$	3,886	$	7,750	$	7,888

XML

Fair Value Measurements and Financial Instruments (Tables)

6 Months Ended

Jun. 30, 2019

Fair Value Disclosures [Abstract]

Schedule of derivative instruments

The following table summarizes the fair value of the Company’s derivative instruments and other financial instruments which are carried at fair value in the Company’s Consolidated Balance Sheets at June 30, 2019 and December 31, 2018:

	Assets					Liabilities
	Account	Fair Value				Account	Fair Value
Designated derivative instruments		June 30, 2019		December 31, 2018			June 30, 2019		December 31, 2018
Interest rate swap contracts	Other current assets	$	—	$	—	Other accruals	$	—	$	1
Interest rate swap contracts	Other assets	4		—		Other liabilities	—		8
Foreign currency contracts	Other current assets	9		20		Other accruals	11		8
Foreign currency contracts	Other assets	—		—		Other liabilities	19		21
Commodity contracts	Other current assets	—		—		Other accruals	—		—
Total designated		$	13	$	20		$	30	$	38
Other financial instruments
Marketable securities	Other current assets	$	66	$	10
Total other financial instruments		$	66	$	10

Schedule of hedged item and cumulative adjustment to carrying amount

The following amounts were recorded on the Condensed Consolidated Balance Sheet related to cumulative basis adjustment for fair value hedges as of:

	June 30, 2019		December 31, 2018
Long-term debt:
Carrying amount of hedged item	$	402	$	888
Cumulative hedging adjustment included in the carrying amount	4		(10		)

Schedule of notional values

The following tables present the notional values as of:

	June 30, 2019
	Foreign Currency Contracts		Foreign Currency Debt		Interest Rate Swaps		Commodity Contracts		Total
Fair Value Hedges	$	355	$	—	$	400	$	—	$	755
Cash Flow Hedges	744		—		—		16		760
Net Investment Hedges	544		2,189		—		—		2,733

	December 31, 2018
	Foreign Currency Contracts		Foreign Currency Debt		Interest Rate Swaps		Commodity Contracts		Total
Fair Value Hedges	$	327	$	—	$	900	$	—	$	1,227
Cash Flow Hedges	782		—		—		14		796
Net Investment Hedges	482		1,396		—		—		1,878

Schedule of gains (losses) recognized in Statements of Income

The following tables present the location and amount of gains (losses) recognized on the Company’s Condensed Consolidated Statements of Income:

	Three Months Ended June 30,
	2019								2018
	Cost of sales		Selling, general and administrative expenses			Interest (income) expense, net			Cost of sales			Selling, general and administrative expenses			Interest (income) expense, net
Gain (loss) on hedges recognized in income:
Interest rate swaps designated as fair value hedges:
Derivative instrument	$	—	$	—		$	(10	)	$	—		$	—		$	(1	)
Hedged items	—		—			10			—			—			1
Foreign currency contracts designated as fair value hedges:
Derivative instrument	—		11			—			—			6			—
Hedged items	—		(11		)	—			—			(6		)	—
Foreign currency contracts designated as cash flow hedges:
Amount reclassified from OCI	1		—			—			(2		)	—			—
Commodity contracts designated as cash flow hedges:
Amount reclassified from OCI	—		—			—			—			—			—
Total gain (loss) on hedges recognized in income	$	1	$	—		$	—		$	(2	)	$	—		$	—

	Six Months Ended June 30,
	2019								2018
	Cost of sales		Selling, general and administrative expenses			Interest (income) expense, net			Cost of sales			Selling, general and administrative expenses			Interest (income) expense, net
Gain (loss) on hedges recognized in income:
Interest rate swaps designated as fair value hedges:
Derivative instrument	$	—	$	—		$	(13	)	$	—		$	—		$	(11	)
Hedged items	—		—			13			—			—			11
Foreign currency contracts designated as fair value hedges:
Derivative instrument	—		10			—			—			(7		)	—
Hedged items	—		(10		)	—			—			7			—
Foreign currency contracts designated as cash flow hedges:
Amount reclassified from OCI	4		—			—			(8		)	—			—
Commodity contracts designated as cash flow hedges:
Amount reclassified from OCI	1		—			—			—			—			—
Total gain (loss) on hedges recognized in income	$	5	$	—		$	—		$	(8	)	$	—		$	—

Schedule of gains (losses) included in Other Comprehensive Income

The following tables present the location and amount of unrealized gains (losses) included in OCI:

	Three Months Ended
	June 30,
	2019			2018
Foreign currency contracts designated as cash flow hedges:
Gain (loss) recognized in OCI	$	(2	)	$	14
Commodity contracts designated as cash flow hedges:
Gain (loss) recognized in OCI	1			—
Foreign currency contracts designated as net investment hedges:
Gain (loss) on instruments	(7		)	43
Gain (loss) on hedged items	7			(41		)
Foreign currency debt designated as net investment hedges:
Gain (loss) on instruments	(24		)	78
Gain (loss) on hedged items	24			(78		)
Total unrealized gain (loss) on hedges recognized in OCI	$	(1	)	$	16

	Six Months Ended
	June 30,
	2019			2018
Foreign currency contracts designated as cash flow hedges:
Gain (loss) recognized in OCI	$	(5	)	$	6
Commodity contracts designated as cash flow hedges:
Gain (loss) recognized in OCI	2			—
Foreign currency contracts designated as net investment hedges:
Gain (loss) on instruments	(1		)	25
Gain (loss) on hedged items	1			(23		)
Foreign currency debt designated as net investment hedges:
Gain (loss) on instruments	5			59
Gain (loss) on hedged items	(5		)	(59		)
Total unrealized gain (loss) on hedges recognized in OCI	$	(3	)	$	8

XML

Leases (Tables)

6 Months Ended

Jun. 30, 2019

Leases [Abstract]

Schedule of Right-of-use Assets and Liabilities for Operating Leases

As of June 30, 2019, the Company’s right-of use assets and liabilities for operating leases were as follows:

Other assets	$	548
Other accruals	$	153
Other liabilities	530
Total operating lease liabilities	$	683

Schedule of Minimum Lease Commitments Under Noncancellable Operating Leases

Lease commitments under noncancellable operating leases were as follows:

Years Ending December 31,	As of June 30, 2019				As of December 31, 2018
2019	$	95		(1)	$	193
2020	155				165
2021	119				123
2022	96				102
2023	60				51
Thereafter	275				32
Total lease commitments	$	800			$	666
Less: Interest	(117		)
Present value of lease liabilities	$	683

⁽¹⁾ As of June 30, 2019, $95 represents the lease commitments for the six months remaining until December 31, 2019.

Schedule of Components of Operating Lease Expense

The components of the Company’s operating lease cost for the three and six months ended June 30, 2019 were as follows:

	Three Months Ended June 30, 2019		Six Months Ended June 30, 2019
Operating lease cost	$	38	$	83
Short-term lease cost	—		2
Variable lease cost	6		16
Sublease income	—		—
Total lease cost	$	44	$	101

XML

Recent Accounting Pronouncements (Details) - USD ($) $ in Millions	Jun. 30, 2019	Jan. 01, 2019
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Operating lease, right-of-use assets	$ 548
Operating lease, liability	$ 683
Accounting Standards Update 2016-02
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Operating lease, right-of-use assets		$ 458
Operating lease, liability		$ 574

XML

Restructuring and Related Implementation Charges - Narrative (Details) - Global Growth and Efficiency Program $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2019 USD ($)	Jun. 30, 2018 USD ($)	Jun. 30, 2019 USD ($) position	Jun. 30, 2018 USD ($)
Restructuring Cost and Reserve [Line Items]
Expected percent of total charges resulting in cash expenditure	75.00%		75.00%
Charges against assets	$ 34		$ 46
Total Global Growth and Efficiency Program charges, pretax	$ 42	$ 61	$ 71	$ 89
Hill’s Pet Nutrition
Restructuring Cost and Reserve [Line Items]
Expected percent of total restructuring charges related to segment for the duration of the program	10.00%		10.00%
Corporate
Restructuring Cost and Reserve [Line Items]
Expected percent of total restructuring charges related to segment for the duration of the program	40.00%		40.00%
North America
Restructuring Cost and Reserve [Line Items]
Expected percent of total restructuring charges related to segment for the duration of the program	15.00%		15.00%
Europe
Restructuring Cost and Reserve [Line Items]
Expected percent of total restructuring charges related to segment for the duration of the program	20.00%		20.00%
Latin America
Restructuring Cost and Reserve [Line Items]
Expected percent of total restructuring charges related to segment for the duration of the program	5.00%		5.00%
Asia Pacific
Restructuring Cost and Reserve [Line Items]
Expected percent of total restructuring charges related to segment for the duration of the program	5.00%		5.00%
Africa/Eurasia
Restructuring Cost and Reserve [Line Items]
Expected percent of total restructuring charges related to segment for the duration of the program	5.00%		5.00%
Employee-Related Costs
Restructuring Cost and Reserve [Line Items]
Estimated percent of total cumulative pretax charges of implementing restructuring program by category	40.00%		40.00%
Charges against assets	$ 2		$ 3
Total Global Growth and Efficiency Program charges, pretax	$ 4		$ 14
Incremental Depreciation And Asset Impairment
Restructuring Cost and Reserve [Line Items]
Estimated percent of total cumulative pretax charges of implementing restructuring program by category	10.00%		10.00%
Charges Resulting Directly From Exit Activities
Restructuring Cost and Reserve [Line Items]
Estimated percent of total cumulative pretax charges of implementing restructuring program by category	30.00%		30.00%
Implementation Of New Strategies
Restructuring Cost and Reserve [Line Items]
Estimated percent of total cumulative pretax charges of implementing restructuring program by category	20.00%		20.00%
Third party Incremental Cost
Restructuring Cost and Reserve [Line Items]
Total Global Growth and Efficiency Program charges, pretax	$ 5		$ 10
Contract Termination
Restructuring Cost and Reserve [Line Items]
Total Global Growth and Efficiency Program charges, pretax	0		3
Other Exit Costs
Restructuring Cost and Reserve [Line Items]
Total Global Growth and Efficiency Program charges, pretax	28		28
Minimum | Expected Completion Date 2019
Restructuring Cost and Reserve [Line Items]
Restructuring program expected cost before tax	1,820		1,820
Restructuring program expected cost after tax	1,350		1,350
Restructuring program expected cost, current fiscal year, before tax	100		100
Restructuring program expected cost, current fiscal year, after tax	70		$ 70
Restructuring and related cost, expected number of positions eliminated (in positions) | position			4,000
Maximum | Expected Completion Date 2019
Restructuring Cost and Reserve [Line Items]
Restructuring program expected cost before tax	1,870		$ 1,870
Restructuring program expected cost after tax	1,380		1,380
Restructuring program expected cost, current fiscal year, before tax	150		150
Restructuring program expected cost, current fiscal year, after tax	$ 100		$ 100
Restructuring and related cost, expected number of positions eliminated (in positions) | position			4,400

XML

Restructuring and Related Implementation Charges - Summary of Restructuring and Related Costs (Details) - Global Growth and Efficiency Program - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Restructuring Cost and Reserve [Line Items]
Total Global Growth and Efficiency Program charges, pretax	$ 42	$ 61	$ 71	$ 89
Total Global Growth and Efficiency Program charges, aftertax	31	51	53	71
Cost of sales
Restructuring Cost and Reserve [Line Items]
Total Global Growth and Efficiency Program charges, pretax	(3)	5	8	11
Selling, general and administrative expenses
Restructuring Cost and Reserve [Line Items]
Total Global Growth and Efficiency Program charges, pretax	10	10	14	15
Other (income) expense, net
Restructuring Cost and Reserve [Line Items]
Total Global Growth and Efficiency Program charges, pretax	33	43	46	56
Non-service related postretirement costs
Restructuring Cost and Reserve [Line Items]
Total Global Growth and Efficiency Program charges, pretax	$ 2	$ 3	$ 3	$ 7

XML

Restructuring and Related Implementation Charges - Restructuring Charges Incurred, by Segment (Details) - Global Growth and Efficiency Program	3 Months Ended		6 Months Ended		81 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019
Restructuring Cost and Reserve [Line Items]
Percent of Total Restructuring Charges Related to Segment	100.00%	100.00%	100.00%	100.00%
Percent of Restructuring Charges Related to Segment, Program-to-date Accumulated Charges					100.00%
Hill’s Pet Nutrition
Restructuring Cost and Reserve [Line Items]
Percent of Total Restructuring Charges Related to Segment	1.00%	22.00%	6.00%	21.00%
Percent of Restructuring Charges Related to Segment, Program-to-date Accumulated Charges					8.00%
Corporate
Restructuring Cost and Reserve [Line Items]
Percent of Total Restructuring Charges Related to Segment	89.00%	56.00%	63.00%	42.00%
Percent of Restructuring Charges Related to Segment, Program-to-date Accumulated Charges					41.00%
North America
Restructuring Cost and Reserve [Line Items]
Percent of Total Restructuring Charges Related to Segment	0.00%	8.00%	3.00%	17.00%
Percent of Restructuring Charges Related to Segment, Program-to-date Accumulated Charges					18.00%
Latin America
Restructuring Cost and Reserve [Line Items]
Percent of Total Restructuring Charges Related to Segment	8.00%	11.00%	21.00%	11.00%
Percent of Restructuring Charges Related to Segment, Program-to-date Accumulated Charges					5.00%
Europe
Restructuring Cost and Reserve [Line Items]
Percent of Total Restructuring Charges Related to Segment	(3.00%)	2.00%	1.00%	2.00%
Percent of Restructuring Charges Related to Segment, Program-to-date Accumulated Charges					19.00%
Asia Pacific
Restructuring Cost and Reserve [Line Items]
Percent of Total Restructuring Charges Related to Segment	7.00%	(6.00%)	7.00%	1.00%
Percent of Restructuring Charges Related to Segment, Program-to-date Accumulated Charges					4.00%
Africa/Eurasia
Restructuring Cost and Reserve [Line Items]
Percent of Total Restructuring Charges Related to Segment	(2.00%)	7.00%	(1.00%)	6.00%
Percent of Restructuring Charges Related to Segment, Program-to-date Accumulated Charges					5.00%

XML

Restructuring and Related Implementation Charges - Summary of Restructuring Charges, Cumulative to Date (Details) - Global Growth and Efficiency Program $ in Millions	Jun. 30, 2019 USD ($)
Restructuring Cost and Reserve [Line Items]
Pretax charges related to the Restructuring Program to date	$ 1,793
Aftertax charges related to the Restructuring Program to date	1,331
Employee-Related Costs
Restructuring Cost and Reserve [Line Items]
Pretax charges related to the Restructuring Program to date	695
Incremental Depreciation
Restructuring Cost and Reserve [Line Items]
Pretax charges related to the Restructuring Program to date	102
Asset Impairments
Restructuring Cost and Reserve [Line Items]
Pretax charges related to the Restructuring Program to date	58
Other
Restructuring Cost and Reserve [Line Items]
Pretax charges related to the Restructuring Program to date	$ 938

XML

Restructuring and Related Implementation Charges - Restructuring Activity and Related Accruals (Details) - Global Growth and Efficiency Program - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Restructuring Reserve [Roll Forward]
Beginning Balance	$ 146		$ 202
Charges	42	$ 61	71	$ 89
Cash payments	(26)		(50)
Charges against assets	(34)		(46)
Foreign exchange	(1)		(2)
Other	0		(48)
Ending Balance	127		127
Employee-Related Costs
Restructuring Reserve [Roll Forward]
Beginning Balance	52		60
Charges	4		14
Cash payments	(12)		(28)
Charges against assets	(2)		(3)
Foreign exchange	(1)		(2)
Other	0		0
Ending Balance	41		41
Incremental Depreciation
Restructuring Reserve [Roll Forward]
Beginning Balance	0		0
Charges	5		10
Cash payments	0		0
Charges against assets	(5)		(10)
Foreign exchange	0		0
Other	0		0
Ending Balance	0		0
Asset Impairments
Restructuring Reserve [Roll Forward]
Beginning Balance	0		0
Charges	0		6
Cash payments	0		0
Charges against assets	0		(6)
Foreign exchange	0		0
Other	0		0
Ending Balance	0		0
Other
Restructuring Reserve [Roll Forward]
Beginning Balance	94		142
Charges	33		41
Cash payments	(14)		(22)
Charges against assets	(27)		(27)
Foreign exchange	0		0
Other	0		(48)
Ending Balance	$ 86		$ 86

XML

Inventories (Details) - USD ($) $ in Millions	Jun. 30, 2019	Dec. 31, 2018
Inventory, Net, Items Net of Reserve Alternative [Abstract]
Raw materials and supplies	$ 258	$ 253
Work-in-process	42	37
Finished goods	1,022	960
Total Inventories	$ 1,322	$ 1,250

XML

Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Net income attributable to Colgate-Palmolive Company
Basic EPS	$ 586	$ 637	$ 1,146	$ 1,271
Diluted EPS	$ 586	$ 637	$ 1,146	$ 1,271
Shares
Basic EPS (in shares)	859,400,000	871,700,000	860,700,000	873,500,000
Stock options and restricted stock units (in shares)	2,500,000	2,300,000	2,000,000.0	3,500,000
Diluted EPS (in shares)	861,900,000	874,000,000.0	862,700,000	877,000,000.0
Per Share
Basic EPS (in dollars per share)	$ 0.68	$ 0.73	$ 1.33	$ 1.46
Diluted EPS (in dollars per share)	$ 0.68	$ 0.73	$ 1.33	$ 1.45
Antidilutive securities excluded from computation of earnings per share (in shares)	18,334,488	16,303,599	21,751,174	16,284,602

XML

Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions	3 Months Ended				6 Months Ended
	Jun. 30, 2019		Jun. 30, 2018		Jun. 30, 2019		Jun. 30, 2018
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total Other comprehensive income (loss), net of tax	$ 36		$ (280)		$ 69		$ (160)
Cumulative translation adjustments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss), Pretax	23		(274)		50		(178)
Total Other comprehensive income (loss), net of tax	30		(289)		51		(184)
Retirement plans and other retiree benefits adjustments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss), before reclassifications, Pretax	0		0		(1)		0
Reclassification from AOCI, Pretax	18		18		35		36
Other comprehensive income (loss), Pretax	18		18		34		36
Other comprehensive income (loss), before reclassifications, Net of Tax	0		0		(1)		0
Reclassification from AOCI, Net of Tax	13		14		26		28
Total Other comprehensive income (loss), net of tax	13		14		25		28
Gains (losses) on cash flow hedges
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss), before reclassifications, Pretax	(1)				(3)
Reclassification from AOCI, Pretax	(1)				(5)
Other comprehensive income (loss), Pretax	(2)				(8)
Other comprehensive income (loss), before reclassifications, Net of Tax	(1)				(3)
Reclassification from AOCI, Net of Tax	(1)				(4)
Total Other comprehensive income (loss), net of tax	(2)				(7)
Gains (losses) on cash flow hedges
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss), before reclassifications, Pretax			14				6
Reclassification from AOCI, Pretax			2				8
Other comprehensive income (loss), Pretax			16				14
Other comprehensive income (loss), before reclassifications, Net of Tax			10				4
Reclassification from AOCI, Net of Tax			1				6
Total Other comprehensive income (loss), net of tax			11				10
Total Other comprehensive income (loss)
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss), Pretax	39		(240)		76		(128)
Total Other comprehensive income (loss), net of tax	$ 41	[1]	$ (264)	[1]	$ 69	[2]	$ (146)	[2]

[1] Accumulated other comprehensive income (loss) includes cumulative translation losses of $3,104 at June 30, 2019 ($3,121 at June 30, 2018) and $3,134 at March 31, 2019 ($2,832 at March 31, 2018), respectively, and unrecognized retirement plan and other retiree benefits costs of $1,013 at June 30, 2019 ($1,048 at June 30, 2018) and $1,026 at March 31, 2019 ($1,062 at March 31, 2018), respectively.

[2] Accumulated other comprehensive income (loss) includes cumulative translation losses of $3,104 at June 30, 2019 ($3,121 at June 30, 2018) and $3,155 at December 31, 2018 ($2,927 at December 31, 2017), respectively, and unrecognized retirement plan and other retiree benefits costs of $1,013 at June 30, 2019 ($1,048 at June 30, 2018) and $1,038 at December 31, 2018 ($923 at December 31, 2017), respectively.

XML

Retirement Plans and Other Retiree Benefits (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Other Retiree Benefits
Components of net periodic benefit cost
Service cost	$ 3	$ 4	$ 7	$ 8
Interest cost	9	9	20	19
Expected return on plan assets	0	0	(1)	0
Amortization of actuarial loss (gain)	3	5	5	9
Net periodic benefit cost	15	18	31	36
United States | Pension Benefits
Components of net periodic benefit cost
Service cost	0	1	0	1
Interest cost	23	22	46	43
Expected return on plan assets	(24)	(29)	(49)	(58)
Amortization of actuarial loss (gain)	12	11	25	23
Net periodic benefit cost	11	5	22	9
Voluntary benefit plan contribution			102	0
International | Pension Benefits
Components of net periodic benefit cost
Service cost	3	3	7	7
Interest cost	5	5	10	11
Expected return on plan assets	(4)	(5)	(9)	(11)
Amortization of actuarial loss (gain)	3	2	5	4
Net periodic benefit cost	$ 7	$ 5	$ 13	$ 11

XML

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Charge for U.S. tax reform	$ 275
Charge for U.S. tax reform		$ 80

XML

Contingencies (Details) $ in Millions	1 Months Ended		3 Months Ended	6 Months Ended
	Sep. 30, 2015 appeal	Dec. 31, 2014 USD ($) company	Jun. 30, 2019 USD ($) case	Jun. 30, 2019 USD ($) case country_and_territory	Apr. 30, 2019 USD ($)	Mar. 31, 2019 case	Dec. 31, 2018 case	Jul. 21, 2017 USD ($)
Loss Contingencies [Line Items]
Minimum number of countries and territories serving consumers (more than) (in countries and territories) | country_and_territory				200
Brazilian internal revenue authority, matter 1			$ 158.0	$ 158.0
Loss contingency, number of cases on appeal | case				1
Loss contingency, number of appeals lost (in appeals) | appeal	1
Brazilian internal revenue authority, matter 2			$ 66.0	$ 66.0
Number of consumer goods companies | company		13
Fine imposed french competition authority		$ 57.0
Fine imposed french competition authority - as a result of Sanex acquisition		$ 25.0
Fine imposed by greek competition authority					$ 10.5			$ 11.0
Loss contingency, pending claims, number (in cases) | case			237	237		229	239
Loss contingency, new claims filed, number (in cases) | case			25	62
Loss contingency, claims dismissed or settled, number (in cases) | case			17	64
Minimum
Loss Contingencies [Line Items]
Loss contingency, possible loss			$ 0.0	$ 0.0
Maximum
Loss Contingencies [Line Items]
Loss contingency, possible loss			$ 225.0	$ 225.0

XML

Segment Information - Narrative (Details) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2019 USD ($)	Jun. 30, 2018 USD ($)	Jun. 30, 2019 USD ($) segment	Jun. 30, 2018 USD ($)
Segment Reporting Information [Line Items]
Number of product segments (in segments)			2
Number of reportable segments (in segments)			5
Number of operating segments (in segments)			5
Sales Revenue, Net
Segment Reporting Information [Line Items]
Percentage of consolidated Net sales represented by sales outside US	70.00%		70.00%
Percentage of consolidated Net sales coming from emerging markets	50.00%		50.00%
Global Growth and Efficiency Program
Segment Reporting Information [Line Items]
Total Global Growth and Efficiency Program charges, pretax | $	$ 42	$ 61	$ 71	$ 89
Global Growth and Efficiency Program | Corporate | Included in Operating profit (loss)
Segment Reporting Information [Line Items]
Total Global Growth and Efficiency Program charges, pretax | $	$ 40	$ 58	$ 68	$ 82

XML

Segment Information - Schedule of Segment Information (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Segment Reporting Information [Line Items]
Total Net sales	$ 3,866	$ 3,886	$ 7,750	$ 7,888
Total Operating profit	888	946	1,767	1,929
Operating Segments | Oral, Personal and Home Care
Segment Reporting Information [Line Items]
Total Net sales	3,253	3,294	6,537	6,712
Total Operating profit	874	927	1,741	1,895
Operating Segments | Oral, Personal and Home Care | North America
Segment Reporting Information [Line Items]
Total Net sales	846	824	1,699	1,651
Total Operating profit	254	264	503	521
Operating Segments | Oral, Personal and Home Care | Latin America
Segment Reporting Information [Line Items]
Total Net sales	929	933	1,818	1,862
Total Operating profit	251	262	483	535
Operating Segments | Oral, Personal and Home Care | Europe
Segment Reporting Information [Line Items]
Total Net sales	588	620	1,190	1,268
Total Operating profit	148	156	299	318
Operating Segments | Oral, Personal and Home Care | Asia Pacific
Segment Reporting Information [Line Items]
Total Net sales	646	674	1,346	1,433
Total Operating profit	174	203	363	429
Operating Segments | Oral, Personal and Home Care | Africa/Eurasia
Segment Reporting Information [Line Items]
Total Net sales	244	243	484	498
Total Operating profit	47	42	93	92
Operating Segments | Pet Nutrition
Segment Reporting Information [Line Items]
Total Net sales	613	592	1,213	1,176
Total Operating profit	167	165	331	329
Corporate
Segment Reporting Information [Line Items]
Total Operating profit	$ (153)	$ (146)	$ (305)	$ (295)
Product Concentration Risk | Sales Revenue, Net
Segment Reporting Information [Line Items]
Percent of net sales	100.00%	100.00%	100.00%	100.00%
Product Concentration Risk | Oral Care | Sales Revenue, Net
Segment Reporting Information [Line Items]
Percent of net sales	45.00%	47.00%	47.00%	48.00%
Product Concentration Risk | Personal Care | Sales Revenue, Net
Segment Reporting Information [Line Items]
Percent of net sales	21.00%	20.00%	19.00%	19.00%
Product Concentration Risk | Home Care | Sales Revenue, Net
Segment Reporting Information [Line Items]
Percent of net sales	18.00%	18.00%	18.00%	18.00%
Product Concentration Risk | Pet Nutrition | Sales Revenue, Net
Segment Reporting Information [Line Items]
Percent of net sales	16.00%	15.00%	16.00%	15.00%

XML

Fair Value Measurements and Financial Instruments - Fair Value of Derivative Instruments and Other Financial Instruments (Details) - USD ($) $ in Millions	Jun. 30, 2019	Dec. 31, 2018
Designated derivative instruments
Derivative assets, designated	$ 13	$ 20
Derivative liabilities, designated	30	38
Other financial instruments
Total other financial instruments	66	10
Other current assets
Other financial instruments
Marketable securities	66	10
Other current assets | Interest rate swap contracts
Designated derivative instruments
Derivative assets, designated	0	0
Other current assets | Foreign currency contracts
Designated derivative instruments
Derivative assets, designated	9	20
Other current assets | Commodity contracts
Designated derivative instruments
Derivative assets, designated	0	0
Other assets | Interest rate swap contracts
Designated derivative instruments
Derivative assets, designated	4	0
Other assets | Foreign currency contracts
Designated derivative instruments
Derivative assets, designated	0	0
Other accruals | Interest rate swap contracts
Designated derivative instruments
Derivative liabilities, designated	0	1
Other accruals | Foreign currency contracts
Designated derivative instruments
Derivative liabilities, designated	11	8
Other accruals | Commodity contracts
Designated derivative instruments
Derivative liabilities, designated	0	0
Other liabilities | Interest rate swap contracts
Designated derivative instruments
Derivative liabilities, designated	0	8
Other liabilities | Foreign currency contracts
Designated derivative instruments
Derivative liabilities, designated	$ 19	$ 21

XML

Fair Value Measurements and Financial Instruments - Carrying Value and Estimated Fair Value of Long-term Debt (Details) - USD ($) $ in Millions	Jun. 30, 2019	Dec. 31, 2018
Long-term Debt
Debt Instrument [Line Items]
Carrying amount of hedged item	$ 402	$ 888
Cumulative hedging adjustment included in the carrying amount	4	(10)
Carrying Value
Debt Instrument [Line Items]
Carrying value of long-term debt	6,641	6,354
Fair Value, Inputs, Level 2
Debt Instrument [Line Items]
Estimated fair value of long-term debt	$ 6,545	$ 6,434

XML

Fair Value Measurements and Financial Instruments - Schedule of Notional Values (Details) - USD ($) $ in Millions	Jun. 30, 2019	Dec. 31, 2018
Fair Value Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Notional values	$ 755	$ 1,227
Fair Value Hedges | Foreign Currency Contracts
Derivative Instruments, Gain (Loss) [Line Items]
Notional values	355	327
Fair Value Hedges | Foreign Currency Debt
Derivative Instruments, Gain (Loss) [Line Items]
Notional values	0	0
Fair Value Hedges | Interest Rate Swaps
Derivative Instruments, Gain (Loss) [Line Items]
Notional values	400	900
Fair Value Hedges | Commodity Contracts
Derivative Instruments, Gain (Loss) [Line Items]
Notional values	0	0
Cash Flow Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Notional values	760	796
Cash Flow Hedges | Foreign Currency Contracts
Derivative Instruments, Gain (Loss) [Line Items]
Notional values	744	782
Cash Flow Hedges | Foreign Currency Debt
Derivative Instruments, Gain (Loss) [Line Items]
Notional values	0	0
Cash Flow Hedges | Interest Rate Swaps
Derivative Instruments, Gain (Loss) [Line Items]
Notional values	0	0
Cash Flow Hedges | Commodity Contracts
Derivative Instruments, Gain (Loss) [Line Items]
Notional values	16	14
Net Investment Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Notional values	2,733	1,878
Net Investment Hedges | Foreign Currency Contracts
Derivative Instruments, Gain (Loss) [Line Items]
Notional values	544	482
Net Investment Hedges | Foreign Currency Debt
Derivative Instruments, Gain (Loss) [Line Items]
Notional values	2,189	1,396
Net Investment Hedges | Interest Rate Swaps
Derivative Instruments, Gain (Loss) [Line Items]
Notional values	0	0
Net Investment Hedges | Commodity Contracts
Derivative Instruments, Gain (Loss) [Line Items]
Notional values	$ 0	$ 0

XML

Fair Value Measurements and Financial Instruments - Schedule of Gain (Loss) on Hedges Recognized in Income (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Cost of sales
Derivative Instruments, Gain (Loss) [Line Items]
Total gain (loss) on hedges recognized in income	$ 1	$ (2)	$ 5	$ (8)
Cost of sales | Interest Rate Swaps
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative instrument	0	0	0	0
Gain (loss) on hedged items	0	0	0	0
Cost of sales | Foreign Currency Contracts
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative instrument	0	0	0	0
Gain (loss) on hedged items	0	0	0	0
Amount reclassified from OCI	1		4
Cost of sales | Commodity contracts
Derivative Instruments, Gain (Loss) [Line Items]
Amount reclassified from OCI	0		1
Cost of sales | Cash Flow Hedges | Foreign Currency Contracts
Derivative Instruments, Gain (Loss) [Line Items]
Amount reclassified from OCI		(2)		(8)
Cost of sales | Cash Flow Hedges | Commodity contracts
Derivative Instruments, Gain (Loss) [Line Items]
Amount reclassified from OCI		0		0
Selling, general and administrative expenses
Derivative Instruments, Gain (Loss) [Line Items]
Total gain (loss) on hedges recognized in income	0	0	0	0
Selling, general and administrative expenses | Interest Rate Swaps
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative instrument	0	0	0	0
Gain (loss) on hedged items	0	0	0	0
Selling, general and administrative expenses | Foreign Currency Contracts
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative instrument	11	6	10	(7)
Gain (loss) on hedged items	(11)	(6)	(10)	7
Amount reclassified from OCI	0		0
Selling, general and administrative expenses | Commodity contracts
Derivative Instruments, Gain (Loss) [Line Items]
Amount reclassified from OCI	0		0
Selling, general and administrative expenses | Cash Flow Hedges | Foreign Currency Contracts
Derivative Instruments, Gain (Loss) [Line Items]
Amount reclassified from OCI		0		0
Selling, general and administrative expenses | Cash Flow Hedges | Commodity contracts
Derivative Instruments, Gain (Loss) [Line Items]
Amount reclassified from OCI		0		0
Interest (income) expense, net
Derivative Instruments, Gain (Loss) [Line Items]
Total gain (loss) on hedges recognized in income	0	0	0	0
Interest (income) expense, net | Interest Rate Swaps
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative instrument	(10)	(1)	(13)	(11)
Gain (loss) on hedged items	10	1	13	11
Interest (income) expense, net | Foreign Currency Contracts
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative instrument	0	0	0	0
Gain (loss) on hedged items	0	0	0	0
Amount reclassified from OCI	0		0
Interest (income) expense, net | Commodity contracts
Derivative Instruments, Gain (Loss) [Line Items]
Amount reclassified from OCI	$ 0		$ 0
Interest (income) expense, net | Cash Flow Hedges | Foreign Currency Contracts
Derivative Instruments, Gain (Loss) [Line Items]
Amount reclassified from OCI		0		0
Interest (income) expense, net | Cash Flow Hedges | Commodity contracts
Derivative Instruments, Gain (Loss) [Line Items]
Amount reclassified from OCI		$ 0		$ 0

XML

Fair Value Measurements and Financial Instruments - Schedule of Gain (Loss) Included in OCI (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Cash flow hedges [Abstract]
Gain (loss) recognized in OCI	$ (1)		$ (3)
Gain (loss) recognized in OCI		$ 16		$ 8
Foreign Currency Contracts
Cash flow hedges [Abstract]
Gain (loss) recognized in OCI	(2)		(5)
Gain (loss) recognized in OCI		14		6
Net investment hedges [Abstract]
Gain (loss) on instruments	(7)		(1)
Gain (loss) on instruments		43		25
Gain (loss) on hedged items	7		1
Gain (loss) on hedged items		(41)		(23)
Commodity Contracts
Cash flow hedges [Abstract]
Gain (loss) recognized in OCI	1		2
Gain (loss) recognized in OCI		0		0
Foreign Currency Debt
Net investment hedges [Abstract]
Gain (loss) on instruments	(24)		5
Gain (loss) on instruments		78		59
Gain (loss) on hedged items	$ 24		$ (5)
Gain (loss) on hedged items		$ (78)		$ (59)

XML

Leases - Narrative (Details) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2019	Jan. 01, 2019
Lessee, Lease, Description [Line Items]
Operating lease, right-of-use assets	$ 548
Operating lease, liability	683
Operating cash flows paid for amounts included in the measurement of lease liabilities	102
Lease assets obtained in exchange for lease liabilities	$ 209
Operating lease, weighted-average remaining lease term	8 years
Operating lease, weighted-average discount rate	4.00%
Accounting Standards Update 2016-02
Lessee, Lease, Description [Line Items]
Operating lease, right-of-use assets		$ 458
Operating lease, liability		$ 574

XML

Leases - Balance Sheet (Details) $ in Millions	Jun. 30, 2019 USD ($)
Leases [Abstract]
Other assets	$ 548
Other accruals	153
Other liabilities	530
Total operating lease liabilities	$ 683

XML

Leases - Schedule of Minimum Lease Commitments (Details) - USD ($) $ in Millions	Jun. 30, 2019	Dec. 31, 2018
As of June 30, 2019
2019	$ 95
2020	155
2021	119
2022	96
2023	60
Thereafter	275
Total lease commitments	800
Less: Interest	(117)
Present value of lease liabilities	$ 683
As of December 31, 2018
2019		$ 193
2020		165
2021		123
2022		102
2023		51
Thereafter		32
Total lease commitments		$ 666

XML

Leases - Schedule of Lease Cost (Details) - USD ($) $ in Millions	3 Months Ended	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2019
Leases [Abstract]
Operating lease cost	$ 38	$ 83
Short-term lease cost	0	2
Variable lease cost	6	16
Sublease income	0	0
Total lease cost	$ 44	$ 101

XML

Subsequent Events (Details) - Subsequent Event - Laboratoires Filorga Cosmétiques € in Millions, $ in Millions	Jul. 11, 2019 USD ($)	Jul. 11, 2019 EUR (€)
Subsequent Event [Line Items]
Payments to acquire business	$ 1,690	€ 1,495.5
Annual interest rate	2.00%	2.00%